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ABSTRACT OF DISSERTATION 
 
 
 
 
INFLUENCES OF CHROMIUM (III) PICOLINATE ON PIGS UNDER  
THERMAL, IMMUNE OR DIETARY STRESS, AND  
ON ADRENAL STEROID SECRETION 
 
The objectives were to investigate the effects of chromium (III) picolinate (CrPic; 
up to 2,000 ppb of Cr) on growing pigs subjected to a variety of stressors including 
thermal, immune, or dietary stress and to examine the effects of CrPic on steroidogenesis 
from adrenocortical cells. In the thermal stress study, high ambient temperature caused 
reduced weight gain and feed consumption (P < 0.01), and low ambient temperature 
caused increased feed intake and feed:gain (P < 0.01). However, these effects were not 
moderated by CrPic, and respiratory rate, plasma cortisol, or plasma glucose were 
unaffected by CrPic. In the immune stress study, pigs challenged with lipopolysaccharide 
(LPS) lost 951 g during 12 hours post injection, while the phosphate buffer saline (PBS) 
injected group gained 170 g (P < 0.001). The LPS group showed higher rectal 
temperature (P < 0.05), higher respiratory rate (P < 0.05), greater plasma cortisol (P < 
0.001), and lower plasma glucose (P < 0.05) than the PBS group. These effects were not 
ameliorated by CrPic. In the dietary stress study, pigs fed the high-fat diet (HFD) gained 
weight faster (P < 0.05), consumed less feed (P < 0.001), and had lower feed:gain (P < 
0.001). Plasma insulin concentration on d 14 decreased with CrPic (P < 0.05) in a linear 
manner (P = 0.05). Consumption of the HFD resulted in increases of slaughter weight, 
perirenal fat, and back fat measurements (P < 0.01). The CrPic resulted in linear 
reductions of carcass weight, last rib fat, last lumbar fat and average backfat (P < 0.10). 
The effects of CrPic on carcass fat measurements were more significant in barrows than 
gilts. In the adrenocortical cell study, forskolin stimulated cortisol and DHEAs secretion 
from H295R cells. CrPic inhibited aspects of steroidogenesis in agonist-stimulated 
adrenocortical cells. Overall, dietary CrPic was unable to moderate the stress related 
effects due to high ambient temperature, low ambient temperature, or an endotoxin 
challenge. However, CrPic attenuated effects of HFD, mainly on body fat accretion of 
pigs, especially in barrows, and CrPic inhibited steroidogenesis in stimulated 
adrenocorticoid cells. 
 
KEYWORDS: Chromium (III) Picolinate, Thermal Stress, Immune Stress, High-Fat-
Diets, Adrenal Steroids 
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논문 초록 
 
 
 
 
크롬 피콜리네이트가 온도, 면역, 혹은 영양 스트레스하의 돼지  
및 부신 스테로이드 호르몬의 분비에 미치는 영향 
 
일련의 실험을 통해 사료내 크롬 피콜리네이트가 온도, 면역, 혹은 영양 
스트레스하의 돼지 및 부신 스테로이드 호르몬의 분비에 미치는 영향이 연구 되었다. 온도 
스트레스 실험 (제 3 장)의 경우 높은 환경온도에서 증체 및 사료 섭취량이 낮았고 (P < 
0.01), 낮은 환경온도에서는 사료 섭취량 및 사료요구율 (섭취:증체)가 높았다 (P < 0.01). 
하지만 이러한 환경온도의 영향은 사료내 크롬 피콜리네이트에 의해 완화되지 않았으며, 
호흡률 및 혈청 조사항목들도 크롬 피콜리네이트에 의해 달라지지 않았다. 면역 스트레스 
연구 (제 4 장)에서는 리포다당류 (lipopolysaccharide, LPS)를 주사한 돼지들 (26.0 kg)은 
12 시간 동안 951 g 체중이 낮아진 반면 인산완충식염수 (phosphate buffer saline, PBS)를 
주사한 돼지들은 170 g 증체하였다 (P < 0.001). 체온 (P < 0.05), 호흡율 (P < 0.05) 및 혈청내 
콜티졸 농도 (P < 0.001)는 PBS 처리구에 비해 LPS 처리구에서 높게 나타난 반면 혈청내 
포도당의 농도는 PBS 처리구에서 높은 결과를 보였다 (P < 0.05). 이와 같은 LPS 처리에 
의한 효과는 사료내 크롬 피콜리네이트에 의해 영향을 받지 않았다. 영양학적 스트레스 
연구 (제 5 장) 에서는 고지방 사료를 섭취한 돼지들이 빠른 증체 (P < 0.05), 적은 사료섭취 
(P < 0.001) 및 낮은 사료 요구율 (P < 0.001)을 보였다. 혈청내 인슐린의 농도는 실험 
14 일째에 사료내 크롬 피콜리네이트의 첨가 수준에 따라 직선적으로 (P = 0.05) 낮아졌다 
(P < 0.05). 도축 체중, 신장주위의 지방, 및 등지방 측정치는 고지방 사료 처리구에서 높게 
나타났다 (P < 0.01). 도체중, 제 1 늑골 등지방, 최후 요추 등지방, 및 평균 등지방 두께는 
사료내 크롬의 첨가 수준에 따라 직선적으로 감소하였다 (P < 0.10). 크롬 피콜리네이트가 
도체 지방 측정치에 미치는 이러한 영향은 암퇘지보다는 거세수퇘지에서 더욱 두드러지게 
나타났다. 부신피질 세포를 이용한 연구 (제 6 장)에서는 작용제로 이용된 forskolin 에 의해 
콜티졸 및 DHEAs 의 분비가 촉진되었다. 크롬 피콜리네이트가 부신피질 세포 배양액에 
첨가 되었을 때에는 작용제에 의해 촉진된 스테로이드 호르몬의 합성이 억제되었다. 본 
연구에서 사료내 크롬 피콜리네이트의 첨가는 높은 환경온도, 낮은 환경온도, 혹은 
내독소에 기인한 스트레스를 완화시키지 못하였다. 하지만 크롬 피콜리네이트는 고지방 
사료에 의한 체지방 축적의 증가를 특히 거세수퇘지에서 감소시켰으며, 부신피질에서 
촉진된 스테로이드의 합성을 억제시켰다. 
 
주요어: 크롬 피콜리네이트, 온도 스트레스, 면역스트레스, 고지방 사료, 부신 스테로이드 
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吡啶羧酸铬对温度、免疫、日粮应激下猪的效果及对肾上腺甾类分泌的影响 
 
本项研究通过一系列的试验，探讨了日粮中添加吡啶羧酸铬对处于温度应激
、免疫应激和日粮应激下猪的效果，并研究了吡啶羧酸铬对肾上腺皮质细胞甾类产
生的影响。在温度应激试验中 (第三章)，外界高温导致试验猪体增重和采食量下降
 (P < 0.01)，外界低温导致采食量和料重比增加 (P < 0.01)。日粮中添加吡啶羧酸铬
对这些影响无调控作用，对试验猪呼吸频率、血浆检测指标也无显著作用。在免疫
应激试验中 (第四章)，试验猪 (26 公斤) 在注射脂多糖后 12 小时失重 951 克，而注
射磷酸盐缓冲液的试验猪增重 170 克 (P < 0.001)。与注射磷酸盐缓冲液的试验猪相
比，注射脂多糖组试验猪具有较高的直肠温度 (P < 0.05)、呼吸频率 (P < 0.05)、血
浆皮质醇水平 (P < 0.001)，和较低的血糖水平 (P < 0.05)。日粮中添加吡啶羧酸铬
对这些影响无改善效果。在日粮应激试验中 (第五章)，饲喂高脂饲粮的试验猪具有
较高的增重速度 (P < 0.05) ，较少的饲料消耗 (P < 0.001) 和较低的料重比 (P < 0.00
1)。添加吡啶羧酸铬组试验猪第 14 日血浆胰岛素水平显著下降 (P < 0.05)，并与饲
粮吡啶羧酸铬水平呈线性相关 (P = 0.05)。高脂饲粮提高了猪的屠体重、板油重和
背脂厚 (P < 0.01)。日粮中添加吡啶羧酸铬使胴体重、最后肋骨背脂厚、最后腰骨
背脂厚和平均背脂厚线性下降 (P < 0.10)。吡啶羧酸铬对胴体脂肪的影响在阉公猪
上的效果优于小母猪。在肾上腺皮质细胞培养试验中 (第六章),  毛喉素促进了皮质
醇和 DHEAs 从 H295R 细胞中的分泌。吡啶羧酸铬抑制了受激动剂刺激的肾上腺皮
质细胞的甾类产生状况。总而言之，日粮中添加吡啶羧酸铬无法调节来源于外界高
温、外界低温和内毒素应激产生的对猪的影响。然而，吡啶羧酸铬可以改善高脂饲
粮的不良影响，主要是减少胴体脂肪沉积，尤其表现在阉公猪。吡啶羧酸铬能抑制
激动肾上腺皮质的甾类产生。 
 
关键词: 吡啶羧酸铬，温度应激，免疫应激，高脂饲粮，肾上腺甾类 
 
翻译 - 王敏奇 博士 (浙江大学动物科学学院 中国) 
Translated by Dr. Minqi Wang, College of Animal Science, Zhejiang University, China
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INFLUENCIAS DEL TRIPICOLINATO DE CROMIO EN CERDOS BAJO ESTRÉS 
TÉRMICO, INMUNITARIO O ALIMENTARIO, Y EN LA SECRECIÓN  
ADRENAL DE ESTEROIDES 
 
Los objetivos fueron la investigación de los efectos del tripicolinato de cromio 
(CrPic; hasta 2.000 ppb de Cr) en cerdos en crecimiento bajo una serie de agents 
estresantes de tipo térmico, inmunitario o dietético así como la investigación de sus 
efectos en la esteroidogénesis de las células adrenocorticales. En el estudio del esters 
térmico (capítulo 3), altas temperatures causaron una reducción en ganacia de peso y en 
consume (P < 0.01), y bajas temperaturas ambientales causaron un incremento del 
consumo y del índice de conversión (P < 0.01). Sin embargo, estos efectos no fueron 
moderados por el CAPIC, y el ritmo respiratorio, el nivel plasmático de cortisol o glucosa 
no resultaron afectados por el CAPIC. En el estudio del esters inmunitario (Capítulo 4), 
los cerdos retados con lipopolisacárido (LPS) perdieron 951 g durante las 12 horas 
siguientes a la inyección, mientras que le grupo inyectado con tampón fosfato-salino 
ganó 170 g (P < 0.001). El grupo LPS mostró temperaturas rectales más altas (P < 0.05), 
mayor cortisol plasmático (P < 0.001), y mayor nivel de glucosa en plasma (P < 0.05) que 
el grupo PBS. La adición de CAPIC no disminuyó esos efectos. En el estudio del estrés 
alimentario (Capítulo 5), los cerdos alimentados con la dieta rica en grasa (HFD) 
crecieron más rápido (P < 0.05), consumieron menos pienso (P < 0.001), y tuvieron un 
menor IT (P < 0.001). La concentración de insulina plasmática en el día 14 disminuyó 
mediante la adición de CrPic (P < 0.05) de manera lineal (P = 0.05). El consumo de la 
dieta rica en grasa produjo incrementos de peso al matadero, de grasa perineal y de la 
medida de grasa dorsal (P < 0.01). La adición de CrPic produjo reducciones lineales de 
peso de canal, grasa en la última costilla y en la última lumbar así como de la grasa dorsal 
media (P < 0.10). Los efectos del CrPic en las medidas de grasa en la canal no fueron más 
significativas en machos que en hembras. En el estudio de las células adrenocorticales 
(Capítulo 6), forskolin estimuló las secreciones de cortisol y DHEAs de las células 
H295R. El CrPic inhibió aspectos de la esteroidogénesis en las células adrenocorticales 
de estimulación agonista. En resumen, el CrPic dietético fue incapaz de moderar los 
efectos del estrés causado por altas o bajas temperaturas ambientales o mediante reto 
endotóxico. Sin embargo, CrPic atenuó los efectos de una dieta rica en grasas, 
 
principalmente con respecto a la deposición de grasa corporal, sobre todo en machos, y el 
CrPic inhibió la esteroidogénesis en células adrenocorticales estimuladas. 
 
PALABRAS CLAVE: Tripicolinato de cromio, estrés térmico, estrés inmunitario, dietas 
ricas en grasa, esteroides adrenales 
 
Traducido por Sr. Aitor Balfagon, SCA Iberica, Mequinenza, España 
 
Translated by Mr. Aitor Balfagon, SCA Iberica, Mequinenza, Spain 
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CHAPTER 1. Introduction 
 
Since chromium (Cr) was first reported to be an essential component in the 
glucose tolerance factor (Schwarz and Mertz, 1959), the functions of Cr have been 
widely investigated in humans, animal models, and livestock. Generally Cr has been 
shown to potentiate the action of insulin (Mertz et al., 1974; Vincent, 2000) and 
accordingly to modulate carbohydrate, protein, and lipid metabolism (Davis and Vincent, 
1997; Cefalu et al., 2002; Bernao et al., 2004). In domestic animals, Cr has been 
recognized as an essential trace mineral (Anderson, 1987; Offenbacher and Pi-Sunyer, 
1988) and suggested to alleviate stress associated effects (Chang and Mowat, 1992; 
Anderson, 1994; NRC, 1997). 
Khansari et al. (1990) define ‘stress’ as the reaction of the body to stimuli causing 
disturbance of the normal physiological status. In swine production systems, stress 
sources include cold/hot (relative to thermoneutrality) environmental temperature (Stahly 
and Cromwell, 1979), microbial infection (Webel et al., 1997), insufficient floor space 
(Brumm and Miller, 1996; Wolter et al., 2000), social mixing (Barnett et al., 1993; 
Marchant et al., 1995), and nutritional deficiency or excess (NRC, 1998). These stressors 
may cause growth retardation, changes in hormone secretion, increased disease 
susceptibility, and/or behavioral changes. 
Dietary supplementation of Cr has alleviated the detrimental effects of thermal 
stress in poultry (Sahin et al., 2001; Onderci et al., 2003), and transport stress in calves 
(Chang and Mowat, 1992; Moonsier-Shageer and Mowat, 1993). Lindemann and Purser 
(1997) have suggested that dietary Cr may be more effective in a fatter-type animal. In a 
recent study, supplemental Cr has lowered body weight gain, body fat gain, and visceral 
fat gain in obese mice fed fat-enriched diet (Bhattacharya et al., 2006). 
However, studies on dietary Cr for pigs kept in stressful thermal environments or 
for pigs fed high levels of dietary fat have been rare. The effects of dietary Cr on immune 
responses in animals have been inconclusive in pigs (van Heugten and Spears, 1997; Lee 
et al., 2000; van de Ligt et al., 2002c). In addition, direct effects of Cr on adrenocortical 
steroidogenesis have not been reported.  
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Therefore, the objective of the present research was to determine the effects of Cr 
supplementation on pigs in thermoneutral or thermal stress environment (Chapter 3), pigs 
challenged with an immune stressor (Chapter 4), and pigs fed high-fat diets (Chapter 5). 
Additionally, effects of Cr on adrenocortical steroids secretion from H295R 
adrenocortical cells are studied (Chapter 6). 
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CHAPTER 2. Literature Review  
 
2.1. Stressors in swine production 
 Stress can be defined as the reaction of the body to stimuli causing disturbance of 
the normal physiological equilibrium (Khansari et al., 1990). Stressors often result in 
detrimental effects. In the swine industry, various stress sources interfere with animal 
health and limit the maximum production rate. The stressors existing in swine production 
systems would include cold/hot environmental temperature (Stahly and Cromwell, 1979), 
microbial infection (Webel et al., 1997), insufficient space allowance (Brumm and Miller, 
1996; Wolter et al., 2000), social mixing (Marchant et al., 1995; Barnett et al., 2001), and 
nutritional deficiency or imbalance (NRC, 1998). These stressors cause growth 
retardation, changes in hormone release, increased disease susceptibility, and/or 
behavioral changes. 
 
2.1.1. Thermal stress 
The thermal environment is important in pig production, because the ambient 
temperature can directly affect the animal’s energy expenditure, feed intake, weight gain, 
and feed efficiency. Moreover, severe cold or hot temperatures may cause the death of 
pigs. Thus, the effects of environmental temperature in combination with nutritional and 
environmental factors on pig performance have been of great interest to many researchers 
(Stahly and Cromwell, 1979; Schenck et al., 1992ab; Quiniou et al., 2000; Frank et al., 
2003).  
 
Thermoneutral zone 
Ambient temperature affects heat production, heat loss and body temperature. 
Figure 2.1 demonstrates the relation between heat production (heat loss) and body 
temperature as affected by ambient temperature. The thermoneutral zone (alternately 
called the zone of thermal neutrality) was defined as “the range of ambient temperature 
over which, at a fixed level of food intake, heat production is minimal and constant” by 
Mount (1974). The highest and the lowest temperatures of the thermoneutral zone are 
called lower critical temperature (LCT) and the upper critical temperature (UCT), 
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respectively. Body temperature is constant even below the LCT. However, as the ambient 
temperature decreases below the LCT, total heat production linearly increases. Total heat 
production is partitioned into sensible and evaporative heat loss. When ambient 
temperature is below LCT, sensible heat loss increases with total heat production, 
whereas evaporative heat loss is constant. In the relatively higher temperature of the 
thermoneutral zone, evaporative heat loss increases as the ambient temperature increases.  
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Figure 2.1. The relationship between heat production (heat loss) and body temperature as 
affected by ambient temperature (Mount, 1968). LCT and UCT represent lower critical 
temperature and upper critical temperature, respectively. 
 
The thermoneutral zone depends on various factors including animal body weight, 
physiological state, air flow speed, humidity, and floor type (Holmes and Close, 1977). 
The LCT is lowered by increasing the number of animals per pen, by using bedding, and 
by reducing air flow rate (NRC, 1998). 
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Low ambient temperature 
Pigs in low ambient temperature below the LCT generally show increased feed 
intake and a diminished feed efficiency. Stahly and Cromwell (1979) reported that 
growing pigs (28 to 60 kg BW) in low ambient temperature (10°C) consumed 15% more 
feed and had 19% higher feed:gain compared with pigs in a thermoneutral environment. 
A similar response was shown in weanling pigs (8.6 to 10.2 kg BW) by Frank et al. 
(2003). The increased feed consumption is used to compensate for the elevated 
maintenance needs for metabolic activity (Holmes and Close, 1977). Thus, BW gain of 
the animal may not be influenced by the cold stress depending on the degree of stress and 
the degree of increase in feed intake. However, Le Dividich (1981) reported that piglets 
housed in a 20°C environment after weaning (below LCT) gained less weight than pigs in 
environments where the temperature decreased from 32, 28 or 24 to 20°C weekly. 
Moreover, in an extremely low ambient temperature, animals may lose BW and even die. 
This ‘extreme’ case will be below the threshold for hypothermia (Figure 2.1).  
Most experiments in the literature used temperatures above the threshold for 
hypothermia and below the LCT for low ambient temperature treatments. Representative 
data of pig growth performance in cold stress situations are summarized (Table 2.1). Pigs 
in cold environments consumed more feed and showed higher feed:gain ratio with no 
major change in growth compared with the pigs in the thermoneutral environment. 
Stressors are generally known to activate the hypothalamic-pituitary-adrenal 
(HPA) axis by stimulating hypothalamus to release corticotrophin-releasing hormone 
(CRH). The CRH stimulates the release of adrenocorticotropic hormone (ACTH), 
resulting in elevated glucocorticoid secretion from the adrenal cortex. Detailed 
mechanism of adrenal steroid secretion is discussed in a later section (2.5. Adrenal 
steroid hormone physiology). 
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Table 2.1. Growth performance changes in low ambient temperature 
Growth performance  Changes in low ambient temperature, % Temp, 
°C 
Initial 
BW, kg 
Final 
BW, kg 
ADG, g ADFI, g Feed:gain  ADG ADFI Feed:gain 
Reference
23 27.5 60.8 794 1,895 2.39  
10 27.5 59.9 772 2,165 2.83  
-2.8 14.2 18.7 1 
           
20 24.3 55.2 735 1,735 2.36  
10 24.3 54.6 721 2,000 2.79  
-1.9 15.3 18.0 1 
           
23 25.3 55.4 717 1,857 2.61  
10 25.3 55.1 710 2,080 2.97  
-0.9 12.0 13.5 2 
           
26.7 8.5 10.1 402 477 1.22  
15.6 8.6 10.2 415 606 1.49  
3.1 27.0 22.5 3 
1 Stahly and Cromwell (1979). Initial BW for each temperature treatment were assumed to be the
same. Final BW was calculated as: Final BW = Initial BW + ADG × 42 d. Values are means of 
three dietary treatments of high protein, low protein, and low protein + Lys. 
2 Stahly et al. (1979). Initial BW for each temperature treatment were assumed to be the same.
Final BW was calculated as: Final BW = Initial BW + ADG × 42 d. Values are means of three 
dietary treatments of 0 and 5% of fat. 
3 Frank et al. (2003). Values are means of six dietary treatments (with or without spray dried 
plasma). 
Stressors resulting in elevated blood cortisol concentration in pigs include 
shipping stress (Nyberg et al., 1988; McGlone et al., 1993), social mixing (Seguin et al., 
2006), and immune stress (Webel et al., 1997; Balaji et al., 2000). Frank et al. (2003) 
reported that cold stress also increased circulating cortisol concentration in pigs. Pigs of 
8.6 kg BW in cold environment (15.6°C) showed higher (P<0.001) serum ACTH (85.1 vs. 
61.3 pg/mL) and cortisol (39.1 vs. 24.1 ng/mL) than those in thermoneutral environment 
(26.7°C). Similarly, Hicks et al. (1998) reported that cortisol concentration was 
numerically higher (53.2 vs. 43.2 ng/mL) in cold stressed pigs (9.0 kg BW) versus 
unstressed pigs. Frank et al. (2003) induced cold stress for 4 d by changing ambient 
temperature, but Hicks et al. (1998) sprayed water on the animals for 30 minutes every 4 
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h with 1.5 m/s of air flow rate with a constant environmental temperature of 24.5°C. It 
may be that the treatment in Hicks et al. (1998) did not induce enough cold stress as the 
feed consumption was not increased, although the behavioral responses of cold stress 
were observed.        
  
High ambient temperature 
In contrast to pigs in a low ambient temperature, those in high ambient 
temperature typically consume less feed in efforts to reduce body heat production from 
digestive and metabolic processes. Stahly and Cromwell (1979) reported that growing 
pigs (28 to 57 kg BW) in the high ambient temperature (35°C) consumed 18% less feed 
and gained 25% less BW compared with pigs in a thermoneutral environment. Similar 
results of decreased feed intake and growth by heat stress have been shown in other 
studies (Stahly et al., 1979; Schenck et al., 1992ab; Kerr et al., 2003) as summarized in 
Table 2.2.  
The feed intake reduction in high ambient temperature depends on several factors 
including BW, breed, feed, and sex. Quiniou et al. (2000) developed an equation to 
predict voluntary feed intake (VFI) from ambient temperature and BW:  
 
VFI (g/d) = −1264 + 117T − 2.40T2 + 73.6BW − 0.26BW2 − 0.95T×BW,  
 
in which VFI is daily voluntary feed intake and T is ambient temperature as degree 
Celsius. 
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Table 2.2. Growth performance changes in high ambient temperature 
Growth performance  Changes in high ambient temperature, % Temp, 
°C 
Initial 
BW, kg 
Final 
BW, kg 
ADG, g ADFI, g Feed:gain  ADG ADFI Feed:gain 
Reference
23 27.5 60.8 794 1,895 2.39  
35 27.5 52.5 595 1,550 2.63  
-25.1 -18.2 10.1 1 
           
23 25.3 57.9 777 1,963 2.55  
35 25.3 52.3 643 1,650 2.58  
-17.2 -16.0 1.3 2 
           
20 14.2 26.9 607 1,228 2.06  
32 13.3 23.7 495 989 2.09  
-18.5 -19.4 1.5 3 
           
20 12.5 25.4 611 1,248 2.09  
30 10.7 19.9 439 973 2.37  
-28.2 -22.0 13.4 4 
           
23 22.5 36.7 394 1,040 2.65  
33 24.3 35.3 313 892 2.87  
-20.6 -14.2 8.0 5 
1 Stahly and Cromwell (1979). Initial BW for each temperature treatment were assumed to be the
same. Final BW was calculated as: Final BW = Initial BW + ADG × 42 d. Values are means of 
three dietary treatments of high protein, low protein, and low protein + Lys. 
2 Stahly et al. (1979). Initial BW for each temperature treatment were assumed to be the same.
Final BW was calculated as: Final BW = Initial BW + ADG * 42 d. Values are means of three 
dietary treatments of 0 and 5% of fat. 
3 Schenck et al. (1992a). Values are means of six dietary treatments (0 or 5% of fat addition × 0.7,
1.0, or 1.3% of Lys). 
4 Schenck et al. (1992b). Values are mean of six dietary treatments (0 or 5% of fat addition × 0.7, 
1.0, or 1.3% of Lys). 
5 Kerr et al. (2003) Values are mean of three dietary treatments of high protein, low protein, and
low protein + Lys. 
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As demonstrated in Figure 2.2, feed intake depends on ambient temperature and 
BW, and the negative effect of high temperature was dramatic in heavier pigs. 
Although high ambient temperature above the UCT is a source of stress to the 
animals, the effect of heat stress on circulating cortisol concentration is inconclusive. 
Occasionally, blood cortisol concentration was decreased by heat stress.  Marple et al. 
(1972) observed decreased plasma cortisol concentration in gilts exposed to heat stress 
(32°C) for 8 d. Similarly, Hicks et al. (1998) reported numerically decreased plasma 
cortisol concentration in pigs exposed to heat stress. Low plasma cortisol of heat stressed 
pigs was confirmed in recent studies (Heo et al., 2005; Sutherland et al., 2006). The 
reasons for low plasma concentration in heat stressed animals may be an increased 
turnover of plasma cortisol and/or decreased adrenal responsiveness to ACTH as 
suggested by Heo et al. (2005). 
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Figure 2.2. Effect of ambient temperature and body weight on voluntary feed intake in 
growing pigs (Adapted from Quiniou et al., 2000). 
  
Pigs in the hot environment generally exhibit more recumbent behavior with 
increased respiratory rate, and thus fewer feeding and standing periods in response to 
chronic (Morrow-Tesch et al., 1994) and acute (Hicks et al., 1998) heat stress treatments. 
The respiratory rate has been demonstrated to be higher (124 vs. 26 breaths/min) in the 
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pregnant sow exposed to heat stress (29°C) compared with those in the thermoneutral 
environment (18°C) (Quiniou and Noblet, 1999). A similar result was reported later by 
the same group (Renaudeau et al., 2001). 
 Taken together, cold stress increases feed intake and feed:gain and elevates 
cortisol secretion. Heat stress decreases feed intake and weight gain. Because thermal 
stress is directly related to an animal’s energy expenditure, nutritional approaches can 
potentially alleviate the detrimental effects of thermal stress. 
  
2.1.2. Immunological stress 
General concepts of immunity 
The immunity refers to the state of protection from foreign organisms or 
substances (antigens) which may cause infectious disease. The immunity is composed of 
nonspecific and specific components. Nonspecific, or innate, immunity is the basic 
inborn resistance to disease by preventing the entrance and establishment of infectious 
agents. Specific, or acquired, immunity requires a functionally active immune system that 
recognizes and eliminates specific foreign microorganisms and molecules (Albert et al., 
1994; Kuby, 1997). Nonspecific and specific components of immunity are summarized in 
Table 2.3. 
 
Nonspecific (Innate) immunity  
 Anatomic barrier skin, mucous membrane 
 Physiologic barrier temperature, pH, chemical mediators 
 Phagocytic/endocytic barrier internalizing cells 
 Inflammatory barrier antibacterial activity and phagocytic cells 
Specific (Adaptive) immunity  
 Humoral response (B cell) antibody secretion and antigen elimination 
 Cell mediated response (T cell) 
  Helper T cell cytokine production 
  Cytotoxic T cell cytotoxic T lymphocytes 
(Adapted from Albert et al., 1994; Kuby, 1997; Parham, 2005)
  
Table 2.3. Summary of nonspecific and specific immunity 
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Nonspecific immunity includes four barrier types: 1) anatomic, 2) physiological, 
3) phagocytic/endocytic, and 4) inflammatory barriers. Anatomic barriers are the first line 
of defense against infection. This type of barrier includes the skin and the surface of 
mucous membranes. These barriers protect the organism from the entry of most 
microorganisms. Physiological barriers include temperature, pH, and various soluble 
factors. For example, the body temperature of chickens is high (41 to 45°C), thus 
pathogens of which the growth condition is not in this temperature range cannot grow 
well in chickens. Gastric acidity also inhibits the survival of pathogens. Soluble factors 
contributing nonspecific immunity are lysozyme (a hydrolytic enzyme in mucosal 
secretions), interferon (natural proteins produced by virus-infected cells), and 
complement (serum proteins in an inactive state). Phagocytosis and endocytosis are the 
process by which cells internalize and breakdown micromolecules and macromolecules, 
respectively.  The inflammatory responses including vasodilation, increase in capillary 
permeability, and influx of phagocytes from the capillaries, also work as a defensive 
system (Kuby, 1997; Parham, 2005). 
 Specific immunity, in contrast to nonspecific immunity, is adaptive and antigen 
(foreign molecule) specific. An effective immune response involves lymphocytes and 
antigen presenting cells. Lymphocytes are a class of white blood cells produced in the 
bone marrow, and mediate the characteristics of acquired immunity, such as specificity, 
diversity, memory, and self/nonself recognition. Two major populations of lymphocytes 
are: 1) B lymphocytes which produce antibodies (humoral), and 2) T lymphocytes which 
are responsible for cell-mediated immune response. In response to antigen, B cells are 
differentiated to antibody-secreting plasma cells, and the secreted antibody binds to the 
antigen and facilitates the antigen elimination. Helper T cells and cytotoxic T cells are 
two main classes of T cells. When an antigen is recognized, helper T cells produce 
cytokines which enhance the responses of other leukocytes and help B cells to make 
antibody responses, and cytotoxic T cells develop into cytotoxic T lymphocytes which 
directly kill altered self-cells such as virus-infected cells (Albert et al., 1994; Kuby, 1997).  
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Immunological stress in swine production 
In conventional swine production environments, pigs are commonly surrounded 
by pathogenic microorganisms including bacteria, viruses, fungi, and parasites. These 
microorganisms may cause infectious disease. In some cases, the infection causes clinical 
disease symptoms. In other cases, however, the infection is subtle and the clinical 
symptoms may not be obvious. In any case, animals consume less feed and grow more 
slowly than those in hygienic environments. This clinical or subclinical pathogenic 
infection is often referred to as immunological stress. The slower growth can by 
explained by nutrient partitioning away from body protein accretion toward metabolic 
responses for the immune system. Nutrient requirements for swine identified by the NRC 
(1998) are based on experimental data. Considering that most experimental environments 
are better controlled than conventional swine production units, the recommended 
amounts or concentrations of nutrients (NRC, 1999) may be lower than the required 
concentrations of nutrients for swine at commercial farms (Johnson, 1997; Johnson et al., 
2001). 
Early weaned pigs (5.4 to 15.6 kg BW) raised in a conventional environment 
gained less weight, consumed less feed, and had higher feed:gain than those in an 
experimental environment (Coffey and Cromwell, 1995). The experimental environment 
was equipped with newly purchased pens, feeders, and waters, thus likely had less 
contamination and less pathogens than the conventional environment. Williams et al. 
(1997) also reported that the pigs in less hygienic environment showed less weight gain, 
feed intake, and higher feed:gain than those in sanitary environmental during 6 to 27, 27 
to 112, and 6 to 112 kg growth phases. In these experiments, animals were exposed to 
several antigens by making the environment unclean. 
 
Lipopolysaccharide  
 In the previously cited studies (Coffey and Cromwell, 1995; Williams et al., 
1997) the immune system was chronically activated by environmental microorganisms. 
Another technique of direct injection of pathogenic bacteria or bacterial endotoxin can 
acutely activate the immune system. In swine experiments, bacterial challenges, such as 
salmonella typhimurium (Balaji et al., 2000; Turner et al., 2002) and Escherichia coli (Yi 
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et al., 2005), have been used to induce immune response. Endotoxins, most frequently 
lipopolysaccharides (LPS), have also been extensively used in pigs to active the immune 
system (van Heugten et al., 1996; van Heugten and Spears, 1997; Webel et al., 1997, 
1998; Frank et al., 2003; Li et al., 2006).  
 In response to the pathogenic bacteria, acute inflammation is caused in animal 
tissues. More specifically, the bacterial molecules that trigger this inflammation are for 
the most part LPS. Lipopolysaccharides are the cell wall component of gram-negative 
bacteria and act on neutrophils to activate integrins, on endothelial cells to activate 
selectins, and on macrophages to produce cytokines (Tizard, 2000). The cytokines 
produced by macrophages include tumor necrosis factor-α (TNF-α), interleukin-1 (IL-1), 
interleukin-6 (IL-6), leukemia inhibitory factor (LIF), and oncostatin M (OSM) (Figure 
2.3). The interleukines act on the hypothalamus to induce a fever response through 
prostaglandin as a mediator (Kuby, 1997). Direct effects of endotoxin on the 
prostaglandin formation have also been reported (Bishai and Coceani, 1996). Increased 
levels of circulating cytokines (TNF-α, IL-1, and IL-6) activate the hypothalamus-
pituitary-adrenal axis causing increased corticosteroid secretion from the adrenal cortex 
(Kuby, 1997). Additionally, LPS can directly stimulate the adrenal cortex to secret 
corticosteroids (Vakharia and Hinson, 2005). Cytokines (TNF-α, IL-1, IL-6, LIF, and 
OSM) and corticosteroids increased by inflammatory response stimulate liver to produce 
acute-phase proteins (C-reactive protein, serum amyloid A, fibrinogen, mannose-binding 
protein, and complement components). Tumor necrosis factor-α, and IL-6 act on bone 
marrow to produce more leukocytes (Kuby, 1997). 
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Figure 2.3. An overview of the organs and mediators involved in a systemic acute-phase 
response. Interleukin-1 (IL-1), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), 
leukaemia inhibitory factor (LIF), and oncostatin M (OSM) are produced by activated 
macrophages at the site of inflammation. These cytokines are particularly important in 
mediating acute-phase effects of inflammation. Lipopolysaccharides (LPS) directly 
trigger prostaglandin and corticosteroids secretion (Adapted from Bishai and Coceani, 
1996; Kuby, 1997; Webel et al., 1997; Vakharia and Hinson, 2005).  
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In pigs, intraperitoneal injection of Escherichia coli LPS induced an increase of 
TNF-α, IL-6, and cortisol (Figure 2.4; Webel et al., 1997). This experiment showed the 
acute activation of the immune system by the LPS challenge to the swine. Additionally, 
the increase of cytokines and a corticosteroid was followed by a three fold increase in 
plasma urea nitrogen. These results represent that immune stress may stimulate skeletal 
muscle protein degradation. 
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Figure 2.4. The time course of elevated plasma levels of tumor necrosis factor-α (TNF-α), 
interleukin-6 (IL-6), cortisol, and plasma urea nitrogen (PUN) following an 
intraperitoneal injection of lipopolysaccharide (5 μg/kg BW) to 12 kg pigs (Webel et al., 
1997). 
 
The optimum dosage of LPS is an important issue in experimentation. Webel et al. 
(1997) reported that 5 μg/kg BW of LPS induced dramatic activation of the immune 
system but 0.5 μg/kg BW of LPS had very minor effects. The dosage level of LPS to 
induce an immune response has varied from 5 to 150 μg/kg BW in the literature (Table 
2.4). The optimum dosage level depends on various factors including the serotype of LPS, 
extraction method, animal body weight, injection method, and other environmental 
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conditions. It is notable that a higher dosage of LPS was required with 0111:B4 serotypes 
(Matteri et al., 1998; Frank et al., 2003) compared to K235 serotypes (Webel et al., 1997, 
1998; Warren et al., 1997), although environmental variations exist among the 
experiments.  
 Overall, immune stress exists in conventional swine production systems. Dietary 
strategies may resolve at least some of immune stress. In identifying nutrients which can 
alleviate immune stress, LPS can be used to activate the immune system of the animal. 
Additionally, nutrient requirements may need to be established for specific swine 
production system based on the immunological environment.   
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Table 2.4. Effects of Escherichia coli lipopolysaccharide challenge to the pigs on 
circulating tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and cortisol 
concentration1  
Plasma concentration3, 
ng/ml Serotype BW, kg 
Dosage, 
μg/kg BW 
Injection 
method2
Hrs post 
injection
TNF-α IL-6 Cortisol 
Reference 
K-235 12 5 IP 4 1.3 3.9 290 Webel et al., 19974 
K-235 10 5 IP 2  2.3 180 Webel et al., 1998 
055:B5 9 25 IP 3 5.9 0.4 141 Li et al., 2006 
055:B5 18 30 IP 1.5  2.1 510 Sakumoto et al., 20035
K-235 20 50 IP 1.5 17.0  140 Warren et al., 19976 
0111:B4 6 75 IV 4 32.0 20.0 210 Frank et al., 2003 
055:B5 10 100 IP 2 3.0  160 Wright et al., 2000 
0111:B4 6 150 IP 3 2.1 0.4 385 Matteri et al., 19987 
1 When blood samples were collected at multiple time points, the time when cytokines or 
cortisol showed the peak was selected. In all the cited studies, LPS significantly (P < 
0.05) increased cytokines and cortisol concentration. 
2 IP and IV represent intraperitoneal and intravenous, respectively. 
3 In the references 6 and 8, serum samples were analyzed. 
4 TNF-α concentration was highest (1.9 ng/ml) at 2 h post injection. 
5 Cortisol concentration was highest (610 ng/ml) at 2.5 h post injection and Chinese 
Meishan pigs were used. 
6 Cortisol concentration was highest (195 ng/ml) at 3 h post injection. 
7 Body weight was estimated based on the age (28 d old). 
 
2.1.3. Crowding stress  
Floor space allowance and group size for optimal pig growth are critical 
determinants for designing modern swine production system (Brumm and Gonyou, 2001). 
Swine producers try to maximize benefits by minimizing both performance retardation 
and waste of space. Crowding stress - inadequate space allowance - deleteriously affects 
growth performance of pigs and potentially reproductive performance.  
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Floor space allowance  
A number of studies demonstrated that the shortage of space allowance decreases 
growth rate and feed intake. During the nursery period, inadequate space allowance 
caused more than 10% of growth retardation (NCR-89, 1989; Kornegay et al., 1993ab). 
NCR-89 (1989) allowed the space of 0.12 m2/pig for the reduced area treatment and that 
of 0.248 m2/pig for the control group in a four-week nursery trial. Kornegay et al. 
(1993ab) used reduced space allowance of 0.14 m2/pig for a treatment group in contrast 
to the space of 0.28 m2/pig for a control group during 5 or 6 weeks after weaning. 
The relationship between space allowance and body weight can be expressed as: 
SA, m2 = k × kg BW0.667 (Petherick and Baxter, 1981), where SA is space allowance and 
k is an empirical coefficient. Body weight is proportional to body volume which is three-
dimensional and space allowance is expressed as floor area which is two-dimensional. 
Thus the use of two thirds of power on the BW is reasonable. Edwards and Armsby 
(1988) suggested the optimal coefficient k was between 0.035 and 0.040. In the 
previously described nursery studies (NCR-89, 1989; Kornegay et al., 1993ab; Wolter et 
al., 2000), the coefficients for reduced floor area treatments were calculated as less than 
0.020.  
High stocking density negatively affects growth performance of pigs during the 
growing-finishing period. Kornegay and Notter (1984) suggested the following equation 
predicting the effect of decreasing space allowance on daily gain of growing pigs: daily 
gain, kg = 0.489 + 0.520 × S – 0.281 × S2 (R2 = 0.93), where S is space per pig in m2/pig. 
Brumm and Miller (1996) reported about 4 to 5% of daily gain decrease in space 
restricted treatment (k = 0.024) compared to control (k = 0.034) in three experiments. 
Gonyou and Stricklin (1998) also reported 4.8% decrease of growth with space restriction 
(k = 0.030 vs. 0.039). In both articles, space restriction had no effect on feed efficiency. 
When space restriction was more severe (k = 0.017 vs. 0.038), daily gain and feed 
efficiency decreased by 16% and 10%, respectively (Hyun et al., 1998ab). These results 
may be related to the fact that a high stocking density made pigs visit the feeder fewer 
times but for a longer time and eat more feed per visit compared to uncrowded pens 
(Hyun et al., 1998b). 
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If a floor space restriction negatively affects growth performance due to the low 
chance of feed intake, the interaction between sex and space allowance may exist because 
barrow generally consume more feed than gilts when an ad libitum feed intake is allowed. 
Hamilton et al. (2003a) observed that barrows had higher carcass lean percent in a space 
unrestricted situation but gilts were leaner in a space restricted environment. However, no 
interaction between sex and space allocation in growth performance or carcass lean 
percent was observed by Hamilton et al. (2003b) or Brumm (2004). 
Most of the studies on space allowance did not adjust the pen size as the pigs 
grew and fixed pen size for a relatively long period, which resulted in enough space 
allowance even in the space restricted treatment during the early period of experiments. 
Even though this traditional design reflected actual conditions of commercial farms, it 
prohibited examining the effect of stocking density during the early period of trials. 
Gonyou and Stricklin (1998) adjusted pen sizes every two weeks to reflect the 
requirements of the pigs at the midpoint of the subsequent two-week period. 
Because limited space allowance is clearly detrimental to the growth of pigs, the 
critical point of the flooring area is more important information to the swine industry. 
Edwards and Armsby (1988) suggested the optimal coefficient k was between 0.035 and 
0.040. In prediction equations suggested by Kornegay and Notter (1984), maximum 
weight gain is achieved at a coefficient k of 0.048. In a recent meta-analysis study, 
Gonyou et al. (2006) collected data from published studies and analyzed the data using 
broken-line analysis to decide the critical k value. The critical coefficient k was estimated 
as 0.034 from the analysis of nine peer-reviewed studies (Figure 2.5). 
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Figure 2.5. Broken-line analysis of average daily gain for grower-finisher pigs on fully 
slatted floors. The allometric expression of space allowance coefficient is k, where k = 
area in m2 / BW in kg0.667. The average daily gain is expressed as a percentage of that in 
the most spacious treatment within each experiment; r2 = 0.90, P < 0.001 (Gonyou et al., 
2006).  
 
In Figure 2.6, the critical space allowance for the maximal growth of pigs in various 
k values of 0.02, 0.03, 0.04, and 0.05. Additionally the k value of 0.0336 (Gonyou et al., 
2006) was added. The dashed line shows that 0.65 m2/pig of the space allowance is 
insufficient for 100 kg pigs but sufficient for 80 kg pigs based on the critical k value of 
0.036. In the experimentation, it is important to note that a fixed floor area can become a 
stress to the pigs as the animals grow, but the space may not be a stress until the pigs 
reach some marginal body weight.  
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Figure 2.6. Space allowance requirement for various values of coefficient k. The 
allometric expression of space allowance coefficient is k, where k = area in m2 / BW in 
kg0.667 (Petherick and Baxter, 1981). The coefficient k, 0.0336, was recently suggested by 
Gonyou et al. (2006). The dashed line shows that a specific space allowance as a fixed 
area per pig can be a crowding stress at the BW of 100 kg but not for pigs lighter than 80 
kg. 
 
Factors on floor space allowance  
Factors affecting the space allowance include floor types, ambient temperature, 
air flow, and nutritional composition.  
The type of floor may affect the optimal space allowance. The Canadian Code of 
Practice (AAFC, 1993) suggested an increase in space allowance if pigs are on partially 
slatted floor rather than totally slatted floor. However, Gonyou et al. (2006) reported that 
floor type did not influence the space allowance effects.  
If the decreased weight gain of pigs in crowding stress is because of decreased feed 
intake, one may postulate that nutritional modifications can overcome the floor area issue. 
Actually, antibiotics showed an interaction with space allowance on daily gain of pigs 
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during first three weeks of the nursery period (NCR-89, 1984).  In most of the other 
studies, however, antibiotics (NCR-89, 1986), vitamin C (NCR-89, 1989), lysine 
(Kornegay et al., 1993a; Brumm and Miller, 1996), and energy (Brumm and Miller, 
1996) did not show any interaction with space allowance on the growth performance of 
pigs.  
 
Crowding stress on subsequent performance  
The crowding stress on the subsequent performances has been studied by a few 
groups. However, the residual effect of crowding stress is inconclusive. Wolter et al. 
(2003) investigated the subsequent effect of eight weeks space restriction in weanling 
pigs. During the first eight weeks, space restricted pigs showed growth retardation 
compared with the pigs that had enough space (27.4 vs. 29.3 kg BW). However, during 
the subsequent 15 weeks (all the pigs had enough floor allowance), the pigs with 
restricted space previously compensated their BW gain, resulting the similar final BW 
(114.5 vs. 114.3 kg). However, Brumm et al. (2001) reported no residual effect of nursery 
crowding on grow-finish performance. Pigs that were crowded during the nursery period 
and uncrowded during the grow-finish period had similar, although numerically rather 
lower, daily gain (849 vs. 867 g/d, during the grow-finish period) than pigs that were 
uncrowded during both the nursery and grow-finish period.   
Space restriction of gilts during the growing-finishing period has been shown to 
affect subsequent reproductive performance. Kuhlers et al. (1985) allowed control gilts to 
have enough space of 1.06 and 1.25 m2/pig for 30 to 65 and 65 to 100 kg BW, 
respectively, with eight pigs per pen. In the same size pens, 16 gilts were raised for the 
crowding stress treatment group. In the subsequent reproductive performance, crowding 
stress decreased the litter size by 1.0 pig at birth but increased 21-d litter size, litter 
weights, and survival rates. The mechanism of the positive effects of the crowding stress 
on some reproductive traits is not clear. The space allowance coefficient k (Edwards and 
Armsby, 1988) of this experiment is calculated as 1.06 ÷ 650.667 = 0.065 and 1.25 ÷ 
1000.667 = 0.058 for 65 kg and 100 kg space unrestricted gilts, respectively. For the space 
restricted gilts, the k values are 0.033 and 0.029 for 65 kg and 100 kg gilts, respectively. 
Based on the critical k value of 0.0336 suggested by Gonyou et al. (2006), the crowding 
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stress in the experiment by Kuhlers et al. (1985) may be insufficient at least in the early 
period of each phase, for example 30 to 55 kg and 65 to 90 kg. More severe stress during 
the grow-finishing stage may result in a more clear response in the subsequent 
reproductive performance. In addition, the effects of crowding stress during the early 
growth stage (< 10 weeks) on the subsequent reproductive traits have been unanswered. 
Further research is warranted to investigate the effect of crowding stress on subsequent 
reproductive performance. 
 
Group size  
Group size is also an important factor for designing a pig house. Petherick et al. 
(1989) reported a decrease of daily gain of growing pigs when group size increased from 
8 or 16 to 32, and Gonyou and Stricklin (1998) also reported a reduction of daily gain and 
feed intake with increasing group size as 3, 5, 6, 7, 10, and 15. During the finishing 
period, individually caged gilts grew faster than gilts penned in groups of four (Gomez et 
al., 2000). Wolter et al. (2000) reported that piglets grouped as 100 gained 6% less 
weight compared to the piglets grouped as 20.  
However, other studies have demonstrated no effect of group size, 5 and 20 
(Randolph et al., 1981), 10, 20 and 30 (Walker, 1991), and 10, 20, 40 and 80 (Schmolke 
et al., 2003) on performance. Hyun and Ellis (2001, 2002) reported a negative effect of 
large group size on growth rate and feed intake in growing pigs, but no effect in finishing 
pigs. More recently, O’Connell et al. (2004) reported no effect of the number of pigs (10, 
20, 30, 40, and 60) per pen on growth or feed intake. 
Overall, space allowance and group size for optimal pig growth are important for 
planning and designing modern swine production system. Many factors are involved in 
the decision of a space allocation. Crowding stress has deleterious effects on growth 
performance and potentially subsequent growth and/or reproductive performance.  
 
2.1.4. Social mixing stress 
In the commercial swine production environment, piglets are sorted at weaning by 
weight for equal opportunity during the nursery period. Moreover, most of modern swine 
farms rear 10 to 30 pigs in a pen (Wolter et al., 2000). Thus, in most cases pigs from 
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more than one litter are inevitably placed in the same pen. Mixing with previously 
unacquainted pigs clearly induces acute stress, as fighting behavior and increased 
respiration rate are easily observed. Socially mixing the pigs results in increased cortisol 
secretion indicating that the animals are stressed. Growth performance is also affected by 
mixing stress during the first d. However, mixing stress may be an affordable stress to the 
pigs for the long term growth performance. 
  
Mixing stress on behavioral and hormonal responses 
Social mixing of unfamiliar individual pigs results in acute aggressions and 
increased corticosteroid secretion. The intensity and the length of the aggressions are 
related to the number of alien pigs and the severe fighting behavior generally lasts less 
than 24 h. Mixing stress may also affect feed consumption patterns.  
Increased aggressive behavior by combining alien pigs has been observed in 
many studies (Friend et al., 1983; McGlone et al., 1980; McGlone and Curtis, 1985; 
Spoolder et al., 2000). Friend et al. (1983) reported that mixing 4-week-old piglets from 
different litters showed apparently more fighting behavior than the littermates. Piglets 
were regrouped at weaning as: treatment 1) one pig from each of eight different litters, 
treatment 2) four pigs from each of two different litters, or treatment 3) eight pigs from 
the same litter. When none of the piglets were littermates, the fighting frequency was the 
highest during the first 3 h post mixing and the agonistic behavior was alleviated at 3 h 
after mixing (Figure 2.7).  
This is a theoretically reasonable result, because the number of couples that are 
unaware of each other is 28, 12, and 0 for treatment 1, 2, and 3, respectively assuming 
that the dominance of the littermates has been established during the suckling period. The 
lowest fighting frequency in the littermate only treatment suggests that the increased 
aggression was not by the weaning. In addition, vigorous fighting behavior was mostly 
alleviated within 24 h after social mixing in pigs of eight weeks old (Meese and Ewbank, 
1973) and finishing pigs of 84 kg BW (Stookey and Gonyou, 1994). However, in a 
mixing stress study with 76 kg pigs (Tan et al., 1991), aggressive behavior pattern caused 
by social mixing lasted up to three weeks. However, Tan et al. (1991) provided feed 
twice daily which may have caused extension of mixing stress period.  
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Figure 2.7. The effect of grouping methods on the number of fighting bouts occurring. 
Short and long fights were combined. There were 10 pens of eight pigs in each treatment 
(Friend et al., 1983). 
 
The social stress of mixing may stimulate the HPA axis, resulting in cortisol 
secretion with other physiological changes in the body (Christian, 1961). Mixing piglets 
at weaning increased circulating cortisol concentration (Blecha et al., 1985). And when 
piglets were regrouped at two weeks after weaning, plasma cortisol concentration was 
increased again. Similarly, Warriss and Brown (1985) reported that the greater the 
damage by fighting, the higher were the concentration of cortisol, glucose, and lactate. 
Recently, Séguin et al. (2006) also observed elevated salivary cortisol concentration in 
sows exposed to mixing stress. 
Hyun et al. (1998b) reported that social mixing did not influence the feeding 
pattern during the first day after mixing in 36 kg pig. However, the feeder occupation 
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time and the feed intake per visit were higher and the feeder visiting frequency was lower 
in socially mixed groups compared to unmixed groups on d 3, 4, and 5 after mixing with 
no changes in daily feed intake. These results suggest that even though agonistic behavior 
occurs only during the first few hours post mixing, feeding patterns may be influenced a 
bit later after fighting. In the nursery pigs, eating activity was unaffected by social mixing 
during the first 48 h after weaning (Dybkjær et al., 2006). Although this result may not be 
directly compared with the study by Hyun et al. (1998b) because eating behavior was 
recorded only for 48 h after mixing, and weaning pigs consume very little amount of feed 
during the first few days after weaning, both studies are in agreement in that feeding 
pattern is unaffected initially by social mixing.  
Taken together, mixing stress causes agonistic behaviors in the pigs within a few 
hours regardless of growth stage and elevates circulating cortisol concentration. Feeding 
pattern is also affected by mixing unfamiliar pigs. 
 
Mixing stress on growth performance 
Growth performance is also affected by mixing stress during the first few days. 
However, mixing stress may be an affordable stress to the pigs for the long term growth 
performance. Initial decreases of growth performance by social mixing stress have been 
reported in nursery (Friend et al., 1983), growing (Rundgren and Lofquist, 1989) and 
finishing (Spoolder et al., 2000) swine. Friend et al. (1983) observed higher feed:gain in 
the mixed weanling piglets during the first 7 d after mixing. However, they found no 
difference in feed:gain among the mixing stress treatments during the first 28 d post 
mixing. Daily feed intake and daily weight gain were unaffected by mixing treatments 
either during the first 7 d or 28 d. The high feed:gain may be explained by the high 
energy expenditure in the pigs exposed to mixing stress, as Heetkamp et al. (1995) 
reported that pigs exposed to mixing produced significantly higher total heat production 
and activity-related heat production.  
Rundgren and Lofquist (1989) observed lower weight gain during the initial 7 d 
following mixing in 23 kg pigs. However, body weight gain during the first 14 d post 
mixing was unaffected by the mixing stress. Although Heetkamp et al. (1995) observed 
acute changes of heat production by mixing stress in 10-week-old pigs, the authors failed 
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to find the effects of mixing stress (five pigs from each of two litters) on feed intake, 
daily gain, or feed efficiency during the initial two weeks post mixing. The possibility 
that the growth performance may be affected by the mixing stress during the earlier 
period cannot be ruled out.       
 In the case of finishing pigs (55 and 75 kg BW; ten pigs per pen), daily weight 
gain was decreased by more than 10% and 30%, respectively, in the mixed group 
compared to the unmixed group during the first two weeks following mixing (Spoolder et 
al., 2000). It may be that heavier pigs hurt each other more severely during the 
dominance establishing procedure. In the same experiment, more skin lesions were 
observed in pigs mixed at 75 kg than in those mixed at 55 kg, although the levels of 
aggression were indifferent. 
 Stookey and Gonyou (1994) conducted three mixing stress trials with pigs of 84 
kg BW (three to five pigs per pen). The weight gain during the first week and second 
week following the mixing was measured. The results were inconclusive: weight gain 
was decreased by mixing during the first and the second week in trial 1, only the second 
week in trial 2, and only the first week in trial 3. When the data from three trials were 
pooled and analysed, mixing stress affected weight gain during only the second week. 
The pooled data may be explained by the finding that fighting was decreased after 
establishing a dominance order, but the aggressiveness such as threats and submissive 
action were present within a stable group (Jensen, 1982). The other issue was group size: 
Stookey and Gonyou (1994) grouped three to five pigs per pen, while Spoolder et al. 
(2000) grouped ten pigs in each pen.   
 An opaque barrier – an incomplete wall separating the area in the pen – affects the 
aggressive behavior and thus growth performance. Warant and Broom (1993) examined 
the effects of a barrier on the behavioral responses and growth performance after mixing 
at weaning. The presence of an opaque barrier in the pen alleviated the aggressive 
behavior by 40% and improved weight gain by 15% during the first week after weaning. 
As the space restriction is a stressor to the pigs, the quantity of the pen space is important. 
In addition, the quality of the pen space is also important especially when animals are 
exposed to mixing stress. Using a barrier in the pen may provide a hiding area where pigs 
can escape from the unwanted attention of other pen mates. This is a possible mechanism 
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whereby the presence of barrier decreased the frequency of aggression and improved the 
growth performance. In a quantitative aspect, the area of walls was approximately 17% 
increased by using a barrier. 
 Recently, Wellock et al. (2003) developed a model equation to calculate the 
response of mixing stress as following: 
 
 Rmix = b3 – [(g4 × BW) – {(g5 × BW) × Ln(t)}] 
 
where Rmix is the performance (%) relative to that of a nonmixed pig, the constant b3 is 
equal to 100, g4 and g5 are scalars likely to change with genotype, and t is the time in 
days where mixing occurs on d 1 (g4 = 0.8 + 0.04EX and g5 = 1.033 – 0.066EX, where 
increasing EX – coping ability – from 0 to 10 represent a decreasing ability to cope and 
modifies the effect of each stressor). The accuracy of this equation is limited, because the 
amount of available data was insufficient. However, this model shows the general 
relationship between mixing stress and growth performance. An example of the model is 
demonstrated in Figure 2.8. Pigs of 70 kg BW encountered mixing stress on d 1 and 
coping ability was 4, 5, or 6 (a decreasing coping ability).  
Social mixing stress has deleterious effects on growth performance during a short 
period post mixing. In the longer period, growth retardation by social mixing may be 
compensated. The use of a physical barrier in the pen alleviates the deleterious effects of 
social mixing with unacquainted pigs.  
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Figure 2.8. Proportional performance (%) of pigs exposed to mixing stress relative to that 
of a nonmixed pig (Adapted from Wellock et al., 2003).  
    
  Overall, mixing unfamiliar pigs results in aggressive behaviors and a high 
concentration of circulating cortisol within a few hours. Mixing stressor also affects 
feeding pattern. As a result, social mixing deleteriously affects growth performance 
during a short period after mixing. 
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2.2. Chromium (III) picolinate in animal production 
Trivalent chromium (Cr) is an essential micro element for animals (Anderson, 
1987; Offenbacher and Pi-Sunyer, 1988). Since the first report on the essentiality of Cr in 
rats (Schwarz and Mertz, 1959), roles of Cr have been widely studied in humans and 
animals. Generally Cr has been shown to potentiate the action of insulin (Mertz et al., 
1974; Vincent, 2000). In addition, Cr has been suggested to alleviate stress in animals 
and humans (Chang and Mowat, 1992; Anderson, 1994; NRC, 1997). 
Page et al. (1993) suggested that Cr is more available as an organic chelate. 
Effects of the specific organic form of trivalent Cr, CrPic, on growth, carcass leanness, 
and reproduction have been investigated in swine nutrition research. Influences of 
supplemental CrPic on pigs under stress situations have also been studied.   
 
2.2.1. Swine growth performance 
The effects of Cr on growth performance of pigs have been variable. Some 
researchers have reported that supplemental CrPic to swine diets may improve weight 
gain (Mooney and Cromwell, 1995) and feed efficiency (Lindemann et al., 1995). Others 
have reported that dietary CrPic effects on growth performance were absent or may be 
even negative (Boleman et al., 1995; Mooney and Cromwell, 1999; Matthews et al., 
2001). 
Lindemann et al. (1995) suggested that the supplementation of CrPic (200 ppb Cr) 
improved feed efficiency in pigs fed marginal levels of lysine but not in pigs fed 120% of 
the estimated requirement of lysine. Using the same dose of CrPic, Mooney and 
Cromwell (1995) observed improved weight gain (979 vs. 929 g/d; P < 0.09) in pigs fed 
supplemental Cr compared with the control group.   
Boleman et al. (1995) reported that pigs fed 200 ppb Cr as CrPic during growing 
finishing periods consumed less feed (P < 0.08) and grew slower (P < 0.05) than pigs fed 
no supplemental Cr. Mooney and Cromwell (1999) observed no effects of supplemental 
CrPic on weight gain, feed intake, or feed efficiency regardless of lean gain potential of 
the animals. Matthews et al. (2001) conducted two experiments to assess the effects of 
supplemental Cr on growing-finishing barrows. In the first experiment, supplemental Cr 
decreased weight gain (P = 0.03) and feed intake (P = 0.05). But the growth trial was 
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conducted only for 28 d (20 to 38 kg BW). In the second experiment (23 to 115 kg BW), 
growth performance was unaffected by supplemental Cr. 
In a review of supplemental CrPic in pig trials, an interaction between 
supplemental Cr and dietary protein level was suggested (Lindemann, 1999), in that 
supplemental Cr improves feed efficiency in the pigs fed protein marginal to the 
requirement whereas not in the pigs fed excess protein. In a recent review (Lindemann, 
2007), effects of Cr on the growth performance of pigs are inconsistent. However, the 
author did not rule out the possibility of positive effects of Cr on feed efficiency in some 
situations, based on the improved digestibilities of crude protein and dry matter by 
supplemental CrPic (Kornegay et al., 1997).   
 
2.2.2. Carcass leanness 
The effects of supplemental Cr on the carcass characteristics of pigs have been 
inconsistent. Since Page et al. (1993) reported that the supplemental Cr increased carcass 
leanness, favorable effects of supplemental Cr have been demonstrated in multiple 
experiments (Lindemann et al., 1995; Lien et al., 2001). However, these effects were not 
observed in other studies (Evock-Clover et al., 1993; Mooney and Cromwell, 1999; 
Matthews et al., 2001).  
Page et al. (1993) found quadratically increased (P < 0.01) loin muscle area 
(LMA) and percentage of muscling and quadratically decreased (P < 0.01) tenth rib fat 
depth (TRF) by supplemental Cr (0, 100, 200, 400, or 800 ppb) as CrPic. Lindemann et al. 
(1995) also reported that the supplementation of 200 ppb Cr as CrPic increased (P < 0.04) 
LMA and decreased TRF (P < 0.04) regardless of dietary lysine levels (100 or 120% of 
requirements). Lien et al. (2001) supported these findings by demonstrating similar 
effects of CrPic on carcass leanness.  
In contrast, Evock-Clover et al. (1993) reported that supplemental CrPic (300 ppb 
Cr) to the pigs from 30 to 60 kg BW had no effects on carcass characteristics. Mooney 
and Cromwell (1999) evaluated effects of supplemental CrPic (200 ppb Cr) to the pigs of 
different lean gain potential from 55 to 109 kg BW on carcass characteristics and tissue 
accretion. They found no effects of supplemental Cr on carcass traits, or accretion rates of 
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carcass protein or lipid. Matthews et al. (2001) reported that the supplementation of 200 
ppb Cr to barrows from 23 to 115 kg BW did not affect carcass traits.  
Mooney and Cromwell (1995) observed increased muscle percentage and 
decreased fat percentage of dissected carcass by supplemental Cr, but found no changes 
in LMA or backfat depth. This implies that the carcass measurements of LMA and TRF 
may not represent overall body leanness or fatness. Thus, in some studies that showed no 
effects of supplemental Cr on the carcass measurements, there could have existed true 
effects of supplemental Cr on the overall body lean percentage.   
In an experiment involving 1,000 pigs under commercial environment, 
Lindemann and Purser (1997) suggested that dietary CrPic (200 ppb Cr) was more 
effective in animals with high propensity for body fat deposition. In this experiment, the 
increase of percentage lean in the carcass by supplemental Cr was evident in barrows but 
not in gilts. Generally barrows consume more feed but have a lower daily lean gain than 
gilts. In barrows, thus, more extra energy is stored as body fat due to a lower energy need 
for muscle synthesis (Cline and Richert, 2001).  
 
2.2.3. Reproductive performance in swine 
 Since Lindemann et al. (1995) first reported that supplemental CrPic to the sow 
diets increased litter size, similar effects of CrPic have been observed in other studies 
(Hagen et al., 2000; Lindemann et al., 2004). 
 Lindemann et al. (1995) reported remarkable improvements of sow productivity 
by dietary supplementation of CrPic. Supplemental Cr (200 ppb) from early in the growth 
phase throughout later reproduction resulted in improved (P < 0.04) litter sizes in total 
born (11.82 vs. 9.58 pigs/litter), born live (11.25 vs. 8.93 pigs/litter), at d 21 (10.30 vs. 
8.15 pigs/litter), and at weaning (10.25 vs. 8.10 pigs/litter) compared with the control 
group. Litter weights were also improved (P < 0.03) in total born (17.04 vs. 13.79 
kg/litter) and born live (16.27 vs. 12.86 kg/litter) by supplemental CrPic. However, mean 
BW of piglets at weaning was lower (6.79 vs. 8.15 kg; P = 0.01) in the CrPic group than 
controls.    
Hagen et al. (2000) studied the effects of supplemental CrPic on productivity of 
sows in a commercial environment. In this study about 100,000 litters were used, and the 
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Cr dose was 0 or 200 ppb. Supplemental CrPic increased percent sows bred within 7 d 
(90.6 vs. 87.8%; P = 0.09). Dietary supplementation of CrPic increased pigs born live per 
litter (10.42 vs. 10.05 pigs/litter; P = 0.02) and pigs weaned per litter (9.08 vs. 8.75 
pigs/litter; P = 0.02). Sow mortality was lower (9.38 vs. 10.95%; P = 0.11) in the Cr 
supplemented group than controls. 
 In a cooperative study involving 353 litters at three experimental stations 
(Lindemann et al., 2004), influences of dietary CrPic (0, 200, 600, or 1,000 ppb Cr) 
supplementation on the reproductive performance were investigated. The number of pigs 
born live per litter was linearly (P = 0.08) and quadratically (P = 0.05) increased (9.49, 
9.82, 10.94, and 10.07) and sow lactating weight change was linearly (P = 0.01) increased 
(–0.2, 0.8, –4.1, and –3.9 kg) by increasing levels of supplemental CrPic. The Cr contents 
in the adrenal gland, kidney, and liver linearly increased (P < 0.01) as more CrPic was 
supplemented.  
Taken together, supplemental CrPic positively influences reproductive 
performance of swine in a variable magnitude perhaps due to the differences in animals, 
diets, environment, and other factors. Further research to identify the specific factors 
affecting the effectiveness of supplemental Cr may be needed.  
 
2.2.4. Animals under stress situations  
The inconsistent effects of dietary CrPic may be related to the condition of the 
animals and the experimental environments. Supplemental Cr has been suggested to be 
more effective in the animals under stress situations (Anderson, 1994; NRC, 1997). The 
stressors existing in swine production systems include cold/hot environmental 
temperature (Stahly and Cromwell, 1979; Schenck et al., 1992a,b), microbial infection 
(Webel et al., 1997), nutritional deficiency or imbalance (NRC, 1998), insufficient space 
allowance (Brumm and Miller, 1996; Wolter et al., 2000), and social mixing (Barnett et 
al., 1993; Marchant et al., 1995). 
 
Thermal stress 
Studies of supplemental Cr on swine under thermal stress have been rare. In 
poultry, however, effects of supplemental Cr in the stressful thermal environment have 
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been extensively studied (Sahin et al., 2001, 2002abc, Onderci et al., 2003; Sahin et al., 
2005).   
In an experiment employing 150 laying Japanese quail (Sahin et al., 2002b), 
supplemental Cr (0, 200, 400, 800, or 1,200 ppb) as CrPic linearly increased feed intake, 
BW, and feed efficiency of egg production (P < 0.05) of laying quail under conditions of 
heat stress (32.5°C). Egg qualities were also linearly improved by increasing 
supplemental CrPic levels including egg weight, specific gravity, eggshell thickness, and 
interior egg quality (P < 0.05). In this experiment, all the measurements responded 
linearly but not quadratically responded to supplemental Cr levels, and the highest 
concentration (1,200 ppb) of Cr resulted in the best results. Thus supplemental Cr over 
1,200 ppb may potentially cause even better results. The heat stress (32.8°C) on the 
broiler chickens was also alleviated by dietary supplemental CrPic (Sahin et al., 2002a). 
Dietary supplementation of Cr at levels of 0, 200, 400, 800, or 1,200 ppb linearly 
increased feed intake, BW, and feed efficiency (P < 0.05). Similar effects of 
supplemental CrPic on growth performance of Japanese quail under heat stress (34°C) 
have been reported by the same research group (Sahin et al., 2005).  
Supplemental CrPic has also attenuated the detrimental effects of cold stress in 
poultry. Sahin et al. (2001) investigated the effects of supplemental Cr (0, 100, 200 or 
400 ppb as CrPic) on performance and circulating hormones of laying hens housed under 
low ambient temperature (6.9°C). They reported that BW gain, egg production, and feed 
efficiency of egg production were linearly improved by supplemental CrPic (P < 0.001). 
The circulating insulin concentration was linearly elevated (P < 0.001), but the 
corticosterone concentration was linearly lowered (P < 0.001) by increasing levels of 
supplemental CrPic. Onderci et al. (2003) conducted an experiment to determine the 
effects of supplemental CrPic on nutrient digestibility, lipid peroxidation, and serum 
antioxidants of laying hens under cold stress (6.9°C). Supplemental Cr of 400 ppb 
improved digestibilities of dry matter, organic matter, crude protein, and crude fat (P < 
0.05). Lipid peroxidation was lowered and serum vitamins C and E were increased by 
supplemental CrPic (P < 0.05). 
While studies on dietary CrPic in thermal stressed swine have been rare, based on 
the results of poultry studies, in that supplemental CrPic moderated detrimental effects of 
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thermal stress, stress alleviating effects of high dose CrPic in the pigs under thermal 
stress seem warranted. 
 
Immune stress 
The immune system of swine can be chronically activated by environmental 
pathogenic bacteria (Coffey and Cromwell, 1995; Williams et al., 1997). Another 
technique is the direct injection of pathogenic bacteria (Turner et al., 2002; Yi et al., 
2005) or bacterial endotoxin (Yi et al., 2005). Influences of supplemental CrPic have 
been investigated in pigs challenged with LPS, the most widely employed endotoxin, but 
the results have been inconsistent (van Heugten and Spears, 1997; Lee et al., 2000). 
The effects of 200 ppb of supplemental Cr as CrCl3, CrPic or Cr-nicotinate on the 
pigs challenged with LPS have been studied by van Heugten and Spears (1997). 
Supplemental Cr tended to improve weight gain and feed intake (P < 0.10) in the pigs not 
challenged with LPS. However, supplementation with Cr did not moderate the depressed 
growth performance due to immune challenge. In vitro cellular immune response was 
increased (P < 0.10) but antibody response to ovalbumin was decreased (P < 0.05) in the 
pigs fed supplemental CrPic. However, supplemental CrPic did not moderate serum 
cortisol elevated by ACTH injection. 
In an experiment involving specific pathogen free pigs, 400 ppb of Cr 
supplementation as CrPic ameliorated the physiological responses due to immune 
challenge (Lee et al., 2000). Although supplemental Cr had no effect on growth 
performance of pigs challenged with LPS, plasma cortisol elevation was delayed by Cr 
supplementation. 
In an experiment at the University of Kentucky, supplemental CrPic (200 ppb of 
Cr) had no or limited effects on immune status of pigs during the post weaning period 
(van de Ligt et al., 2002c). General growth performance was unaffected by supplemental 
CrPic. Total IgG was decreased in the pigs fed supplemental CrPic on d 28 (P < 0.05). 
The authors suggested that CrPic had no positive effects on immunocompetence in pigs 
during the post-weaning period. 
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Nutritional stress  
Nutrition stress includes deficiency and imbalance of essential nutrients. In a 
review of supplemental CrPic in pig trials, an interaction between supplemental Cr and 
dietary protein level was suggested (Lindemann, 1999) in that supplemental Cr improved 
feed efficiency in pigs fed protein marginal to the requirement whereas not in pigs fed 
excess protein. Indeed supplemental CrPic improved feed efficiency by 7% on average 
(2.81 vs. 3.02 of feed:gain) in the experiments providing marginal protein, while feed 
efficiency was unaffected by CrPic supplementation in the experiments feeding excess 
protein. This concept was well demonstrated in an experiment by Ward et al. (1997). 
Supplemental Cr (400 ppb as CrPic) improved weight gain and feed efficiency in pigs fed 
the 80% of lysine requirement but not in the pigs fed the 120% of lysine requirement. 
However, van de Ligt et al. (2002b) failed to observe effects of supplemental 
CrPic in pigs fed deficient dietary protein. They observed linear increase of protein 
accretion and linear decrease of lipid accretion with increasing levels of dietary protein. 
However, they failed to observe major effects of supplemental CrPic on growth, carcass, 
or blood measurements in the pigs fed 76, 83, or 90% of lysine requirement. No major 
interactions between CrPic and dietary protein levels were observed. In another study by 
van de Ligt et al. (2002a), supplemental CrPic in pigs fed various levels of energy (70, 80, 
or 90% of requirement) was studied. But they failed to find the effects of supplemental 
CrPic on the growth or carcass characteristics. 
Although the influence of supplemental CrPic on pigs fed an insufficient amount 
of nutrients has been investigated, the effects of CrPic on the pigs fed excessive energy 
and/or fat have rarely been studied. The consumption of excessive amounts of dietary fat 
may cause obesity in humans (Lissner and Heitmann, 1995; Shepard et al., 2001) and 
rodents (Masek and Fabry, 1959; Lemonnier et al., 1975). Furthermore, the high-fat diet 
may result in insulin resistance (Lavau et al., 1979; Rocchini et al., 1997; Jones et al., 
2005) and cardiovascular disease (Aguila and Mandarim-de-Lacerda, 2003; Davis et al., 
2006).  
In a recent study employing obese mice induced by a high-fat diet (Bhattacharya 
et al., 2006), supplemental Cr as Cr carnosinate (Carnochrome) lowered body weight 
gain (3.04 vs. 7.29 g), body fat mass gain (0.95 vs. 3.13 g), and visceral fat mass gain 
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(0.26 vs. 1.09 g) in the mice fed experimental diets for 14 weeks (P < 0.05). Martin et al. 
(2006) studied effects of supplemental CrPic on patients with non-insulin-dependent 
(Type 2) diabetes mellitus taking an antidiabetic drug (sulfonylurea). Dietary CrPic 
intake for 24 weeks decreased weight gain (0.9 vs. 2.2 kg; P < 0.05), the changes of body 
fat percentage (0.12 vs. 1.17 %), subcutaneous fat (P < 0.05), visceral fat (P < 0.05), and 
total abdominal fat (P < 0.01) compared with the placebo group. 
Overall, effects of supplemental Cr on pigs fed insufficient nutrients have been 
variable, and further investigation may be needed to elucidate the effects of dietary CrPic. 
Based on the recent report in mice and humans, research to elucidate effects of 
supplemental CrPic on pigs fed excessive fat seems warranted. 
 
Crowding stress  
Insufficient floor space allowance induces stress and causes adverse effects in 
swine (Brumm and Miller, 1996; Wolter et al., 2000). Ward et al. (1997) reported that 
supplemental Cr (400 ppb as CrPic) did not moderate the adverse effects caused by 
inadequate space allowance. Siberio et al. (1996a,b) also observed no effects of 
supplemental Cr from Cr-yeast on growth performance, immune status, or mineral 
retention in nursery pigs reared in a crowded environment. 
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2.3. Diabetes mellitus and chromium (III) picolinate 
2.3.1. Classification of diabetes mellitus 
Diabetes mellitus (DM), a metabolic disorder, is related to the elevated blood 
glucose level. Although the disease can be simply defined as hyperglycemia, it is a highly 
heterogeneous disease (Bach, 1994). The causes and signs of this hyperglycemia include 
a deficiency of insulin secretion, a resistance of the insulin action, or a combination of 
these (Harris, 2000). The characteristic symptoms of diabetes include excessive thirst, 
polyuria (frequent urination), and polydipsia (intake of a large volume of water), due to 
glucosuria (the large amount of glucose excretion in urine). The meaning of DM is 
“excessive excretion of sweet urine.” Other characteristic metabolic changes include 
ketosis (overproduction of ketone bodies) and acidosis (Lehninger et al., 1993).  
Based on the major causes, DM is classified into insulin-dependent diabetes 
mellitus (IDDM) and non-insulin-dependent diabetes mellitus (NIDDM); with a lower 
incidence rate, other types of DM and gestational diabetes mellitus also exist (Table 2.5). 
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Table 2.5. Classification of diabetes mellitus (DM) 
 Causes Results 
Type 1 DM 
(IDDM) 
Pancreatic β-cell destruction, often 
immune mediated 
Loss of insulin secretion and 
insulin deficiency 
Type 2 DM 
(NIDDM) 
Genetic factors and nongenetic 
factors including age, high caloric 
diet, overweight, central adiposity, 
and low birth weight  
Insulin resistance and insulin 
deficiency 
Other types of 
DM 
Genetic defects affecting β -cell 
function or insulin action, diseases 
of the exocrine pancreas, and 
drug-induced pancreatic changes 
Type 1 and/or Type 2 
symptoms 
Gestational DM 
(GDM) 
Age Insulin resistance and relative 
insulin deficiency; delivery 
complications; increased risk 
of macrosomia and perinatal 
mortality 
(Adapted from Harris, 2000)
 
Type 1 diabetes mellitus (insulin-dependent diabetes mellitus; IDDM) 
The IDDM, also called juvenile-onset DM, is known as a hereditary disease and is 
the most common form of DM among children and adolescents. This type of DM 
comprises approximately 5 to 10% of cases in the DM patients (Harris, 2000). The IDDM 
patients require insulin therapy and a lifelong control of the balance between glucose 
intake and insulin dose (Lehninger et al., 1993).  
In IDDM patients, insulin secretion is completely inactive due to the insulin-
producing β-cell destruction, which leads to absolute insulin deficiency. Two subclasses 
of IDDM are an autoimmune class and an idiopathic (from an obscure or unknown cause) 
class. In the autoimmune form, cellular-mediated autoimmune destruction of the β-cell 
destruction occurs, and the disease continues chronically (Harris, 2000). 
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Type 2 diabetes mellitus (non-insulin-dependent diabetes mellitus; NIDDM) 
The NIDDM is also called adult-onset DM or type 2 DM. This type of DM 
comprises approximately 90% of cases in DM patients (Harris, 2000). The NIDDM 
develops more slowly and is milder compared with IDDM and often goes without 
recognition due to a lack of clinical symptoms (Lehninger et al., 1993).  
The causes of NIDDM are genetic factors and nongenetic factors, including age, 
high caloric diet, overweight, central adiposity, and low birth weight. These factors lead 
to insulin resistance in muscle, liver, and adipose tissue. Eventually, defects in insulin 
secretion leading to hyperglycemia precipitate clinical onset of the disease. In many cases, 
NIDDM patients alter diet or take oral agents to correct fasting hyperglycemia. However, 
if this correction cannot be achieved with the diet or oral agents, exogenous insulin 
therapy is required (Harris, 2000). 
  
2.3.2. Diabetic animal model 
Animal models provide important information about the pathogenic and 
physiological aspects of human diseases. Animal models of DM have been widely 
employed in basic and clinical research. Although these animal models do not necessarily 
exhibit the same symptoms present in human DM, they are valuable tools to study human 
diabetes (Young and Edwards, 2004). 
Several commonly used DM animal models and their metabolic characteristics are 
listed in Table 2.6. Diabetic animal models of IDDM have been generated using either 
the surgical removal of the pancreas, the genetically predisposed autoimmune, or β-cell 
toxic chemicals. The Bio-Breeding (BB) rat and non-obese diabetic (NOD) mouse are 
examples of genetically predisposed autoimmune (spontaneous) IDDM. The features in 
these animal models are very similar to human IDDM in most measurable criteria (Bach, 
1994). Streptozotocin and alloxan have been used to induce diabetes in animals due to 
their β-cell specific toxicity (Szkudelski, 2001). The NIDDM animal models exhibiting 
spontaneous hyperphagia include transgenetic models such as the ob/ob mouse, db/db 
mouse, and Zucker rat (Young and Edward, 2004). 
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Animal model Features Etiology Type1
 Total insulinopenia (insulin lack) 
  Subtotal insulin deficiency, hyposecretion 
   Insulin excess, peripheral insulin resistance 
    Dyslipidemia, vascular disease 
     Severe hyperglycemia 
      Moderate hyperglycemia 
       Ketosis, hyperglucagonemia 
        Easy to obtain or induce 
         Easy to maintain or manage 
 
Pancreatectomy x    x     Surgical 1 
BB rat x    x  x   Autoimmune 1 
NOD mouse x    x  x   Autoimmune 1 
Streptozotocin 
animal  x   x  x x x Cytotoxicity via GLUT2 1 
Alloxan animal  x   x  x x x Cytotoxicity via GLUT2 1 
Gold thioglucose   x   x   x Neurotoxic to glucosensors 2 
ob/ob mouse   x   x  x x Leptin deficiency 2 
db/db mouse   x   x  x x Leptin receptor deficiency 2 
Zucker rat   x x  x  x x Leptin receptor deficiency 2 
ZDF rat  x x x x    x Leptin receptor, secretory 2 
OLETF rat   x   x   x CCK receptor deficiency 2 
LAN corpulent rat   x x  x   x Unknown 2 
1 Type 1 diabetes, IDDM; type 2 diabetes mellitus, NIDDM. 
(Adapted from Young and Edwards, 2004)
 
Table 2.6. Diabetic animal models and the characteristics 
 
Diabetic animal models can be classified by the developing methods: 1) surgical 
removal of pancreas, 2) administration of diabetogenic chemicals, 3) dietary strategy with 
high-fat/high-sugar, 4) breeding animals, and 5) gene targeting and transgenesis. These 
methods have been developed and applied in DM studies. 
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Surgical removal of pancreas  
One of the most straightforward methods to study diabetes in animal models is 
surgically removing the pancreas. In the late nineteenth century, the surgical removal of 
the pancreas from a dog caused a condition resembling human DM (Lehninger et al., 
1993). In the 1920s, Banting and Best pancreatectomised dogs in their studies on the 
isolation and purification of insulin (Rees and Alcolado, 2005). Thereafter, a number of 
researchers employed this method in their diabetes studies. Barnes and Bloom (1976) 
used a pancreatectomised man to study glucagons in IDDM. This technique was 
employed to validate the use of the implanted insulin pump (Grau and Saudek, 1987). 
The artificial pancreas was applied in the clinical trials based on the in vitro studies. 
Depending on the research purpose and the animals, the partial removal of the pancreas 
was also used (Bonner-Weir et al., 1983; Brockenbrough et al., 1988; Hardikar et al., 
1999). Partial pancreatectomy caused moderate hyperglycemia without body weight or 
circulating insulin level changes (Bonner-Weir et al., 1983). These characteristics 
represent NIDDM. 
In pig studies, Wilson et al. (1986) induced IDDM by pancreatectomy or by 
intravenous administration of streptozotocin (150 mg/kg BW; diabetogenic agent). The 
authors reported that pancreatectomised pigs were unsuitable for long-term studies 
because of high morbidity and mortality whereas streptozotocin-injected pigs were 
suitable for long-term studies, including transplantation of pancreatic islet tissue. 
Recently, Kobayashi et al. (2004) reported that the pancreatectomised pig model was 
suitable for short term studies such as 5 d, with a mean survival of 7.7 d post surgery.  
 The advantages of this surgical method include high reproducibility and a 
similarity to human IDDM. However, the surgery requires postoperative analgesia and 
antibiotics administration. Moreover, chronic pancreatic enzyme supplementation is 
required for a longer period of study (Sieher and Traystman, 1993). 
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Administration of diabetogenic substances  
 Non-surgical methods of damaging the pancreas are available using diabetogenic 
agents listed in Table 2.7. These chemicals, especially alloxan and streptozotocin, have 
been widely used in diabetes studies due to the convenience and simplicity (Szkudelski, 
2001). The administration of these chemicals induces hyperglycemia by selectively 
destroying pancreatic β-cells. Depending on the dosage level and/or the administration 
method, the diabetogenic chemicals may cause either IDDM or NIDDM.  
 The advantage of the chemical method is that some chemicals are selectively 
toxic to β-cells leaving other pancreatic cells intact and that it is relatively easy to induce 
diabetes in model animals. However, the chemically induced diabetes may not be very 
stable and is frequently reversible due to the regeneration of β-cells, while other 
diabetogenic agents may be toxic to other organs in the body. More detailed information 
on these diabetogenic agents will be discussed in the next section (2.4.3. Diabetogenic 
chemicals). 
 
Table 2.7. Diabetogenic agents in experimental animals 
Name 
Alloxan  
Streptozotocin  
Dexamethasone  
Vancomycin  
Dithizone  
8-hydrozyquinolone  
(adapted from Rees and Alcolado, 2005)
 
 
Dietary strategies to induce diabetes 
 Dietary modulation can trigger diabetic symptoms in animal models. This 
nutritional method causes DM associated with obesity resulting from over-nutrition. 
Nutritional methods induce obesity and NIDDM in specific animal models including the 
Sand rat, the Spiny mouse, and the C57BL/6J mouse, as well as general animals, by 
affecting the glucose-stimulated insulin secretion mechanism.   
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 The Sand rats (Psammonys obesus) develop obesity and DM when they consume 
a high-energy diet. The initial signs are hyperphagia, obesity, hyperinsulinemia, and 
glucose intolerance. In later stages of the development, these animals show insulin 
deficiency with β-cell degeneration and necrosis and ultimately require insulin injection 
for survival (Shafrir and Ziv, 1998; Sahfrir, 2001). Spiny mice (Acomys calirinus) secrete 
low levels of insulin in their natural habitat but develop diabetes when they consume a 
high-energy diet. They gain weight rapidly and show severe pancreatic β-cell hyperplasia, 
hypertrophy, and increased pancreatic insulin content. This animal model accumulates 
insulin in β-cells, which may produce insulin deficiency and hyperglycemia (Velasquez 
et al., 1990; Srinivasan and Ramarao, 2007). The NIDDM can be induced by feeding a 
high-fat diet to the C57BL/6J mouse. This mouse strain is highly susceptible to diet-
induced obesity, NIDDM, and atherosclerosis (Surwit et al., 1988; Nishina et al., 1990). 
The three aforementioned diabetic models are specific subspecies or strains that 
are susceptible to nutrition-induced DM. A high-fat diet modulates circulating glucose 
and insulin concentration in general (genetically normal) animal models as well (Kim et 
al., 1995; Ahren et al., 1999).  
Recently, Cerf (2007) reviewed how a high-fat diet modulates glucose sensing 
and insulin secretion. Figure 2.9 shows a glucose-stimulated insulin secretion mechanism 
and effects of a high-fat diet on this pathway. Glucose enters the β-cell through 
membrane-bound glucose transporter isoform 2 (GLUT-2) and is phosphorylated to 
glucose-6-phosphate by glucokinase. In the following glycolysis, the intracellular 
ATP:ADP ratio increases, which triggers the inhibition of the ATP-sensitive K+ channels 
and results in depolarization of the cell membrane. The depolarization activates voltage-
gated calcium channels and Ca2+ release from the intracellular store, which results in an 
increased intracellular Ca2+ concentration. This electrical excitability causes exocytosis of 
the insulin via the cell membrane. Adrenergic agonists are also involved in the insulin 
secretion by regulating cAMP, protein kinase A, the ATP-sensitive K+ channels, and thus 
insulin secretion (Kahn et al., 2006; Cerf, 2007). 
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Glucose 
 
Figure 2.9. A high-fat diet regulation of glucose sensing and the glucose-stimulated 
insulin secretion in the beta-cell. Ca2+e extracellular calcium, [Ca2+]i intracellular calcium 
concentration, FFA free fatty acids, GLUT-2 glucose transporter isoform 2, Pdx-1 
pancreatic duodenal homeobox-1, TCA tricarboxylic acid cycle. Solid arrows denote a 
glucose-stimulated insulin secretion pathway; dotted arrows denote high fat diet 
regulation (Adapted from Kahn et al., 2006; Cerf, 2007). 
 
A high-fat diet and saturated free fatty acids increase circulating plasma glucose 
concentration. However, they inhibit the expression of the glucose transporter (GLUT-2) 
and glucokinase, which down regulates the increase of ATP:ADP ratio and subsequently 
inhibits insulin secretion. In addition, a high-fat diet and saturated free fatty acids reduce 
the expression of pancreatic duodenal homeobox-1. Pancreatic duodenal homeobox-1, 
mainly found in the nucleus, is a crucial transcription factor regulating β-cell 
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maintenance. Although this transcription factor is not directly involved in the glucose-
stimulated insulin secretion pathway, it may indirectly inhibit the expression of GLUT-2 
and insulin genes. A high-fat diet and saturated free fatty acids induce oxidative stress 
and directly or indirectly cause β-cell death (Cerf, 2007). 
 The advantages of using nutritional methods are that this diabetes mimics 
diabesity syndrome in the human population and that the over-nutrition is relatively non-
toxic to the other organs of the body. However, this strategy requires a long period of 
nutritional treatment to induce DM.  
            
Breeding animals 
Spontaneously diabetic animals can be obtained by inbreeding animals with 
specific selection criteria for diabetes for several generations. Depending on the selection 
criteria, both IDDM and NIDDM models can be developed. The spontaneous animal 
models are listed in Table 2.8. The most commonly used inbred animal models for IDDM 
are non-obese diabetic (NOD) mouse and bio breeding (BB) rat. The inbred animal for 
NIDDM include ob/ob mouse, db/db mouse, Zucker rat, Goto Kakizaki rat, and Kuo 
Kondo mouse (Rees and Alcolado, 2005; Srinivasan and Ramarao, 2007). 
The NOD mouse was developed from outbred ‘Swiss’ mice in a selection 
experiment in Japan (Makino et al., 1980). The NOD mouse develops insulitis, histologic 
change (edema) in the islets of Langerhans, at the age of 4 to 5 weeks and circulating 
insulin concentration decreases. Apparent diabetic symptoms can be observed at 12 to 20 
weeks of age. In contrast to human IDDM, ketoacidosis is not very severe and the animal 
can survive with the insulin administration (Atkinson and Leiter, 1999).  
 The BB rat was recognized in the Bio Breeding Laboratories, a breeding company 
(Nakhooda et al., 1977). At about 10 weeks of age, the animals demonstrate 
hyperglycemia, hypoinsulinemia, and hyperketonemia. Similarly to human IDDM, the 
ketoacidosis is severe and the animals may die unless insulin is administered (Rees and 
Alcolado, 2005).    
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Table 2.8. Spontaneous animal models of diabetes mellitus 
IDDM 
 NOD (non-obese diabetic) mouse 
 BB (bio breeding) rat 
 LETL (Long Evans Tokushima lean) rat 
 New Zealand white rabbit 
 Keeshong dog 
NIDDM 
 ob/ob mouse - monogenic model of obesity (leptin deficient) 
 db/db mouse - monogenic model of obesity (leptin resistant) 
 Zucker (fa/fa) rat - monogenic model of obesity (leptin resistant) 
 GK (Goto Kakizaki) rat 
 KK (Kuo Kondo) mouse 
 NSY (Nagoya-Shibata-Yasuda) mouse 
 OLETF (Otsuka Long-Evans Tokushima fatty) rat 
(Adapted from Rees and Alcolado, 2005) 
 
 The ob/ob (obese) mouse, also called Lepob, is derived from an autosomal 
recessive mutation on chromosome 6 (obese) in C57BL/6J mouse strain. Leptin, an 
appetite regulating hormone, is lacking in the ob/ob mice, which results in hyperphagia, 
decreased energy expenditure, and obesity. The ob/ob mouse gains weight rapidly and 
may become three times heavier that the wild type mouse. Apparent obesity with 
increased carcass lipid can be observed at four weeks of age. In addition, these animals 
develop diabetes-like symptoms including hyperglycemia, mild glucose intolerance, 
severe hyperinsulinemia, and impaired wound healing (Srinivasan and Ramarao, 2007). 
These animals exhibit both hypertrophy and hyperplasia of the pancreatic islets with 
obesity (Velasquez et al., 1990). The administration of leptin into the ob/ob mouse results 
in decreased body weight gain, lower feed intake, and improved insulin sensitivity 
(Asensio et al., 2004). 
 The db/db (diabetic) mouse, also called Leprdb, is derived from an autosomal 
recessive mutation on chromosome 4 in the C57BL/KsJ mouse strain. In this animal 
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model, lack of leptin receptor leads to hyperphagia, obesity, hyperglycemia, 
hyperinsulinemia, and insulin resistance within a month of age. At the age of four months, 
hypoinsulinemia and hyperglycemia can be observed. In contrast to the ob/ob mouse, the 
injection of leptin does not alleviate the diabetic symptoms in the db/db mouse. The 
Zucker rat, also called Leprfa, is derived from the simple autosomal recessive gene (fa) on 
chromosome 5. The metabolic characteristics of this rat are similar to the db/db mouse 
(Srinivasan and Ramarao, 2007).    
 The advantage of the spontaneous diabetic animal models is that the 
characteristics of the animals resemble those of human diabetes and the genetic 
homogeneity decreases the variation in the experiments. However, the availability of the 
inbred model animals is limited, and the animals are costly. Moreover, the mortality due 
to the severe ketosis is high and the animals may need complicated maintenance care 
including exogenous insulin administration (Srinivasan and Ramarao, 2007). 
 
Gene targeting and transgenesis 
Recent progress in molecular and embryological techniques enabled gene 
targeting and transgenesis. Gene targeting means the process by which a gene may be 
interrupted in an embryonic stem cell followed by the transmission along the germ cell 
line. This process results in ‘knockout’ animals. Transgenesis refers to the incorporation 
of transgenes (modified genes) into the pronucleus of a zygote (Rees and Alcolado, 2005). 
The knockout and transgenic animal models have been extensively used in diabetes 
research. 
The target genes used to produce animals for insulin action studies include insulin 
receptor, insulin receptor substrate, glucose transporter (GLUT-4), and peroxisome 
proliferated receptor-γ. The disruption of one of these genes produces animals with the 
characteristics of insulin resistance, hyperglycemia, and/or ketoacidosis. The insulin 
secretion related genes, such as glucokinase and GLUT-2, have also been targeted to 
develop animals lacking insulin secretion in response to glucose load. As previously 
demonstrated, these genes play crucial roles in the glucose-stimulated insulin secretion 
mechanism (Figure 2.4.1). Targeting multiple genes results in model animals lacking 
both insulin action and insulin secretion. For instance, disrupting both insulin receptor 
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substrate and glucokinase produced animals with insulin resistance and β-cell dysfunction 
(Kadowaki, 2000; Nandi et al., 2004; Plum et al., 2005). 
The gene targeting and transgenesis approach has produced animal models 
exhibiting diabetic signs and has enabled the dissection of complex genetics of diabetes. 
However, this approach is sophisticated and expensive for the model production and for 
animal maintenance. Moreover, the lack of a gene may influence undesired tissues and/or 
unintended periods of life such as during embryogenesis. Subsequently, animals may 
have abnormality in other organs not of importance for diabetes study and may die even 
before birth. 
The limitations of the conventional gene targeting approach have been partially 
overcome by recent technical advances. A major technical invention recently developed 
is tissue-specific knockout method. This technique enables researchers to study the action 
of insulin in specific target tissues such as muscle, adipose, and liver in diabetic objects 
and to overcome the problems in classical knockout technique (Nandi et al., 2004; Plum 
et al., 2005). 
 
2.3.3. Diabetogenic chemicals 
Alloxan 
The name ‘alloxan’ was made as this substance was derived from a combination 
of allantoin (a product of uric acid among others excreted by the fetus into the allantois) 
and oxalsaure (oxaluric acid derived from oxalic acid and urea, found in urine). The 
chemical structure of alloxan is shown in Figure 2.10, and this chemical is brownish-red 
crystals and strongly hydrophilic. This substance is very unstable with a half-life of a few 
minutes in water at room temperature and even less stable at body temperature 
(McLetchie, 2002). In order to maximize the activity of alloxan, this chemical is 
administrated to the animals shortly after being dissolved in an acidic buffer. Since the 
diabetogenic properties of alloxan were first reported in rabbits (Dunn et al., 1943), it has 
been widely used for the induction of experimental DM (Romsos et al., 1971; Fischer et 
al., 1983; Katsumata et al, 1994; Huang and Wu, 2005).  
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Figure 2.10. Chemical structure of alloxan 
 
Alloxan has been widely used to induce diabetes in experimental animals because 
of its selective toxicity to the β-cells of the pancreas (Romsos et al., 1971; Weaver et al., 
1978). In rat islets maintained in a simple perfusion system, the insulin release suddenly 
reached to its maximum and rapidly declined to a very low level (Weaver et al., 1978). In 
the same study, the presence of glucose reversed some of the subsequent inhibition of 
insulin secretion by alloxan injection, suggesting that alloxan and glucose were sharing, 
and thus competing for, a common transporter on the β-cell. Kliber et al. (1996) also 
reported that alloxan treatment induced a sudden, short-term release of insulin and that a 
high concentration of glucose in the perfusion media inhibited the alloxan effects. 
The uptake of alloxan by β-cells is followed by the production of reactive oxygen 
species in the alloxan reduction process (Heikkila et al., 1976). One of the reactive 
oxygen species, H2O2, was shown to induce DNA strand breaks in the β-cells (Okamoto, 
1985; Takasu et al., 1991).     
The β-cell-specific toxicity to alloxan is notable. If alloxan administration causes 
serious damage in other tissues, the animal model generated by alloxan may not represent 
only DM but other disease or malfunctioning status. This diabetogenic chemical may 
cause liver and kidney damage, but at dosages generally used to induce diabetes there is 
no significant damage by routine examination methods (McLetchie, 2002). In addition, 
Boquist et al. (1983) showed that the uptake of alloxan was greater in endocrine pancreas 
than in the other organs including liver, exocrine pancreas, and heart. 
The diabetogenic action of alloxan depends on the nutritional status, the 
administration route, the dosage level, and the animal species. Perhaps because alloxan 
competes with glucose for a common transporter (Weaver et al., 1978; Kliber et al., 
1996), fasted animals were more susceptible to alloxan than those provided glucose 
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administration (Szkudelski et al., 1998). The animals injected with glucose represent 
nutritionally a post-prandial status. The effective dose of intravenous alloxan injection 
ranges generally from 40 to 60 mg/kg BW in mice (Fischer et al., 1983; Huang and Wu, 
2005) and rats (Matsushita et al., 1989; Diaz et al., 1996). When alloxan is administered 
intramuscularly or intraperitoneally, the effective dosage levels are between 120 and 200 
mg/kg BW in rats (Katsumata et al., 1994; Khandkar et al., 1995). 
Compared with the rodent models, swine are more resistant to alloxan toxicity. 
O’Hea and Leveille (1970) failed to induce DM by an intravenous administration of 50 
mg/kg BW alloxan to 12 kg pigs. Romsos et al. (1971) observed three- to four-fold 
increased blood glucose in alloxan injected pigs with 200 mg/kg BW of dosage. In the 
same experiment, alloxan induced DM in pigs fasted for 48 h and in pigs provided with 
NH4Cl in drinking water whereas animals fed diet continuously did not show any diabetic 
signs. The continuous feeding results in an elevated level of blood glucose which is 
competing with alloxan for a transporter on the β-cells. The provision of NH4Cl induces 
systemic acidosis and thus may potentiate the diabetogenic action of alloxan. Emmrich et 
al. (1982) observed increased glucose with very low insulin in the pigs injected with 100 
mg/kg BW of alloxan whereas a 200 mg/kg BW dose resulted in only fatal outcomes. In 
the case of pregnant pigs, an intravenous injection of 50 mg/kg BW of alloxan induced 
gestational diabetes (Ramsay et al., 1995). The low sensitivity of pigs to alloxan may be 
related to the low expression of GLUT-2 in the β-cells (Dufrane et al., 2006). Thus, the 
optimum dose of alloxan for DM induction in pigs is higher than in rodent models, but it 
varies depending on many factors including nutritional status, acidic condition, and the 
physiological stage of the pigs. 
 Alloxan has been widely employed to produce diabetic animal models due to its 
β-cell specific toxicity. In addition to the rodents, swine can also be used as a diabetic 
model with a high dose of alloxan. 
  
Streptozotocin 
Streptozotocin is an antibiotic synthesized by Streptomycetes achromogenes. The 
chemical structure of streptozotocin is shown in Figure 2.11. This chemical is structurally 
a glucosamine derivative of nitrosourea. The glucose portion is responsible for the 
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transport across the cell membrane via a glucose transporter (GLUT-2), and the 
nitrosourea triggers toxic action in the cells (Srinivasan and Ramarao, 2007). The 
diabetogenicity of streptozotocin was first reported in dogs and rats by Rakieten et al. 
(1963). Like alloxan, streptozotocin induces DM by destroying pancreatic β-cells. But 
this diabetogenic agent has a longer half-life (15 minutes) and lower mortality than 
alloxan in diabetic animal production (Ozturk et al., 1996). 
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Figure 2.11. Chemical structure of streptozotocin 
 
The manner of diabetogenic action of streptozotocin is similar to that of alloxan, 
while the toxicity is induced by a different mechanism. West et al. (1996) 
intraperitoneally injected 80 mg/kg BW of streptozotocin to fasted rats. They reported 
hypoglycemia associated with a high concentration of circulating insulin at 6 h after the 
streptozotocin injection and subsequent hyperglycemia development related with 
decreasing levels of plasma insulin. The damages of the β-cells were also observed in 
histological examinations. This observation is similar to the manner of alloxan action 
(Weaver et al., 1978). However, streptozotocin has been reported to induce β-cell death 
mainly by alkylation of DNA (Elsner et al., 2000), while the toxicity alloxan is derived 
from reactive oxygen species (Takasu et al., 1991). 
The dosage level of streptozotocin varies in the literatures. In rodents, intravenous 
injection doses varied from 60 to 240 mg/kg BW for diabetogenic action (Weber et al., 
1984; Almdal et al., 1986; Gorska et al., 2004), and intraperitoneal doses were between 
40 and 200 mg/kg BW (Bansinath et al., 1991; Julu and Mutamba, 1991; Zhang et al., 
2002; Lau et al., 2006). The most frequently used dose of streptozotocin was between 60 
to 100 mg/kg BW in both intravenous and intraperitoneal routes of administration. The 
similarity in dosage levels of streptozotocin in both injection methods may be due to the 
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relatively long half-life of streptozotocin. Jamal and Saggerson (1988) induced DM in 
rats by subcutaneous administration of 100 mg/kg BW of streptozotocin. 
In the case of pigs, Gabel et al. (1985) reported that 100 to 150 mg/kg BW of 
streptozotocin induced a complete and permanent DM in a titration study. When 35 
mg/kg BW of streptozotocin was injected, glucose metabolism was unaffected, but 85 
mg/kg BW of the chemical resulted in transient diabetic signs. Other studies employing 
swine as a model used 100 to 150 mg/kg BW as the streptozotocin dosage (Edwards et al., 
1996; Ramsay and White, 2000; Koopmans et al., 2006). In a recent study, a low dose, 50 
mg/kg BW, did not affect circulating glucose whereas 150 mg/kg BW of streptozotocin 
caused blood glucose elevation by 4.5-fold (Dufrane et al., 2006). In the same experiment, 
a low dose of 50 mg/kg BW streptozotocin destroyed over 97% of the β-cell mass in rats 
and primates, and the destructed β-cells were not regenerated at least for six months. In 
contrast, pigs showed partial correction of hyperglycemia even at the high dose of 150 
mg/kg BW streptozotocin, and destroyed cells were regenerated. The low sensitivity of 
pigs to streptozotocin toxicity may be related to the low expression of GLUT-2 (Dufrane 
et al., 2006). 
Streptozotocin has been widely used to induce diabetes in model animals due to 
its β-cell specific toxicity. This diabetogenic agent can more easily induce diabetes than 
alloxan because of the higher stability. In pigs, the diabetogenic action of streptozotocin 
may be effective for a relatively short period. 
 
Dexamethasone 
The administration of glucocorticoids reduces inflammation and immune 
activation in transplantation, asthma, allergic disease, and many systemic diseases. 
However, excess glucocorticoid decreases insulin sensitivity leading to the metabolic 
syndromes including insulin resistance and hypertension (Schäcke et al., 2002). The 
negative aspects of glucocorticoids have been applied to induce DM in animal models. 
Dexamethasone is a synthetic form of glucocorticoid hormone (Figure 2.12) and has been 
used as a diabetogenic agent in animal models (Ogawa et al., 1992; Ohneda et al., 1993; 
Novelli et al., 1999; Bernal-Mizrachi et al., 2003).   
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Figure 2.12. Chemical structure of dexamethasone 
 
Although dexamethasone induces insulin resistance in genetically normal animal 
models, the diabetogenic action of this steroid is more apparent in inbred animal models. 
All the obese Zucker (fa/fa) rats (n=5) showed diabetic symptoms by a single 
intraperitoneal injection of a small dose (0.4 mg/kg BW) (Ohneda et al., 1993). However, 
the daily intraperitoneal administration of 5 mg/kg BW for 24 d induced DM only in 4 
out of 25 normal Wistar rats (Ogawa et al., 1992). The effectiveness of dexamethasone is 
also dependent upon the age of the animals. Novelli et al. (1999) reported that the 
subcutaneous daily injection of dexamethasone (0.13 mg/kg BW) for 13 d increased 
plasma glucose up to diabetic levels in most of 18-month-old and in all 26-month-old 
Sprague-Dawley (genetically normal) rats. In 3-month-old rats, however, plasma glucose 
was unaffected by dexamethasone administration.    
In swine, instead of diabetogenic action of dexamethasone, studies have focused 
on its positive effects such as growth promotion. The intramuscular injection of this 
chemical (1 mg/kg BW) within 1 h of birth increased weaning BW by 10 to 23% (Carroll, 
2001; Seaman-Bridges et al., 2003). Gaines et al. (2002) also observed 10% increased 
weaning BW in pigs injected with 2 mg/kg BW of dexamethasone within 24 h of birth. 
Carroll (2001) reported increased insulin-like growth factor I associated with the 
increased weight gain in the suckling piglets. However, Gaines et al. (2004) failed to 
demonstrate the growth promoting effect of dexamethasone in the commercial condition 
perhaps due to the rather good experimental environment compared to their previous 
experiment (Gaines et al., 2002). 
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Dexamethasone is a less efficient diabetogenic agent compared to alloxan and 
streptozotocin. But this steroid is useful for insulin resistance related studies and 
glucocorticoid-induced diabetes research. 
 
2.3.4. Chromium effects in diabetes 
The essentiality of Cr in blood glucose regulation was first reported in the late 
fifties (Schwarz and Mertz, 1959) and the roles of Cr have been widely studied in humans 
(Ravina et al., 1999ab; Anderson et al., 1997; Cheng et al., 2004), animals (Schroeder, 
1966; Raz and Havivi, 1988; Lindemann et al., 1995), and in vitro models 
(Deliconstantinos et al., 1984; Chang et al., 1996). A well-known function of Cr is its 
action on the insulin potentiation (Mertz et al., 1974; Vincent, 2000). Although detailed 
mechanisms of Cr have not been fully understood, the effect of Cr on glucose metabolism 
has been shown in diabetic animal models and human patients. The beneficial effects of 
Cr have been reported mostly in NIDDM due to the direct effect of Cr on insulin action. 
In the other types of DM including non-insulin-dependent, gestational, and steroid-
induced DM, the disease symptoms and signs were alleviated with the supplemental Cr. 
However, the diabetes alleviating effects of dietary Cr have been inconsistent in clinical 
and experimental conditions (Anderson, 2000; Cefalu and Hu, 2004). 
 
Insulin potentiation action of chromium 
The major role of Cr is involved with the effects of insulin on the uptake of 
glucose in the muscle and adipose tissue. Chromium has been reported to inhibit 
phosphotyrosine phosphatase which decreases insulin sensitivity (Davis et al., 1996). In 
other words, Cr increases insulin sensitivity. In addition, Cr has been suggested to 
improve insulin binding, insulin receptor number, insulin internalization, and β-cell 
sensitivity (Anderson, 1997). At the cellular level, the action of Cr for glucose and insulin 
metabolism is achieved via a low-molecular-weight chromium-binding substance 
(chromodulin). Vincent (2000) proposed the cellular mechanism of action for Cr and 
chromodulin in response to insulin (Figure 2.13). The major carrier protein for Cr is 
transferrin in the circulation system. When the insulin receptor is activated by the binding 
of insulin to its receptor in the insulin-sensitive cells, the transferrin receptors migrate to 
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the plasma membrane and the Cr bound to tranferrin is internalized by endocytosis. Then, 
the Cr is released from transferrin and transferred to an apo (inactive) form of 
chromodulin to make a holo (active) form of chromodulin, resulting in the binding of 
holochromodulin to an insulin receptor. The result of this process is an increase of 
insulin-dependent kinase activity and thus enhancing the function of insulin. With the 
decrease of circulating insulin concentration, the holochromium is eliminated from cells.  
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Figure 2.13. Proposed mechanism of action for chromium and chromodulin potentiating 
the action of insulin. The inactive form of the insulin receptor (InR) is converted to the 
active form by binding insulin (In). This triggers a movement of Cr (presumably in the 
form of Cr-transferrin) from the blood into insulin-dependent cells, which in turn results 
in the binding of Cr to apochromodulin (triangle). Finally, the holochromodulin (square) 
binds to the insulin receptor, further activating the receptor kinase activity. 
Apochromodulin is unable to bind to the insulin receptor and activate kinase activity. 
When the insulin concentration drops, holochromodulin is released from the cell to 
relieve its effects (Adapted from Vincent, 2000). 
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Effects of chromium on IDDM 
In a few clinical studies, beneficial effects of Cr supplementation on IDDM 
patients have been observed, although most of the clinical reports on the effects of Cr 
were in NIDDM patients. Ravina et al. (1995) reported that 10 d of supplemental Cr (200 
μg/d) as CrPic increased insulin sensitivity in IDDM patients. These patients were able to 
reduce the insulin dose by 30%. Fox and Sabovic (1998) also reported that glycosylated 
hemoglobin (HbA1c) decreased from 11.3% to 7.9% in a 28-year-old female patient with 
an 18 year history of IDDM by the supplemental Cr (three times of 200 μg/d) as CrPic. 
The measured hemoglobin, HbA1c, represents average circulating glucose concentration 
over the previous few weeks to months (Koenig et al., 1976), thus the cumulative 
concentration of blood glucose.  
Recently, Shindea et al. (2004) produced IDDM rats by injecting streptozotocin 
intravenously (40 mg/kg BW) to adult rats. The supplementation of CrPic in the drinking 
water for six weeks decreased cumulative glucose concentration (35.4 vs. 19.2 g/dL 120 
min) during the first 2 h after insulin injection. This result was accompanied by increased 
insulin sensitivity index in the insulin tolerance test with Cr treatment. 
  
Effects of chromium on NIDDM 
 The clinical effects of Cr have been studied most frequently in NIDDM patients 
and animal models. In many studies, dietary supplementation of Cr improved glucose and 
insulin variables. However, others failed to demonstrate significant improvements by Cr 
in NIDDM.  
 A number of clinical studies showed beneficial effects of Cr in NIDDM patients. 
Anderson et al. (1997) investigated the effects of supplemental Cr on HbA1c, glucose, 
insulin, and cholesterol in patients with NIDDM. Compared with a placebo group, the 
patients receiving Cr (1 mg/d as CrPic) for four months had lower HbA1c, fasting 
glucose, 2-h glucose (2 h after glucose administration), fasting insulin, 2-h insulin, and 
total cholesterol. In the same study, four months of Cr supplementation relieved most of 
the DM criteria, whereas two months of Cr provision improved only a few criteria. The 
high dose of Cr (1 mg/d) showed quite clear improvements, but the responses to 0.2 mg/d 
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of Cr supplementation were not as significant as the high dose. Ghosh et al. (2002) also 
reported that the supplemental CrPic for 12 weeks reduced fasting serum glucose, post-
prandial serum glucose, HbA1, and fasting insulin in NIDDM patients. In elderly 
(average 73 years old) NIDDM patients, Cr (0.4 mg/d as CrPic for three weeks) lowered 
fasting blood glucose, HbA1c, and total cholesterol (Rabinovitz et al., 2004). The 
positive effects of dietary CrPic on glucose and insulin metabolism were reported also in 
NIDDM patients receiving sulfonylurea, a drug that stimulates pancreatic cells to release 
insulin (Martin et al., 2006). Recently, the combination of CrPic and biotin was shown to 
improve glucose management in NIDDM patients (Singer and Geohas, 2006). 
In agreement with the aforementioned clinical studies, the beneficial effects of Cr 
have been reported in NIDDM model animals. Yoshimoto et al. (1992) tested the effect 
of Cr administration on glucose tolerance in streptozotocin-induced NIDDM rats. 
Intraperitoneally administered Cr (20 μg/d/kg BW for four weeks) reduced plasma 
glucose concentration after intraperitoneal glucose injection. More recently, Shindea et al. 
(2004) produced NIDDM rats by intraperitoneally injecting streptozotocin (90 mg/kg 
BW) to 2-d-old neonate rats and investigated the effects of CrPic in drinking water on 
NIDDM. The provision of CrPic for six weeks decreased cumulative glucose 
concentration during the first 2 h after insulin injection and increased insulin sensitivity 
index.   
 However, dietary supplementation of Cr (0.1 mg/d as Cr yeast for eight weeks) 
had no effects on glucose tolerance, plasma insulin, and lipoprotein in NIDDM patients 
(Trow et al., 2000). Moreover, high dose of CrPic (1 mg/d) was reported to have no 
effects on weight, blood pressure, HbA1c, or lipid profile compared with a placebo group 
(Kleefstra et al., 2006). The lack of response in the report of Trow et al. (2000) can be 
explained by the differences in the source of Cr, and the dosage level compared with 
Anderson et al. (1997). However, Kleefstra et al. (2006) used the same source and dose 
of Cr with Anderson et al. (1997). Kleefstra et al. (2006) postulated that the difference in 
the population, thus different nutritional Cr status, resulted in the lack of Cr effects. They 
used the NIDDM subjects from western population whereas NIDDM patients in 
Anderson et al. (1997) were from Chinese population.  
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 The beneficial effects of supplemental Cr in NIDDM patients have been reported 
in many papers. The lack of effects in other studies can be partially explained by the 
differences in Cr source, dose, and nutritional status. However, the inconsistency of Cr 
effects has not been fully understood.  
 
Effects of chromium on gestational DM 
Gestational DM refers to glucose intolerance with onset or first recognition during 
pregnancy (American Diabetes Association, 2002). An insulin-resistant state increases 
during pregnancy and gestational DM occurs if the maternal pancreas is unable to 
increase insulin production enough to compensate for the increased needs (Jovanovic-
Peterson and Peterson, 1996). If a woman with gestational DM is deficient in Cr, dietary 
Cr may improve glucose and insulin metabolism in gestational DM patients. The 
deficiency of Cr in pregnancy can often occur by an increase in urinary Cr excretion 
(Saner, 1981) and an accumulation of Cr in the developing fetus (Davidson and Burt, 
1973) with advancing pregnancy. Thus, it may be postulated that nutritional 
supplementation of Cr to the women with gestational DM would be beneficial. However, 
available data on this topic are limited and inconclusive. 
Positive effects of supplemental Cr on gestational DM were reported by 
Jovanovic et al. (1999). They provided 0, 4, or 8 μg/d/kg BW of Cr as CrPic for eight 
weeks to the women with gestational DM. The supplemental Cr lowered fasting glucose 
and insulin level compared with the placebo group. In a pregnant gilt study, Lindemann 
et al. (1995) also reported that supplemental CrPic alleviated serum insulin at 2 h after 
feeding, the change of serum insulin concentration from prefeeding levels, and the ratio 
of insulin to glucose. However, Aharoni et al. (1992) found that the hair Cr content in the 
women with gestational DM was rather higher than in normal pregnancy. They suggested 
that the glucose intolerance in gestational DM may be due to impaired Cr utilization but 
not because of Cr deficiency. In an animal experiment, no effect of dietary CrK(SO4)2 on 
hyperglycemia or pregnancy outcome was observed in the streptozotocin-induced 
diabetic pregnant rats (Spicer et al., 1998).   
Although the beneficial effects of Cr in gestational DM can be logically expected, 
the responses to Cr have been unclear. The inconsistency in the literature may be related 
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to the dose of Cr, the form of supplemented Cr, and physiological differences among the 
species.  
 
Effects of chromium on steroid-induced DM 
Steroid hormones, especially glucocorticoids oppose the action of insulin and 
increase gluconeogenesis. If the insulin resistance by excessive glucocorticoid cannot be 
compensated by additional insulin secretion, steroid-induced DM may occur (Andrews 
and Walker, 1999). The glucocorticoids are often administered as an anti-inflammatory 
and anti-immune activation agent to humans with asthma, allergic disease, on systemic 
diseases or with organ transplantation (Schäcke et al., 2002). Thus steroid-induced DM 
often occurs as a side effect of a glucocorticoid therapy. Because Cr improves insulin 
sensitivity and alleviates stresses, it can be postulated that Cr may positively influence 
steroid-induced DM.  
Ravina et al. (1999a) observed an increase of daily urinary Cr excretion in the 
first 3 d following corticosteroid treatment. In the same study, CrPic supplementation of 
patients with steroid-induced DM decreased fasting glucose. The required amount of 
hypoglycemic agents to maintain a normal glucose level was also decreased by 50% with 
supplemental Cr. These results were confirmed in a follow-up study by the same group 
(Ravina et al., 1999b). More recently, Kim et al. (2002) conducted an experiment to 
investigate the effects of CrPic on dexamethasone-treated rats. In the insulin sensitivity 
test, cumulative glucose concentration during the first 2 h after insulin injection was 
decreased by CrPic treatment. The dietary treatment of CrPic also reduced fasting serum 
insulin levels and insulin concentration during the first 2 h after glucose load. 
 60
2.4. Adrenal steroid hormone physiology 
2.4.1. Anatomy of adrenal gland 
Gross anatomy of the mammalian adrenal gland 
The adrenal glands, also called suprarenal glands, are located close to the upper 
surface of each kidney (Figure 2.14). Their shapes are slightly different. The left gland is 
crescentic in shape, and the right gland is pyramidal in outline and resembles ‘a cocked-
hat.’ The average size of adult human adrenal gland is 5.0 cm by 2.5 cm along their major 
axes, and the left gland is generally 2 to 3 mm wider (Neville and O’Hare, 1982). Usually, 
peri-renal fat surrounds the adrenal gland (Asif, 2004), and arterial branches vascularize 
the adrenal gland from the aorta (Hadley, 1996). 
 
Figure 2.14. Gross anatomy of adrenal gland (Pickett, 2000) 
 
The adrenal gland can be partitioned into a head, a body, and a tail in a 
macroscopic examination (Figure 2.15). The head includes a large portion of medulla, 
and the depth is up to 6 mm. The body contains some medullary tissue, and the tail 
consists only of cortical tissue (Neville and O’Hare, 1979). 
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Figure 2.15. Adrenal gland showing the central vein (CV) surrounded by the cuff of clear 
cortical cells (CF) and its relationship to the distribution of the medulla (M) (Neville and 
O’Hare, 1979) 
 
The adrenal gland is composed of chromaffin and steroidogenic tissue. The 
steroidogenic tissue, which is cortical mass of the adrenal gland, surrounds the 
chromaffin tissue which is the inner medullary component. In many mammals, including 
humans, the steroidogenic tissue is called the adrenal cortex, which comprises almost 
90% of the mass of the adrenal gland. The chromaffin tissue is called adrenal medulla 
which is the center of the gland (Hadley, 1996; Ross et al., 1995). The adrenal gland and 
adrenal cortex are often thought to be separate glands, because they are structurally and 
functionally different in spite of their similar location. 
Concerning the close anatomical coupling of the cortex and medulla, several 
interaction mechanisms have been suggested. In terms of hormone flow, released 
products of the cortex perfuse the medulla through the blood vessel and sphincter-like 
muscles in the central adrenal vein may regulate the blood flow. Steroidogenesis is also 
interrelated between these two tissues. In the chromaffin tissue, many enzymatic 
reactions of the cortex can be carried out, and thus steroid intermediates are converted 
into active glucocorticoids (Hadley, 1996).  
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Comparative anatomy of the adrenal gland 
Adrenal glands of cows, horses, and pigs are dark brown color, whereas that of a 
dog is light brown. Most of the adrenal glands look flat, and the pig adrenal has a small 
indent. The location of adrenal glands varies according to the species. The adrenal of the 
horse is attached to the inner side of the kidney. Ruminants, pigs, and dogs have the 
adrenal gland more on the cranial side of the kidney compared to horses. The left adrenal 
gland of a dog is a little apart from the kidney, and the rabbit adrenal gland is positioned 
quite far from the kidney (Yoon, 1996).  
 
Microscopic anatomy of the adrenal gland 
The adrenal cortex can be partitioned into three morphologically and functionally 
different layers: zona glomerulosa, zona fasciculata, and zona reticularis (Figure 2.16). 
The narrow outer zona glomerulosa, the thick middle zona fasciculate, and the inner 
reticularis constitute 15%, 80%, and 5 to 7% of the cortical volume, respectively (Ross et 
al., 1995).  
 
 
Figure 2.16. Three cortical zones and medula of adrenal gland (Austgen et al., 1998) 
 
The blood is supplied to the adrenal glands through the superior, middle, and 
inferior adrenal arteries (Figure 2.17). These blood vessels branch out and make many 
small arteries when the vessels enter the capsule. Cortical arteries and arterioles branch 
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into capillary beds inside the cortical region, and these vessels merge into veins at the 
corticomedullary junction. Medullary arteries and arterioles, which penetrate the cortical 
region without branching and splitting, form capillary beds in the medulla (Ross et al., 
1995; Austgen et al., 1998). 
A number of preganglionic sympathetic nerve fibers are linked to parenchymal 
cells of the adrenal medulla. Because catecholamine-secreting medullary cells respond to 
nerve impulses delivered through the sympathetic fibers, medullary cells are considered 
postganglionic neuron equivalents (Ross et al., 1995).  
 
 
Figure 2.17. Vasculature of adrenal gland (Austgen et al., 1998) 
 
From an experimental point of view, three different zones of the adrenal cortex 
are not easy to culture together and represent the steroidogenesis pathway (described in 
the next section). The H295R adrenocortical carcinoma would be a good model for 
studying the metabolism of adrenocortical steroid synthesis because the pluri-potent cells 
synthesize three major adrenal steroids: aldosterone, cortisol and dehydroepiandrosterone 
(Rainey et al., 1994). In addition, the H295R cells are useful in molecular level research 
(Bassett et al., 2004a; Metzeler et al., 2004). 
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2.4.2. Chemistry and biochemistry of adrenal steroids 
Chemical nature of a steroid  
One of the most important chemical characteristics of a steroid is the fact that it is 
mostly lipid soluble. Until 1929, scientists failed to demonstrate the effect of adrenal 
cortex extract in adrenalectomized animals because they assumed that the compound in 
question was water soluble (Samuels and Uchikawa, 1967).  
A steroid is an organic molecule, and its structure is composed of the tetracyclic 
ring system (Figure 2.18). All the steroids produced from the adrenal cortex contain the 
cyclopentanoperhydrophenanthrene nucleus (Hadley, 1996). The four rings are named A, 
B, C, and D from lower left, and the carbon atom numbers start from the A ring. At room 
temperature, cyclohexane rings are conformationally mobile. In a steroid, however, 
cyclohexane ring-flips are constrained by rigid conformations of three cyclohexane rings 
which adopt an energy-minimizing chair conformation (McMurry, 1994). 
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Figure 2.18. A steroid 
 
Adrenal steroids 
Adrenal cortex cells produce various kinds of steroids from cholesterol. The 
major adrenal steroids are shown in Figure 2.19. In early in vivo studies, scientists 
compared the steroid concentration difference between adrenal venous blood and arterial 
blood. The steroids present in higher concentration in venous blood than in arterial blood 
were considered to be released from the adrenal gland (Samuels and Uchikawa, 1967). 
The adrenal steroid hormones are grouped into three categories by their effects. 
The names of these categories were also according to their biological effects: 
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mineralocorticoids, glucocorticoids, and gonadocorticoids. Aldosterone secreted from the 
zona glomerulosa is a main mineralocorticoid hormone and regulates electrolyte 
homeostasis. Cortisol secreted from the zona fasciculata is a main glucocorticoid 
hormone. Glucose metabolism regulation is one of the functions of cortisol. Adrenal 
gonadocorticoids, which are not significant in quantity, function as sex steroids (Ross et 
al., 1995; Hadley, 1996). 
 
Biochemical pathways of adrenal steroidogenesis 
Major pathways and enzymes in adrenal steroidogenesis are shown in Figure 2.19. 
Cholesterol is the precursor for adrenal steroid hormone biosynthesis. Cholesterol is 
converted to pregnenolone by the enzyme desmolase, which is required to cleave the 
terminal six carbons of the side chain of cholesterol (Hadley, 1996).  
Pregnenolone is a common precursor of numerous steroidogenic pathways. 
Pregnenolone can be converted either to progesterone or 17α-hydroxy pregnenolone by 
different enzymes. The enzyme 3β-hydroxysteroid dehydrogenase converts pregnenolone 
to progesterone by oxidizing the hydroxyl group at C3. The enzyme 17α-hydroxylase 
converts pregnenolone to 17α-hydroxy pregnenolone by hydroxylation of C17. For the 
synthesis of aldosterone and cortisol, the action of 3β-hydroxysteroid dehydrogenase is 
indispensable. The more 3β-hydroxysteroid dehydrogenase expresses, the less 
dehydroepiandrosterone (DHEA) is synthesized (Mason et al., 1993). The 17α-
hydroxylase has been suggested to compete with the 3β-hydroxysteroid dehydrogenase 
(Conley and Bird, 1997). The competition between these two enzymes influences the 
production of aldosterone versus cortisol and DHEA. 
In the zona fasciculata, pregnenolone is transformed into progesterone, and 
hydroxyls are successively added at C17 and C21. The resultant 11-deoxycortisol is 
hydroxylated in C11. Aldosterone is secreted exclusively in the zona glomerulosa. The 
last step of hydroxylation by 11β-hydroxylase is essential in synthesizing glucocorticoid. 
Deoxycorticosterone is synthesized by similar steps as in the zona fasciculata. However 
the critical last step to synthesize aldosterone is catalyzed by 18-hydroxylase and 18-OH-
dehydrogenase (Bern and Levy, 2000) 
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Figure 2.19. Major pathways in adrenal steroidogenesis (Adapted from Hadley, 1996) 
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2.4.3. Secretion 
Hypothalamic-pituitary-adrenal axis 
Hypothalamic corticotrophin-releasing hormone (CRH) controls the release of 
pituitary adrenocorticotropic hormone (ACTH). The pituitary ACTH modulates cortisol 
release by the cells of the fasciculata zone. Blood concentration of cortisol regulates CRH 
secretion from the hypothalamus and ACTH secretion from the anterior pituitary by 
feedback mechanism (Figure 2.20). In addition, physiological actions induced by 
corticosteroids can also inhibit further corticosteroid secretion through the negative 
feedback on the adrenal cortex, the anterior pituitary, the hypothalamus, and the higher 
brain centers (Ross et al., 1995). Homeostasis of cortisol secretion is modulated by this 
negative feedback mechanism of cortisol and physiological action induced by 
corticosteroids. 
 
 
Hypothalamus
Anterior Pituitary
Adrenal Cortex
Cortisol
CRH (Corticotropin-Releasing Hormone)
ACTH (Adrenocorticotropic Hormone)
(―) 
(―) 
Figure 2.20. Hypothalamus-pituitary-adrenal axis 
 
Adrenal corticosteroids negatively regulate mRNA and peptide expression of 
CRH in parvocellular neurosecretory neurons; whereas, many stressors positively 
regulate CRH (Sawchenko et al., 1993). In adrenalectomized rats, antisera to ovine CRH 
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lowered the ACTH level, which showed the stimulatory effect of CRH on ACTH 
secretion (Chrousos, 1992).   
A suggested mechanism of ACTH on adrenal steroidogenesis is illustrated in 
Figure 2.21. ACTH interacts with the plasmalemma of the zona fasciculata cells, 
resulting in increased intracellular cAMP and Ca2+ which ultimately activates the enzyme 
system of cortisol biosynthesis. After ACTH binds to the melanocortin 2 receptor (Liakos 
et al., 1998), ACTH activates cAMP production through adenylyl cyclases, and Ca2+ 
enters the cell through ionic channels. Calcium ion and protein kinase A (PKA) activated 
by cAMP stimulate the expression of enzymes and transcription factors (Gallo-Payet and 
Payet, 2003). Recently, nerve growth factor-induced clone B (NGFIB) was suggested to 
play an important role in regulating 3β-hydroxysteroid dehydrogenase (Bassett et al., 
2004b).   
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Figure 2.21. Proposed mechanism of ACTH on adrenal cortex (adapted from Gallo-Payet 
and Payet, 2003) 
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The interactions between secretagogues, such as CRH and arginine-vasopressin 
(AVP), and inhibitors, such as cortisol, were studied by Evans et al. (1996). They 
reported that CRH may protect the ACTH response to pulses of AVP in the presence of 
cortisol. In other words, background CRH can allow an increase in ACTH in response to 
AVP released by a new stress, in spite of the presence of an elevated cortisol level. 
Livesey et al. (2000), the same author group as Evans et al. (1996), further elucidated the 
interaction using dispersed equine anterior pituitary cells. They suggested that when the 
CRH level is physiologically high, it “permissively” prevented the cortisol-induced 
inhibition of the ACTH response to AVP. A basal level of cortisol “permissively” primed 
the HPA axis to maximally respond to stimulated levels of CRH and AVP. 
 
Cortisol patterns in blood 
The activity of the HPA system cyclicly changes over a 24-h diurnal period. The 
blood level of cortisol peaks between 3 and 8 am with a nadir at 18 to midnight. A similar 
pattern of pituitary ACTH secretion results in a diurnal rhythm of cortisol secretion 
(Jones, 1979). The detailed mechanism of ACTH on cortisol secretion is shown in Figure 
2.21. The cortisol rhythm is mainly regulated by the autonomic nervous system (Buijs 
and Kalsbeek, 2001). The diurnal rhythm of blood ACTH and cortisol is not present in 
patients with Cushing’s disease because of the high level of ACTH and cortisol secretion 
(Jones, 1979).  
 
2.4.4. Transport of adrenal steroid hormones 
Steroid hormones circulation – steroid binding protein 
The adrenal steroids are secreted into the blood, followed by the circulation to all 
parts of the body through the blood vessels. Most steroid hormones are transported to 
their target tissues by plasma proteins. Albumin nonspecifically binds most steroids. 
However, the affinities of albumin to cortisol, testosterone, and estradiol are low. These 
steroids are bound to specific binding proteins such as sex hormone binding globulin and 
cortisol binding globulin with higher affinity (Table 2.9). The concentration of the 
specific binding proteins is relatively low; whereas, the non-specific binding proteins are 
 70
present in high concentrations and thus have high capacity to bind steroids (Brooks, 
1979). 
 
Table 2.9. Steroid binding proteins in the plasma 
Parameter Albumin Sex hormone binding globulin 
Cortisol binding 
globulin 
Concentration (moles/liter) 5.0 × 10-4 3.9 × 10-8 6.0 × 10-7 
    
Association constant [(moles/liter)-1] at 37°C  
Cortisol 0.3 × 104  3.0 × 107 
Progesterone 12.0 × 104  9.5 × 107 
Aldosterone 0.3 × 104  6.5 × 108 
Testosterone 3.6 × 104 1.9 × 109 1.4 × 106 
Estradiol 6.0 × 104 6.0 × 108  
(Brooks, 1979)
 
The transcortin or corticosteroid-binding globulin (CBG) is a major cortisol 
binding protein, and with a lower affinity α-2 globulin also binds cortisol. Over 90% of 
cortisol is transported as bound to protein, and only about 6% of cortisol as unbound form 
(Hadley, 1996). Cortisol has a higher association constant (affinity) with CBG than with 
albumin (Table 2.9). Therefore, the binding to cortisol to albumin occurs only when CBG 
is limiting. The concentration of estrogen influences the CBG level as well as sex 
hormone binding globulin concentration (Vinson et al., 1992). 
 
Physiological significance of CBG 
The steroids bound to a binding protein are not utilized at target tissues, and only 
free hormones can enter cells and metabolize inside the cells (‘free hormone hypothesis’; 
Mendel, 1989). According to this hypothesis, the major role of CBG is to control the 
availability of corticosteroids (Westphal, 1983). Although many scientists agree that free 
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hormone may be the primary regulator of the action of hormone, more complex action of 
CBG has been reported (Breuner and Orchinik, 2002).  
In normal conditions, CBG provides a reservoir of cortisol. Different 
physiological or environmental conditions increase the level of unbound cortisol 
available to tissues by lowering the total CBG capacity. Tinnikov (1993) reported that 
starvation or immobilization decreased the total CBG capacity. Social stress (Alexander 
and Irvine, 1998; Spencer et al., 1996) and electric shock on the tail (Fleshner et al., 
1995) also decreased the capacity of CBG. 
The cell membrane CBG receptor may uptake CBG-corticosteroid complex 
across the membrane. Endocytosis is another possibility for CBG complex internalization. 
In the cell, cortisol would be cleaved from CBG as an active form of unbound cortisol. 
The membrane binding sites for CBG have been identified in human (Hryb et al., 1986) 
and rat (Maitra et al., 1993) livers. 
The cellular cAMP stimulating effect of CBG has also been reported (Nakhla et 
al., 1988; Strel’chyonok and Avvakumov, 1991). In both studies, unbound CBG showed 
no effect. Meanwhile the CBG-cortisol complex bound to the cell membrane receptor and 
increased the intracellular cAMP level. Therefore, the CBG molecule has its own 
biological activity as well as storage and delivery functions.  
 
2.4.5. Action of glucocorticoid 
Hormone receptors 
Hormones are delivered to all parts of the body through the blood vessel. 
However, they regulate only specific target tissues, not all cells. Different tissues express 
different types of proteins. A major protein contributing to allow hormone specificity is a 
hormone receptor. Receptors may be membrane bound, cytosolic, or nuclear elements 
(Hadley, 1996). 
The importance of hormone receptors may be explained by abnormal receptor 
expressions as suggested by Hadley (1996). If a cortisol receptor is absent in a tissue, the 
tissue would be irresponsive to cortisol secreted to play important roles. If cortisol 
receptors were concentrated in the left fingers’ muscle cells, stress would make the left 
fingers atrophic and weak, and there would be insufficient cortisol for normal purposes. 
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Furthermore, if all the tissues have non-specific hormone receptors, all the tissues will 
respond to a single hormone. Therefore, the existence, specificity and normal quantity of 
hormone receptors in tissues are important in hormone action in the body. 
The specificity of hormone receptors can be applied in medical therapy. For 
example, abnormally high levels of a certain hormone secretion might be treated by 
administration of a drug which binds to the hormone receptor but lacks intrinsic 
biological activity (Hadley, 1996). 
 
Steroid hormone – receptor interaction 
Steroid hormones freely diffuse into cells due to their hydrophobicity. In a 
classical model of steroid hormone action, steroid receptors in the cell change their 
conformation in response to hormones and act as transcription factors. A stepwise 
mechanism is described as follows (Figure 2.22). The steroid hormone binds to its 
cytoplasmic or nuclear hormone receptor specifically with high affinity. The receptor is 
activated into DNA-binding form. The hormone-receptor complex binds to hormone 
response elements in the promoter region of genes. Then, mRNA is translated into cell-
specific protein synthesis (Hadley, 1996). 
 
 
Figure 2.22. Steroid hormone – receptor interaction (Kimball, 2005) 
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Besides the receptor mediated action of steroid hormones, direct membrane 
actions of steroid hormones also exist. The receptor-independent fast action of steroid 
hormones in the neuronal membrane has been reported by Orchinik et al. (1991). The 
rapid signal transduction through neuronal membrane receptors were suggested to be 
mediated by guanine nucleotide-binding proteins (Orchinik et al., 1992). 
 
Glucocorticoid receptor 
The glucocorticoid receptor (GR) is present in almost every tissue. In humans, 
two types of highly homologous GR isoforms exist. Alternative splicing of the two 
terminal exons of the encoding gene in chromosome 5 generates these two isoforms 
(Figure 2.23). The classic form, GRα mediates most of the well known effects of cortisol; 
while, the role of GRβ has not yet been elucidated (Beato et al., 1995; Bamberger et al., 
1995; Tliba et al., 2006).  
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Figure 2.23. Genomic, complementary DNA, and protein structures of the human 
glucocorticoid receptor (GR). The human GR gene, located on chromosome 5, consists of 
10 exons. Exon 1 is untranslated, exon 2 encodes for the immunogenic domain, exons 3 
and 4 for the DNA binding domain (DBD), and exons 5–9 for the hinge region (HR) and 
the ligand binding domain (LBD). The GR gene contains two terminal exons, 9α and 9β, 
alternatively spliced to generate two isoforms, the classic GRα and the nonligand-binding 
GRβ (Manoli et al., 2004). 
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The GRα mechanism is shown in Figure 2.24. In the unliganded state, most of 
GRα exists in the cytoplasm. Cytoplasmic GRα is complexed with other proteins such as 
the heat-shock protein (Hsp) 90, 70, and 50; the immunophilin FKBP52; the cyclophilin 
Cyp40; the p23 protein; and their related molecules (hip, hop). When glucorticoid binds 
to the specific ligand binding domain (LBD) of GRα, the receptor changes its 
conformation, is separated from the oligomeric complex, and forms the free cortisol-
receptor subunit in the DNA-binding form. The activated receptor couples as a 
homodimer and enters into the nucleus through the nucleopore. Inside the nucleus, the 
receptor complex binds to specific glucocorticoid responsive elements (GRE) located in 
the promoter region of responsive genes and changes their transcriptional activity 
(Manoli et al., 2004). 
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Figure 2.24. Schematic illustration of the glucocorticoid receptor cell tracking and 
signaling (adapted from Sigma-Aldrich, 2005) 
 
The GR binding site of regulatory regions can be categorized by five different 
binding types and two different effects (Figure 2.25). GR can activate gene transcription 
by direct binding to so-called simple GRE (Figure 2.25.a). In many genes, the 
glucocorticoid response depends on other transcription factors close to the binding sites 
as well as GR binding to a GRE. Because these response elements are spatially and 
functionally clustered, they are called glucocorticoid responsive units (Figure 2.25.b). 
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Besides homodimer binding to GREs, GR can also bind the DNA as a monomer, which is 
called GRE half-sites (Figure 2.25.c). Occasionally, GR is recruited to DNA-bound 
transcription factors in a regulatory complex instead of binding directly to the DNA 
(Figure 2.25.d and g). The GRE that has negative influence on gene expression of 
responsive genes is called a negative GRE (nGRE) (Figure 2.25.e). In the competition 
model, GR binding to the nGRE inhibits other transcription factors from binding to their 
response elements, causing a negative response (Figure 2.25.f) (Schoneveld et al., 2004). 
 
 
Figure 2.25. Mechanisms of GR interactions with regulatory elements (Schoneveld et al., 
2004) 
 
Selected modulators of the glucocorticoid receptor activity are shown in Table 
2.10. The GR can also interact with other transcription factors, such as nuclear factor-κB 
(NF-κB), activator protein-1 (AP1), and signal transducers and activators of transcription 
(STATs). Many molecules and compounds have been suggested to regulate the activity 
of GR (Manoli et al., 2004). 
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Function Modulator 
Ligand binding  
    Agonists/modulators Steroids, ursodeoxycolic acid, cortivazol, thioredoxin 
    Antagonists RU 486 
GR trafficking Hsps, RAP46, FKBPs, 14-3-3s 
Transcription regulators 
 
 
 
Coactivators: BRG1 (SWI/SNF), p/CAF (ADA/SAGA), 
CBP/p300, p160, TIF2/GRIP1, AIB1, DRIP 
(TRAP/ARC), PGC-1, L7/SPA, ASC-2, PNRC, AIB1; 
viral proteins: E1A (adenovirus), Vpr (HIV-1), FLASH 
Corepressors: NCoR, SMRT 
Transcription factors 
 
NF-κB, COUP-TFII, AP-1, STATs, CREB, C/EBP, Nur77, 
HNF-6, p53, GATA-1, Sp-1, Oct-1, NF-1 
Abbreviations: Hsps, heat-shock proteins; RAP46, receptor-associating protein of .46 kDa; 
FKBPs, FK506-binding proteins; BRG1, Brahma-related gene 1; SWI, mating-type switching; 
SNF, sucrose nonfermenting; p/CAF, p300/CBP associated factor; ADA, alteration/deficiency 
in activation; SAGA, Spt-Ada-Gcn5-acetyltransferase; CBP, CREB-binding protein (cAMP 
response element binding protein); TIF2, transcriptional intermediary factor 2; GRIP1, GR 
interacting protein-1; AIB1, amplified in breast cancer; DRIP, vit D receptor interacting 
protein; TRAP, thyroid hormone receptor associated protein; PGC-1, peroxisome proliferator-
activated receptor γ–coactivator; L7/SPA, ribosomal protein L7/switch protein for antagonists; 
ASC-2, activating signal cointegrator 2; FLASH, FLICE associated huge protein; NCoR, 
nuclear receptor corepressor; SMRT, silencing mediator of retinoid and thyroid hormone 
receptor; NF-κB, nuclear factor κB; COUP-TFII, chicken ovalbumin upstream promoter 
transcription factor II; AP-1, activator protein 1; STATs, signal transducers and activators of 
transcription; CREB, cAMP-responsive element binding protein; C/EBP, CCAAT/enhancer 
binding protein; HNF-6, hepatocyte nuclear factor-6; GATA-1, erythroid transcription factor; 
Oct-1, octamer factor-1; NF1, nuclear factor-1.                                             (Manoli et al., 2004)
 
Table 2.10. Selected known modulators of the glucocorticoid receptor activity 
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2.5. Conclusion 
In swine production system various stress sources exist including thermal stress, 
immune stress, social stress, and dietary stress. These stressors may cause growth 
retardation, changes in hormone release, increased disease susceptibility, and/or 
behavioral changes. Many scientists have suggested that Cr may ameliorate negative 
effects associated with stress. Dietary supplementation of Cr has alleviated the negative 
effects of thermal stress in poultry and transport stress in calves. Supplemental Cr has 
favorably affected obese mice fed fat-enriched diet. 
However, studies on dietary Cr for pigs kept in stressful thermal environment 
have been sparse. The effects of dietary Cr on immune-challenged animals have been 
inconclusive in pigs. The influence of Cr on pigs fed fat-enriched diets has not been 
tested. In addition, effects of Cr on adrenocortical steroidogenesis have not been reported.  
Therefore, the objective of the current research is to investigate the effects of 
dietary Cr supplementation on pigs under thermoneutral or thermal stress environment in 
Chapter 3, pigs challenged with an endotoxin in Chapter 4, and pigs fed high-fat diets in 
Chapter 5. Additionally, effects of Cr on adrenocortical steroids secretion from H295R 
adrenocortical cells stimulated with an agonist are studied in Chapter 6. 
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CHAPTER 3. The Effects of Dietary Chromium (III) Picolinate on Growth 
Performance, Blood Measurements, and Respiratory Rate in High and Low 
Ambient Temperature 
 
Abstract  
Three experiments were conducted to investigate the effects of thermal stress and 
dietary chromium (Cr) on growth performance and physiological variables in weanling 
pigs. In Exp. 1, a total of 54 pigs (BW of 5.95 ± 0.84 kg) were allotted to a 2 × 3 factorial 
arrangement using two ambient temperatures (23.7 or 40.5°C during d 14 to 28 post-
weaning) and three dietary levels of Cr (0, 1,000, or 2,000 ppb) as Cr (III) picolinate. In 
Exp. 2, a total of 54 pigs (BW of 5.94 ± 1.29 kg) were allotted in the same treatment 
arrangement but with different ambient temperatures (26.5 or 16.0°C during d 14 to 26 
post-weaning). In Exp. 3, a total of 36 pigs (BW of 6.40 ± 0.72 kg) were allotted in the 
same treatment arrangement with ambient temperatures of 25.9 or 13.8°C during d 14 to 
28 post-weaning. During d 0 to 14 of all experiments, a neutral ambient temperature (NT) 
was maintained. In Exp. 1, pigs in high ambient temperature (HT) gained less weight 
(575 vs. 663 g/d; P < 0.001), and consumed less feed (926 vs. 1,074 g/d; P < 0.01) than 
pigs in NT during d 14 to 28. However, feed:gain was unaffected by ambient temperature 
(1.61 vs. 1.62; P = 0.79). Dietary Cr had no effect on growth performance. Pigs in HT 
had lower plasma cortisol on d 18 (44.3 vs. 56.9 ng/ml; P = 0.05), and on d 27 (37.4 vs. 
52.5 ng/ml; P < 0.01). Respiratory rate of pigs in HT was higher compared to the pigs in 
NT (114.6 vs. 65.0 breath/min; P < 0.001) on d 27. In Exp. 2 and 3 (pooled), pigs in low 
ambient temperature (LT) had higher ADFI (1,026 vs. 942 g/d; P < 0.01) and feed:gain 
(1.57 vs. 1.51; P < 0.01) during d 14 to 26 (28). Plasma cortisol was minimally affected 
by thermal temperature. Dietary Cr supplementation had no effects on blood 
measurements. In Exp. 3, the respiratory rate measured on d 22 and 27 was lower (43.2 
vs. 54.2 breath/min and 42.2 vs. 57.0 breath/min, respectively; P < 0.001) in the pigs in 
LT than the pigs in NT with no effects of dietary Cr supplementation. These results 
indicate that growth performance is affected by thermal stress and plasma cortisol is 
decreased by heat stress, but these effects are not moderated by dietary CrPic. 
Key Words: Thermal stress, Chromium, Pigs 
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3.1. Introduction 
Trivalent chromium (Cr) is an essential micro element for animals (Anderson, 
1987; Offenbacher and Pi-Sunyer, 1988). Since the first report on the essentiality of Cr in 
rats (Schwarz and Mertz, 1959), the metabolic roles of Cr have been widely studied in 
humans and animals. In addition to the insulin potentiation (Mertz et al., 1974; Vincent, 
2000), Cr has been suggested to alleviate stress in animals and humans (Chang and 
Mowat, 1992; Anderson, 1994; NRC, 1997). The stressors existing in swine production 
systems would include cold/hot (relative to thermoneutrality) environmental temperature 
(Stahly and Cromwell, 1979; Schenck et al., 1992ab), microbial infection (Webel et al., 
1997), insufficient space allowance (Brumm and Miller, 1996; Wolter et al., 2000), social 
mixing (Barnett et al., 1993; Marchant et al., 1995), and nutritional deficiency or 
imbalance (NRC, 1998). These stressors may cause growth retardation, changes in 
hormone release, increased disease susceptibility, and/or behavioral changes. 
Dietary supplementation of Cr alleviated the detrimental effects of cold stress 
(Sahin et al., 2001; Sahin et al., 2002c; Onderci et al., 2003) and heat stress (Sahin et al., 
2002ab; Onderci et al., 2005; Sahin et al., 2005) in poultry studies. However, studies on 
the dietary Cr in thermal stressed swine have been rare. Therefore, the purpose of the 
current research was to determine the effects of supplemental Cr on the pigs in 
thermoneutral or thermal stress environment. 
 
3.2. Experimental procedures 
Three experiments were carried out in environmentally controlled rooms at the 
University of Kentucky. The experiments were conducted under protocols approved by 
the Institutional Animal Care and Use Committee of the University of Kentucky.  
 
3.2.1. Experiment 1 (heat stress) - Animals and treatments 
 In a 28-d experiment, a total of 54 crossbred weanling pigs with an average initial 
BW of 5.95 ± 0.84 kg were used. Animals were allotted to a 2 × 3 factorial arrangement 
using two ambient temperatures (23.7 or 40.5°C during d 14 to 28) and three 
supplemental levels of dietary Cr (0, 1,000, or 2,000 ppb). Piglets were grouped into 
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three blocks by initial BW and randomly allotted to six treatment groups with three 
animals per pen, with balanced sex and ancestry using Experimental Animal Allotment 
Program (Kim and Lindemann, 2007). Two males and one female were housed in each 
plastic woven floored 1.2 m × 1.2 m pen. Each pen was equipped with a four-hole, 
stainless steel feeder and a nipple waterer. The height of each nipple was adjusted weekly. 
Pigs had ad libitum access to feed and water.  
The ambient temperature during d 0 to 14 was maintained in the thermoneutral 
zone. On d 14 the ambient temperature was changed to induce thermal stress, and the 
high temperature was maintained until the end of the experiment (Figure 3.1). The 
medians of maximum and minimum temperatures were calculated for each day, and the 
averages of daily median temperature of neutral and hot rooms during d 14 to 28 were 
23.7 and 40.5°C, respectively. 
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Figure 3.1. Daily median ambient temperature in the neutral (squares) and hot (circles) 
rooms (Exp. 1). The ambient temperature during d 0 to 14 was maintained in the 
thermoneutral zone; on d 14 the ambient temperature of hot room was changed to induce 
thermal stress, and the high temperature was maintained until the end of the experiment. 
The medians of maximum and minimum temperatures were calculated for each day, and 
the average of daily median temperature of neutral and hot rooms during d 14 to 28 were 
23.7 and 40.5°C, respectively. 
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One male fed no supplemental Cr in neutral ambient temperature died during the 
first week. Two males in neutral temperature (NT) – 1,000 ppb Cr treatment were 
considered as outliers and removed from the data set because they gained less than 43% 
of their pen mates during the first two weeks and during the last week, respectively. The 
feed intake of the remaining animals was estimated using the model suggested by 
Lindemann and Kim (2007).  
 
3.2.2. Experiment 2 and 3 (cold stress) - Animals and treatments 
 In Exp. 2, a total of 54 pigs (initial BW of 5.95 ± 0.84 kg) were housed in groups 
of three pigs per pen for a 26-d experimental period. In Exp. 3, a total of 36 pigs (initial 
BW of 6.40 ± 0.72 kg) were housed in groups of two pigs per pen for a 28-d period. The 
treatment structure and other procedures of Exp. 2 and 3 were the same as Exp. 1.     
 During the first 14 d of the experiments, the environment was maintained 
thermoneutral. The average ambient temperatures of neutral and cold rooms were 26.5 
and 16.0°C, respectively, during d 14 to 26 in Exp. 2 (Figure 3.2). The average ambient 
temperatures of neutral and cold rooms were 25.9 and 13.8°C, respectively, during d 14 
to 28 in Exp. 3 (Figure 3.3).  
In Exp. 2, one female in low ambient temperature – 2,000 ppb Cr treatment was 
considered as an outlier and removed from the data because this animal gained less than 
48% of its pen mates throughout the experimental period. 
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Figure 3.2. Daily median ambient temperature in the neutral (squares) and cold (triangles) 
rooms (Exp. 2). The ambient temperature during d 0 to 14 was maintained in the 
thermoneutral zone; on d 14 the ambient temperature of cold room was changed to induce 
thermal stress, and the low temperature was maintained until the end of the experiment. 
The medians of maximum and minimum temperatures were calculated for each day, and 
the average of daily median temperature of neutral and cold rooms during d 14 to 26 were 
26.5 and 16.0°C, respectively. 
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Figure 3.3. Daily ambient temperature in the neutral (squares) and cold (triangles) rooms 
(Exp. 3). The ambient temperature during d 0 to 14 was maintained in the thermoneutral 
zone; on d 14 the ambient temperature of cold room was changed to induce thermal stress, 
and the low temperature was maintained until the end of the experiment. The medians of 
maximum and minimum temperatures were calculated for each day, and the averages of 
daily median temperatures of neutral and cold rooms during d 14 to 28 were 25.9 and 
13.8°C, respectively. 
 
3.2.3. Experimental diets 
The diets, based primarily on corn, soybean meal, and dried whey, were 
calculated to contain 3,406 kcal/kg ME, 21.7% CP, 1.36% Lys, and 0.31% Met for d 0 to 
14; 3,600 kcal/kg ME, 19.9% CP, 1.19% Lys, and 0.30% Met for d 14 to 28 (Table 3.1). 
Minerals and vitamins were added to meet or exceed NRC (1998). Antibacterial agents 
and antioxidants were also included in the diets. To minimize potential variation that can 
occur with multiple diet mixings, a single batch of basal diet was prepared. 
Approximately the first 5% and last 5% (as manufacture sequence) of the basal diet was 
excluded in the treatment diet manufacturing. In Exp. 1 and 2, the treatment diets were 
made by adding Cr (0, 1,000, or 2,000 ppb) in the form of Cr (III) picolinate (CrPic) to 
the basal diet. In Exp. 3, a commercial product of CrPic (CHROMAX, Prince Agri 
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Products, Inc., Quincy, IL; limestone ) was added to the basal diet at the expense of 
limestone, a carrier in CHROMAX. The organic form of trivalent Cr, CrPic, was used 
based on previous reports suggesting that Cr is more available as an organic chelate (Page 
et al., 1993).  
 
Item D 0 to 14 (Phase I) D 14 to 28 (Phase II) 
Ingredients    
Corn 48.055 57.255 
Soybean meal, 48% CP 26.00 25.50 
Dried whey 12.00 10.00 
Spray dried animal plasma 5.00 2.00 
Lactose 4.00 - 
Corn oil 2.00 2.50 
Dicalcium phosphate 1.00 1.00 
Limestone 1.10 0.90 
Salt 0.40 0.40 
Vitamin premix1 0.10 0.10 
Trace-mineral premix2 0.075 0.075 
Mecadox-103 0.25 0.25 
Santoquin4 0.02 0.02 
Calculated nutrient composition   
ME, kcal/kg 3,406 3,600 
CP, %  21.70 19.91 
Lysine, % 1.36 1.19 
Calcium, % 0.81 0.72 
Phosphorus, % 0.65 0.60 
1 Supplied per kg of diet: vitamin A, 6,600 IU; vitamin D3, 880 IU; vitamin E, 44 IU; vitamin K 
(as menadione sodium bisulfite complex), 6.4 mg; thiamin, 4.0 mg; riboflavin, 8.8 mg; 
pyridoxine, 4.4 mg; vitamin B12, 33 µg; folic acid, 1.3 mg; niacin, 44 mg; pantothenic acid, 22 
mg; D-biotin, 0.22 mg. 
2 Supplied per kg of diet: Zn, 131 mg as ZnO; Fe, 131 mg as FeSO4·H2O; Mn 45 mg, as MnO; 
Cu, 13 mg as CuSO4·5H2O; I, 1.5 mg as CaI2O6; Co, 0.23 mg as CoCO3; Se, 0.28 mg as 
NaSeO3.  
3 Supplied 55 mg carbadox per kg of diet. 
4 Supplied 130 mg ethoxyquin per kg of basal diet. 
 
Table 3.1. Percentage composition of the basal diet (as-fed basis) 
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3.2.4. Data and sample collection 
Animal weights and feed intake were measured weekly. Wasted feed and orts 
were collected and weighed to measure accurate feed intake. Blood samples were 
collected from two pigs per pen (one male and one female) via the jugular vein on d 15, 
18, and 27 (25 in Exp. 2). These blood sampling dates were 1, 4, and 13 (11 in Exp. 2) d 
after the change of ambient temperature. The collected blood samples were kept on ice 
for approximately 1 to 2 h until the plasma was obtained by centrifugation of the blood at 
800 × g and 4°C for 20 min. Plasma samples were stored at -20°C until the chemical 
assays. Respiratory rate was visually measured by counting flank movements over a 
period of 1 min in resting pigs. To facilitate the counting respiration in resting pigs, 
respiratory rate was determined between 19:30 and 22:00. In Exp. 1 the respiratory rate 
was counted once for every pig by a single panelist; in Exp. 3 three panelists 
independently counted the respiratory rate, and mean counts of the three panelists were 
used for analysis.  
 
3.2.5. Laboratory analysis 
The frozen plasma samples were allowed to thaw at room temperature for the 
chemical analysis. The glucose concentration in the plasma was analyzed using a glucose 
autoanalyzer (YSI 2300 STAT PLUS, Yellow Springs Instrument Co., Yellow Springs, 
OH). Samples were analyzed in duplicate, and the calibration was automatically 
performed every 30 min. 
The cortisol concentrations in the plasma samples were determined using coated 
tube radioimmunoassays from Diagnostic Products Corporation (Los Angeles, CA). 
Standards and plasma samples were added to antibody-coated tubes. Radiolabeled 
cortisol (125I) was added to tubes and incubated for 45 minutes at 37°C using a waterbath. 
Then, all moisture in the tube was thoroughly removed and the radioactivity was 
measured using a Packard Cobra Auto-gamma counter (Packard Instrument Co., Meriden, 
CT). Standards and samples were analyzed in triplicate and duplicate, respectively. A 
new set of standards was prepared and analyzed for each separate analysis. 
 
 87
3.2.6. Statistical analysis 
The experimental data were analyzed using GLM procedures of SAS (SAS Inst. 
Inc., Cary, NC). The model for Exp. 1 (heat stress) included two main effects and 
interaction as follows: 
 
Yijk = k + bi + Tempj + Crk + (Temp × Cr)jk + eijk   
 
In this equation, the parameters represent: 
Y = response variables (ADG, ADFI, feed:gain, plasma cortisol, plasma glucose, 
and respiratory rate) 
k = a constant 
bi = block effect 
Tempj = ambient temperature effect 
Crk = supplemental Cr effect 
(Temp × Cr)jk = ambient temperature × supplemental Cr interaction 
eijk = error term of the model  
 
The model for analyzing data pooled from Exp. 2 and Exp. 3 (cold stress) included 
experiment × treatments interactions as follows: 
 
Yijk = k + exph + bi(exph) + Tempj + Crk + (Temp × Cr)jk + (exp × Temp)hj + (exp 
× Cr)hk + (exp × Temp × Cr)hjk + ehijk   
 
In this equation, the parameters represent: 
Y = response variables (ADG, ADFI, feed:gain, plasma cortisol, and plasma 
glucose) 
k = a constant 
exph = experiment effect 
bi = block effect 
Tempj = ambient temperature effect 
Crk = supplemental Cr effect 
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(Temp × Cr)jk = ambient temperature × supplemental Cr interaction 
(exp × Temp)hj = experiment × ambient temperature  
(exp × Cr)hk = experiment × supplemental Cr interaction 
(exp × Temp × Cr)hjk = experiment × ambient temperature × supplemental Cr 
interaction 
ehijk = error term of the model  
 
In cold stress experiments, respiratory rates were measured only in Exp. 3 not in Exp. 2. 
Thus the model for Exp. 1 was used for the analysis of respiratory rate of cold stress 
study. Each pen was considered as an experimental unit for average daily gain (ADG), 
average daily feed intake (ADFI), and feed:gain ratio; individual animals served as the 
experimental unit for other measurements. The alpha level used for determination of 
statistical significance was 0.05. 
 
3.3. Results 
3.3.1. Experiment 1: Heat stress 
Growth performance was affected by the high ambient temperature, but not by 
supplemental Cr (Table 3.2). The BW of the animals were unaffected by the treatments 
on d 7 and 14 (P > 0.20). The ambient temperature was changed on d 14 to induce 
thermal stress. During d 14 to 21, pigs in high ambient temperature (HT) gained less 
weight (550 vs. 657 g/d; P < 0.001) and consumed less feed (858 vs. 1,017 g/d; P = 
0.001) than pigs in NT. However, feed:gain was unaffected by the thermal stress. During 
d 21 to 28, pigs in HT had lower ADG (600 vs. 669 g/d; P = 0.020) and lower ADFI (994 
vs. 1,132 g/d; P = 0.009) than pigs in NT with no difference in feed:gain. During d 14 to 
28, accordingly, HT resulted in decreased ADG (575 vs. 663 g/d; P = 0.001) and ADFI 
(926 vs. 1,074 g/d; P < 0.001) compared with NT, but feed:gain was again unaffected by 
heat stress (1.61 vs. 1.62; P = 0.793). The BW on d 21 and 28 were also lower (P < 0.01) 
in HT than in NT. No effect of supplemental Cr on the growth performance was observed 
(P > 0.10) nor were there any interactions of supplemental Cr and temperature (P > 0.10). 
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Temp2: Neutral (23.7°C) Hot (40.5°C) Temp effect CrPic effect  Interaction 
Cr, ppb: 0 1,000 2,000 0 1,000 2,000 Pr SEM Pr SEM  Pr SEM
Body weight, kg                         
D 0 5.98 5.87 5.94 5.93 5.93 5.93 0.921 0.18 0.231 0.02  0.257 0.03
D 7 8.18 8.15 8.22 8.28 8.30 8.22 0.488 0.83 0.996 0.10  0.890 0.14
D 14 11.90 12.13 11.99 11.78 12.15 11.85 0.612 0.11 0.289 0.13  0.890 0.18
D 21 16.70 16.65 16.45 15.65 16.13 15.55 0.004 0.16 0.391 0.19  0.614 0.27
D 28 21.49 21.40 21.08 19.83 20.50 19.59 0.003 0.25 0.386 0.30  0.655 0.43
D 0 to 7              
ADG, g 315 326 325 336 339 328 0.424 10.5 0.917 12.9  0.880 18.3
ADFI, g 410 398 424 405 421 425 0.668 10.6 0.618 13.0  0.722 18.3
Feed:gain 1.31 1.22 1.31 1.21 1.25 1.31 0.494 0.02 0.192 0.03  0.317 0.04
D 7 to 14              
ADG, g 531 567 539 500 550 518 0.164 11.0 0.113 13.4  0.938 19.0
ADFI, g 759 795 777 695 746 723 0.072 19.5 0.461 23.9  0.975 33.7
Feed:gain 1.42 1.40 1.44 1.40 1.36 1.39 0.448 0.04 0.821 0.04  0.986 0.03
D 14 to 21              
ADG, g 685 646 638 553 569 529 < 0.001 13.3 0.336 16.3  0.515 23.1
ADFI, g 1053 987 1009 832 912 830 0.001 24.6 0.772 30.1  0.258 42.6
Feed:gain 1.54 1.53 1.58 1.50 1.61 1.56 0.864 0.02 0.382 0.03  0.396 0.04
D 21 to 28              
ADG, g 685 662 661 598 625 576 0.020 17.8 0.683 21.8  0.664 30.8
ADFI, g 1149 1124 1122 960 1085 937 0.009 30.0 0.375 36.7  0.298 51.9
Feed:gain 1.68 1.70 1.70 1.60 1.74 1.63 0.585 0.04 0.501 0.05  0.651 0.07
D 0 to 14              
ADG, g 423 447 432 418 444 423 0.590 6.9 0.143 8.4  0.955 11.9
ADFI, g 584 596 600 550 584 574 0.187 12.1 0.524 14.9  0.873 21.0
Feed:gain 1.38 1.33 1.39 1.32 1.31 1.36 0.222 0.02 0.386 0.03  0.859 0.04
D 14 to 28              
ADG, g 685 654 650 575 597 553 0.001 13.1 0.422 16.0  0.526 22.7
ADFI, g 1101 1056 1066 896 999 883 < 0.001 23.5 0.464 28.8  0.197 40.7
Feed:gain 1.61 1.61 1.64 1.56 1.68 1.60 0.793 0.03 0.372 0.03  0.370 0.04
1 Each mean represents three pens of three pigs/pen. 
2 Ambient temperatures during d 14 to 28. The ambient temperature before d 14 was maintained 
in the thermoneutral zone. On d 14 the ambient temperature was changed to induce thermal
stress, and the high temperature was maintained until the end of the experiment. 
 
Table 3.2. Effects of high ambient temperature (Temp) and dietary chromium (III) 
picolinate (CrPic) supplementation on body weight, feed intake and feed:gain of pigs
(Exp. 1)1 
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As shown in Table 3.3, pigs in HT had lower plasma cortisol concentration on d 
18 (44.3 vs. 56.9 ng/ml; P = 0.054) and d 27 (37.4 vs. 52.5 ng/ml; P = 0.009). On d 15, 
circulating cortisol was affected by supplemental Cr with the highest cortisol 
concentration at 1,000 ppb Cr supplementation (P = 0.008), and ambient temperature × 
supplemental Cr interaction was significant for plasma cortisol concentration (P = 0.012). 
Plasma glucose concentration tended to be lower in pigs in HT than the animals in NT on 
d 15 (6.57 vs. 6.90 mmol/L; P = 0.074) and d 27 (6.62 vs. 6.98 mmol/L; P = 0.054). On d 
18, there was a tendency for plasma glucose to be reduced by supplemental Cr (P = 
0.089).  
 
Temp2: Neutral (23.7°C) Hot (40.5°C) Temp effect CrPic effect  Interaction
Cr, ppb: 0 1,000 2,000 0 1,000 2,000 Pr SEM Pr SEM  Pr SEM
Cortisol, ng/mL             
D 15 (1)3 55.1 57.7 42.7 34.9 65.2 32.9 0.209 4.1 0.008 5.1  0.167 7.2 
D 18 (4) 63.4 47.5 59.8 31.1 62.6 39.3 0.054 4.4 0.589 5.4  0.012 7.7 
D 27 (13) 59.5 45.8 52.1 33.7 45.4 33.2 0.009 3.8 0.825 4.7  0.155 6.6 
Glucose, mmol/L             
D 15 (1) 6.85 6.80 7.04 6.43 6.67 6.62 0.074 0.12 0.672 0.15  0.730 0.21
D 18 (4) 7.07 7.03 6.89 7.25 6.58 6.71 0.306 0.10 0.089 0.13  0.239 0.18
D 27 (13) 6.92 7.08 6.92 6.73 6.61 6.53 0.054 0.12 0.840 0.15  0.801 0.22
1 Each mean represents six pigs. 
2 Ambient temperatures during d 14 to 28. The ambient temperature before d 14 was maintained 
in the thermoneutral zone. On d 14 the ambient temperature was changed to induce thermal
stress, and the high temperature was maintained until the end of the experiment. 
3 The numbers in the parenthesis represent the days after the thermal stress.  
 
Table 3.3. Effects of high ambient temperature (Temp) and dietary chromium (III)
picolinate (CrPic) supplementation on plasma cortisol and glucose concentration of pigs 
(Exp. 1)1 
The respiratory rate measured on d 27 was higher (114.6 vs. 65.0 breath/min; P < 
0.001) in the pigs in HT than the pigs in the thermoneutral environment with no effects of 
dietary Cr supplementation (Table 3.4). 
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Table 3.4. Effects of high ambient temperature (Temp) and dietary chromium (III)
picolinate (CrPic) supplementation on respiratory rate of pigs (Exp. 1)1 
Temp2: Neutral (23.7°C) Hot (40.5°C) Temp effect CrPic effect  Interaction
Cr, ppb: 0 1,000 2,000 0 1,000 2,000 Pr SEM Pr SEM  Pr SEM
Respiratory rate, breath/min            
D 27 (13)3 66.8 64.5 63.7 116.9 112.4 114.3 <0.001 3.3 0.816 4.0  0.969 5.7 
1 Each least squares mean represents nine pigs. 
2 Ambient temperatures during d 14 to 28. The ambient temperature before d 14 was maintained 
in the thermoneutral zone. On d 14 the ambient temperature was changed to induce thermal
stress, and the high temperature was maintained until the end of the experiment. 
3 The numbers in the parenthesis represent the days after the thermal stress. 
 
3.3.2. Experiment 2 and 3: Cold stress 
Data from Exp. 2 and 3 are combined for the analysis (Table 3.5). Result tables 
for each experiment are shown in Appendix 1. The cold stress affected growth 
performance, but dietary Cr treatment had no effect on the growth of pigs. Pigs in low 
ambient temperature (LT) had higher feed:gain (1.54 vs. 1.44; P < 0.001) than pigs in NT 
during d 14 to 21. Pigs in LT had higher ADG (711 vs. 625 g/d; P = 0.006) and ADFI 
(1,143 vs. 991 g/d; P < 0.001) than pigs in NT during d 21 to 26 (28). During d 14 to 26 
(28), pigs in LT had higher ADFI (1,026 vs. 942 g/d; P = 0.008) and feed:gain (1.57 vs. 
1.51; P = 0.002) than pigs in NT. However, dietary treatments of Cr had no effects on 
ADG, ADFI, or feed:gain.  
 
 
 
 
 
 
 
  
 
 
 92
Temp2: Neutral Cold Temp effect CrPic effect  Interaction 
Cr, ppb: 0 1,000 2,000 0 1,000 2,000 Pr SEM Pr SEM  Pr SEM 
Body weight, kg                         
D 0 6.18 6.19 6.19 6.18 6.18 6.18 0.837 0.02 0.992 0.03  0.990 0.04 
D 7 7.59 7.59 7.55 7.59 7.59 7.70 0.409 0.04 0.847 0.05  0.540 0.08 
D 14 10.71 10.63 10.57 10.27 10.55 10.89 0.712 0.13 0.576 0.16  0.270 0.23 
D 21 15.29 14.80 14.77 14.31 14.72 15.30 0.561 0.21 0.717 0.26  0.143 0.37 
D 26 (28) 19.10 18.68 18.56 18.52 19.02 19.59 0.498 0.27 0.827 0.33  0.243 0.46 
D 0 to 7              
ADG, g 200 199 195 201 201 217 0.337 5.9 0.814 7.3  0.507 10.3 
ADFI, g 234 228 251 231 268 252 0.275 7.9 0.356 9.6  0.246 13.6 
Feed:gain 1.18 1.16 1.29 1.16 1.32 1.17 0.908 0.04 0.536 0.05  0.106 0.07 
D 7 to 14              
ADG, g 447 435 432 383 423 456 0.459 16.2 0.597 19.8  0.313 28.0 
ADFI, g 567 519 559 483 527 539 0.213 17.6 0.645 21.5  0.320 30.4 
Feed:gain 1.27 1.21 1.30 1.27 1.26 1.22 0.822 0.03 0.708 0.03  0.329 0.05 
D 14 to 21              
ADG, g 654 595 600 577 596 630 0.521 16.6 0.727 20.3  0.182 28.7 
ADFI, g 936 872 854 896 900 967 0.296 22.2 0.711 27.2  0.161 38.5 
Feed:gain 1.43 1.47 1.43 1.56 1.52 1.54 <0.001 0.01 0.869 0.02  0.294 0.03 
D 21 to 26 (28)             
ADG, g 620 638 616 703 719 712 0.006 20.1 0.871 24.6  0.973 34.8 
ADFI, g 1000 974 998 1124 1149 1157 <0.001 24.0 0.908 29.4  0.824 41.5 
Feed:gain 1.63 1.54 1.62 1.60 1.60 1.62 0.766 0.03 0.483 0.03  0.556 0.05 
D 0 to 14              
ADG, g 323 317 313 292 312 336 0.734 9.3 0.569 11.3  0.261 16.0 
ADFI, g 401 374 405 357 397 396 0.546 11.2 0.538 13.7  0.243 19.4 
Feed:gain 1.24 1.18 1.29 1.23 1.27 1.19 0.818 0.02 0.810 0.02  0.014 0.03 
D 14 to 26 (28)             
ADG, g 641 620 612 634 649 668 0.231 15.0 0.980 18.3  0.486 25.9 
ADFI, g 971 928 927 1003 1015 1058 0.008 20.1 0.820 24.6  0.381 34.8 
Feed:gain 1.52 1.50 1.52 1.58 1.56 1.58 0.002 0.01 0.647 0.02  0.990 0.02 
1 Each mean represents six pens of three (Exp. 2) or two (Exp. 3) pigs/pen. The durations of Exp.
2 and 3 were 26 and 28 d, respectively. 
2 The ambient temperature before d 14 was maintained in the thermoneutral zone. On d 14 the 
ambient temperature was changed to induce thermal stress, and the low temperature was 
maintained until the end of the experiment. The average ambient temperatures of neutral and 
cold rooms were 26.5 and 16.0°C, respectively, during d 14 to 26 in Exp. 2; 25.6 and 13.8°C, 
respectively, during d 14 to 28 in Exp. 3. 
Table 3.5. Effects of low ambient temperature (Temp) and dietary chromium (III)
picolinate (CrPic) supplementation on body weight, feed intake and feed:gain of pigs
(pooled data of Exp. 2 and 3)1 
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Plasma cortisol concentration tended to be lower in the pigs in LT (54.2 vs. 65.8 
ng/mL; P = 0.091) on d 15 but tended to be higher in LT (64.3 vs. 53.6 ng/mL; P = 0.083) 
on d 18 than the pigs in NT (Table 3.6). Other blood measure measurements were 
unaffected by the ambient temperature or the dietary Cr treatments. A tendency of 
ambient temperature × supplemental Cr interaction on plasma glucose concentration was 
observed on d 15 (P = 0.077) and d 18 (P = 0.063). 
 
Temp2: Neutral Cold Temp effect CrPic effect  Interaction
Cr, ppb: 0 1,000 2,000 0 1,000 2,000 Pr SEM Pr SEM  Pr SEM
Cortisol, ng/mL             
D 15 (1)3 63.2 74.5 59.7 50.7 54.3 57.6 0.091 4.8 0.644 5.9  0.556 8.3 
D 18 (4) 52.0 62.5 46.4 67.2 60.4 65.3 0.083 4.3 0.739 5.2  0.322 7.4 
D 25 (11) 61.1 61.8 80.1 77.6 64.6 64.1 0.868 4.7 0.531 5.7  0.137 8.1 
Glucose, mmol/L            
D 15 (1) 7.08 7.31 6.83 6.96 6.71 6.96 0.139 0.09 0.688 0.11  0.077 0.16
D 18 (4) 7.17 6.71 6.64 6.94 6.80 7.48 0.213 0.13 0.300 0.16  0.063 0.23
D 25 (11) 6.99 6.92 6.78 7.05 6.99 6.97 0.579 0.14 0.837 0.17  0.958 0.24
1 Each mean represents twelve pigs.  
2 The ambient temperature before d 14 was maintained in the thermoneutral zone. On d 14 the
ambient temperature was changed to induce thermal stress, and the low temperature was
maintained until the end of the experiment. The average ambient temperatures of neutral and 
cold rooms were 26.5 and 16.0°C, respectively, during d 14 to 26 in Exp. 2; 25.6 and 13.8°C, 
respectively, during d 14 to 28 in Exp. 3. 
3 The numbers in the parenthesis represent the days after the thermal stress. The blood collection
d in Exp. 3 were d 15, 18, and 27. 
 
Table 3.6. Effects of low ambient temperature (Temp) and dietary chromium (III) 
picolinate (CrPic) supplementation on plasma cortisol and glucose concentration of pigs
(pooled data of Exp. 2 and 3)1 
In Exp. 3, the respiratory rate measured on d 22 and 27 was lower (43.2 vs. 54.2 
breath/min and 42.2 vs. 57.0 breath/min, respectively; P < 0.001) in the pigs in LT than 
the pigs in NT with no effects of dietary Cr supplementation (Table 3.7). 
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Table 3.7. Effects of low ambient temperature (Temp) and dietary chromium (III)
picolinate (CrPic) supplementation on respiratory rate of pigs (Exp. 3)1 
Temp2: Neutral (25.9°C) Cold (13.8°C) Temp effect CrPic effect  Interaction
Cr, ppb: 0 1,000 2,000 0 1,000 2,000 Pr SEM Pr SEM  Pr SEM
Respiratory rate, breath/min            
D 22 (8)3 52.8 54.2 55.4 42.6 45.6 41.6 <0.001 1.7 0.764 2.1  0.683 3.0 
D 27 (13) 53.6 60.9 56.4 41.5 41.7 43.6 <0.001 1.3 0.259 1.6  0.234 2.3 
1 Each least squares mean represents six pigs. The respiratory rate was measured by three
independent panels and means of three observations were used for statistical analysis.  
2 Ambient temperatures during d 14 to 28. The ambient temperature before d 14 was maintained 
in the thermoneutral zone. On d 14 the ambient temperature was changed to induce thermal
stress, and the low temperature was maintained until the end of the experiment. 
3 The numbers in the parenthesis represent the days after the thermal stress. 
 
3.4. Discussion 
3.4.1. Experiment 1: Heat stress 
Pigs in high ambient temperature generally consume less feed in efforts to reduce 
body heat production from digestive and metabolic processes (Quiniou et al., 2000; Le 
Bellego et al., 2002). The depression of weight gain is largely attributed to the decreased 
feed intake. In the current study, feed intake reduction and growth retardation by heat 
stress were clearly demonstrated in agreement with previous reports (Stahly and 
Cromwell, 1979; Stahly et al., 1979; Schenck et al., 1992ab; Kerr et al., 2003). In the 
present study, weight gain depression and feed intake reduction in pigs in HT were 13.8% 
and 13.3%, respectively. Stahly and Cromwell (1979) observed an 18.2% reduction of 
feed intake and a 25.7% depression of weight gain depression in growing pigs reared in 
hot environment (35°C) compared with pigs in thermoneutral environment (23°C). The 
relatively large reduction of weight gain and feed intake may be related to the length of 
the experiment and BW of the pigs. In our study, the heat stress (40.5°C) lasted for 14 d 
with pigs of 12.0 kg initial BW whereas the Stahly and Cromwell (1979) maintained the 
high environmental temperature for 42 d with pigs of 27.5 kg initial BW. Thus the 
temperature of 35°C was more stressful to the pigs at the end of the experiment compared 
with the pigs at the beginning based on the BW of the pigs. This postulation is supported 
in the finishing pig trial at the same temperature (35°C). Weight gain depression and feed 
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intake reduction were 36.8% and 42.0%, respectively, in the pigs of 68.2 kg initial BW. 
Quiniou et al. (2000) also suggested that heavier pigs are more sensitive to hot ambient 
temperature than lighter pigs.  
Feed efficiency was unaffected by high ambient temperature in the present study. 
In agreement, others have reported minor increases (< 1.5%) of feed:gain in pigs housed 
in high environmental temperature (Stahly et al., 1979; Schenck et al., 1992a). However, 
Stahly and Cromwell (1979) observed 10.1% increase of feed:gain in growing pigs 
housed in the 35°C compared with the pigs in 23°C. The degree of heat stress may 
partially explain these discrepancies as feed:gain increased by 17.9% in finishing pigs in 
35°C environment compared to the 23°C environment. The changes of feed:gain in 
response to elevated environmental temperature may also be related to the degree of feed 
intake reduction (Kerr et al., 2003). The lower the feed intake, the more serious the 
nutrient deficiencies that may occur and feed:gain increases.  
In multiple poultry trials, dietary supplementation of Cr ameliorated the 
detrimental effects of heat stress on growth and egg production performance (Sahin et al., 
2002a; Onderci et al., 2005; Sahin et al., 2005). Dietary supplementation of Cr at 
concentrations of 200 to 1,200 ppb linearly increased feed intake, weight gain, feed 
efficiency, and egg production rate of laying quail reared in high ambient temperature 
(Sahin et al., 2002a), and 400 ppb of dietary Cr supplementation increased weight gain 
and feed efficiency of heat stressed quail by 4.2% and 2.4%, respectively (Sahin et al., 
2005). In the present study, however, we failed to find any effect of dietary Cr 
supplementation on the growth performance of pigs either in high ambient temperature or 
in thermoneutral environment. 
Circulating cortisol concentration was 22.1% lower in pigs housed in HT for 4 d 
compared with pigs in NT. The exposure to HT for 13 d resulted in 28.8% lower cortisol 
concentration. In agreement, Marple et al. (1972) observed decreased plasma cortisol 
concentration in gilts exposed to heat stress (32°C) for 8 d. Similarly, Hicks et al. (1998) 
reported numerically decreased plasma cortisol concentrations in pigs exposed to heat 
stress. Low plasma cortisol in heat stressed pigs has been confirmed in recent studies 
(Heo et al., 2005; Sutherland et al., 2006). The low cortisol concentration in HT may be 
attributed to an increased turnover of plasma cortisol and/or decreased adrenal 
 96
responsiveness to ACTH (Marple et al., 1972). Although the acute response of cortisol 
secretion was not assessed in the current study, Minton and Blecha (1990) reported that 
cortisol secretion was increased for 6 h in response to heat stress (35°C) and the secretion 
was returned to normal within 12 h in lambs. In an earlier report, an exposure to severe 
heat (45°C) and high humidity acutely (4 h) resulted in a rise of plasma corticosteroids 
and ACTH in pigs (Blatchford et al., 1972). Thus the potential changes of cortisol 
turnover rate and adrenal responsiveness to ACTH may be rather acute than chronic. In 
the present study, heat stress tended to decrease plasma glucose concentration on d 13 
post temperature change. The reduction of glucose concentration in the heat stressed 
group is supported by low cortisol concentration in the same treatment group as 
circulating cortisol stimulates glucose release from body reserve.  
Dietary supplementation of Cr (200 to 1,200 ppb) as CrPic linearly decreased 
serum corticosterone concentration in heat stressed laying quail (Sahin et al., 2002b). In 
the present study, however, supplemental Cr had no effects on plasma cortisol 
concentration on d 4 or 13 post ambient temperature change. Further, plasma cortisol was 
numerically increased in the pigs fed 1,000 ppb of supplemental Cr on d 1 post thermal 
change. In heat stressed poultry, supplemental Cr decreased serum glucose concentration 
(Sahin et al., 2002b; Onderci et al., 2005; Sahin et al., 2005). 
In the current study, the respiratory rate was clearly elevated by heat stress. The 
increased respiratory rate of pigs in hot environment has been demonstrated by many 
researchers (Schoenherr et al., 1989; Quiniou and Noblet, 1999; Renaudeau et al., 2001). 
The evaporative heat loss via respiration in the high ambient temperature is important for 
the maintenance of animal body temperature. The respiratory evaporation is even more 
important for swine which have a limited capacity of cutaneous evaporation (Ingram, 
1965). 
 Pigs in a hot environment generally exhibit more recumbent behavior with 
increased respiratory rate, and thus fewer feeding and standing periods in response to 
chronic (Morrow-Tesch et al., 1994) and acute (Hicks et al., 1998) heat stress treatments. 
The respiratory rate has been demonstrated to be higher (124 vs. 26 breaths/min) in the 
pregnant sow exposed to heat stress (29°C) compared with those in a thermoneutral 
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environment (18°C) (Quiniou and Noblet, 1999). A similar result was reported later by 
the same group (Renaudeau et al., 2001). 
 
3.4.2. Experiment 2 and 3: Cold stress 
Pigs in low ambient temperature generally show increased feed intake and 
diminished feed efficiency (Stahly and Cromwell, 1979; Stahly et al., 1979; Frank et al., 
2003). In the present study, ADFI and feed:gain were higher in pigs housed in LT than in 
NT. This is in agreement with Stahly and Cromwell (1979) who reported that growing 
pigs (28 to 60 kg BW) in a low ambient temperature (10°C) consumed 15% more feed 
and had 19% higher feed:gain compared with pigs in a thermoneutral environment. A 
similar response was observed in weanling pigs (8.6 to 10.2 kg BW) by Frank et al. 
(2003). The increased feed consumption is used to compensate for the elevated 
maintenance needs for metabolic activity (Holmes and Close, 1977). Accordingly, ADG 
was unaffected by the low ambient temperature in the present study and other reports 
(Stahly and Cromwell, 1979; Stahly et al., 1979; Frank et al., 2003). However, at an 
extremely low ambient temperature (below the lower critical temperature), BW gain may 
be retarded by cold stress (Le Dividich, 1981).  
Dietary supplementation of Cr as CrPic increased weight gain, egg production, 
and feed efficiency of poultry in a low ambient temperature (Sahin et al., 2001; Sahin et 
al., 2002c). In the present study, however, we failed to observe beneficial effects of 
supplemental Cr on pigs in cold stress. This discrepancy may be attributed to the 
physiological differences between these species and/or the degree of cold stress. 
Although the ambient temperature was below the thermoneutral zone, and the feed intake 
was increased by the cold stress, it may be that the degree of cold stress was affordable to 
the pigs by increasing feed intake. The low ambient temperature (16.0 and 13.8°C in 
Experiment 2 and 3, respectively) used to induce cold stress was higher than the 
temperature (6.8°C) used in the poultry trials (Sahin et al., 2001; Sahin et al., 2002c). 
In a severe cold stress (-5 and -15°C), pigs had elevated plasma corticosteroids 
(Blatchford et al., 1972). Frank et al. (2003) also reported that cold stress increased 
circulating cortisol concentrations in pigs. Pigs of 8.6 kg BW in cold environment 
(15.6°C) had higher (P < 0.001) serum ACTH (85.1 vs. 61.3 pg/mL) and cortisol (39.1 vs. 
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24.1 ng/mL) than those in thermoneutral environment (26.7°C). In the present study, 
however, plasma cortisol was only minimally affected and plasma glucose concentrations 
were unaffected by cold stress (16.0 and 13.8°C in Experiment 2 and 3, respectively).  
The low temperature in Experiment 3 (13.8°C) resulted in a decrease of 
respiratory rate in the pigs in LT than those in NT. Although the cold stress in this study 
induced changes in growth performance and respiratory rate, the stress was perhaps not 
enough to induce changes in plasma cortisol or glucose. In laying hens kept in low 
ambient temperature (6.8 or 6.9°C), supplemental Cr decreased plasma corticosteroid 
concentration (Sahin et al., 2001; Sahin et al., 2002c). It may be that the degree of stress 
in the present study was not severe enough to adequately test the degree to which it may 
be ameliorated by dietary Cr supplementation.  
 In conclusion, heat stress reduced feed intake, weight gain, and plasma cortisol, 
but increased respiratory rate. Cold stressed pigs increased their feed intake and feed:gain, 
but decreased respiration frequency. However, stress alleviating effects of dietary Cr 
were not observed with either type of temperature stress. 
 
3.5. Implications 
The thermal stress in the current study induced marked changes in some growth 
and physiological parameters consistent with previous research. However, stress 
alleviating effects of dietary Cr supplementation were not observed. Further research to 
assess effects and mechanism of Cr on pigs in severely hot or cold environment seems 
warranted.  
 
 
 
 
 
 
Copyright © Beob Gyun Kim 2007 
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CHAPTER 4. The Effects of Dietary Chromium (III) Picolinate on Growth 
Performance, Vital Signs, and Blood Measurements of Pigs during Immune Stress 
 
Abstract  
This experiment investigated the effects of dietary chromium (Cr) on growth, 
rectal temperature, respiratory rate, plasma cortisol, and plasma glucose in pigs 
challenged with lipopolysaccharide (LPS). Twenty four pigs (BW: 26.0 ± 2.8 kg) were 
assigned to one of four treatments with two pigs per pen. Treatments were 1) phosphate 
buffered saline (PBS) injection, no supplemental Cr; 2) LPS injection, no supplemental 
Cr; 3) LPS injection, 1,000 ppb supplemental Cr; and 4) LPS injection, 2,000 ppb 
supplemental Cr. The supplemental Cr levels, in the form of Cr (III) picolinate, were fed 
for 35 d before PBS or LPS injection and continued until the end of the experiment. At 0 
h, PBS or LPS was injected intraperitoneally in each pig. During the first 12 h post 
injection, pigs challenged with LPS lost 951 g, while the PBS group gained 170 g (P < 
0.001). This weight loss began to be recovered after 12 h and the weight gain of the LPS 
group tended to be higher (1,014 vs. 723 g; P = 0.09) than the PBS group during 24 to 48 
h. However, cumulative weight gain of the LPS group still remained lower at 96 h (1,729 
vs. 2,545 g; P < 0.05). Compared to the PBS group, LPS challenged pigs had lower feed 
intake (FI; 874 vs. 2,197 g; P < 0.01), similar FI (1,876 vs. 1,795 g; P = 0.81), and higher 
FI (4,834 vs. 3,924; P < 0.05) during 0 to 24 h, 24 to 48 h, and 48 to 96 h, respectively. 
Dietary Cr had no effect on weight gain or FI. Rectal temperature was higher in the LPS 
vs. the PBS group at 2 h (40.2 vs. 39.5°C; P < 0.01) and 4 h (40.2 vs. 39.5°C; P < 0.05). 
Respiratory rate was also higher in the LPS vs. the PBS group at 1.3 h (83.4 vs. 58.0 
breath/min; P < 0.05) and at 8.5 h (55.1 vs. 43.0 breath/min; P < 0.05). Plasma collected 
at 3 h had higher cortisol (178 vs. 29 ng/ml; P < 0.001) and lower glucose (5.87 vs. 6.88 
mmol/l; P < 0.05) concentrations in the LPS group than the PBS group. Dietary Cr did 
not affect rectal temperature, respiratory rate, plasma cortisol, or plasma glucose. These 
results demonstrate that LPS challenge affects weight gain, FI, body temperature, 
respiratory rate, plasma cortisol, and plasma glucose but dietary Cr is unable to moderate 
the stress related effects due to an LPS challenge. 
Key Words: Immune stress, Chromium, Pigs 
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4.1. Introduction 
Since the first report on the essentiality of chromium (Cr) as an active component 
in the glucose tolerance factor (Schwarz and Mertz, 1959), the roles of Cr have been 
widely studied in humans and animals. Generally Cr has been shown to potentiate the 
action of insulin (Mertz et al., 1974; Vincent, 2000) and accordingly to modulate 
carbohydrate, protein, and lipid metabolism (Davis and Vincent, 1997; Cefalu et al., 
2002; Bernao et al., 2004). In domestic animals, Cr has been recognized as an essential 
trace mineral (Anderson, 1987; Offenbacher and Pi-Sunyer, 1988) and suggested to 
alleviate stress associated effects (Chang and Mowat, 1992; Anderson, 1994; NRC, 1997). 
In swine production systems, stress sources include cold/hot (relative to 
thermoneutrality) environmental temperature (Stahly and Cromwell, 1979; Schenck et al., 
1992), microbial infection (Webel et al., 1997), insufficient space allowance (Brumm and 
Miller, 1996; Wolter et al., 2000), social mixing (Barnett et al., 1993; Marchant et al., 
1995), and nutritional deficiency or imbalance (NRC, 1998). These stressors may cause 
growth retardation, changes in hormone secretion, increased disease susceptibility, and/or 
behavioral changes. Dietary supplementation of Cr alleviated the detrimental effects of 
thermal stress in poultry (Sahin et al., 2001; Sahin et al., 2002b; Onderci et al., 2003; 
Onderci et al., 2005), and transport stress in calves (Chang and Mowat, 1992; Moonsier-
Shageer and Mowat, 1993). 
However, the effects of dietary Cr on immune responses in animals have been 
inconsistent in cattle (Burton et al., 1993; Burton et al., 1996; Chang et al., 1996) and in 
pigs (van Heugten and Spears, 1997; Lee et al., 2000; van de Ligt et al., 2002c). 
Therefore, the objective of the present research was to determine the effects of dietary Cr 
supplementation on growth performance, body temperature, respiratory rate, plasma 
cortisol, and plasma glucose in pigs challenged with an immune stressor. 
 
4.2. Experimental procedures 
This experiment was carried out in environmentally controlled rooms at the 
University of Kentucky. The experiments were conducted under protocols approved by 
the Institutional Animal Care and Use Committee of the University of Kentucky.  
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4.2.1. Animals, treatments, and diets 
Twenty four crossbred weanling pigs with an average initial BW of 26.0 ± 2.8 kg 
were assigned to one of four treatments. Treatments included: 1) phosphate buffered 
saline (PBS) injection, no supplemental Cr; 2) LPS injection, no supplemental Cr; 3) LPS 
injection, 1,000 ppb of supplemental Cr; 4) LPS injection, 2,000 ppb of supplemental Cr. 
Pigs were grouped into three blocks by initial BW, four treatment groups, and two pigs 
per pen with mixed sex. One male and one female were housed in each plastic woven 
wire floored 1.2 m × 1.2 m pen. Each pen was equipped with a four-hole, stainless steel 
feeder and a nipple waterer. Pigs had ad libitum access to feed and water. 
The diets, based primarily on corn, soybean meal, and dried whey, were 
formulated to contain 3,600 kcal/kg ME, 19.9% CP, and 1.19% Lys (Table 4.1). Minerals 
and vitamins were added to meet or exceed NRC (1998). Antibacterial agents and 
antioxidants were also included in the diets. To minimize potential variation that can 
occur with multiple diet mixings, a single batch of basal diet was prepared. 
Approximately first 5% and last 5% (as manufacture sequence) of the basal diet was 
excluded in the specific treatment diet manufacturing. The treatment diets were made by 
adding Cr (0, 1,000, or 2,000 ppb) as Cr (III) picolinate (CrPic) to the basal diet. The 
specific organic form of trivalent Cr, CrPic, was used based on previous reports 
suggesting that Cr is more available as an organic chelate (Page et al., 1993). The 
supplemental Cr levels were fed for 35 d before the challenge and continued until the end 
of the experiment. The animals in the present study were used for heat stress study of 
Chapter 3 (Experiment 1) during d 0 to 28. The animals for LPS challenge were kept in 
the thermoneutral environment during the entire period; the animals for PBS injection 
were reared under high ambient temperature (40.5°C) during d 14 to 28. Body weight and 
ADG of these animal during 35 d before the challenge are shown in Appendix 2. 
 102
 
Table 4.1. Percentage composition of the basal diet (as-fed basis) 
Item   
Ingredients    
Corn 57.255 
Soybean meal, 48% CP 25.50 
Dried whey 10.00 
Spray dried animal plasma 2.00 
Lactose - 
Corn oil 2.50 
Dicalcium phosphate 1.00 
Limestone 0.90 
Salt 0.40 
Vitamin premix1 0.10 
Trace-mineral premix2 0.075 
Mecadox-103 0.25 
Antioxidant4 0.02 
Calculated nutrient composition  
ME, kcal/kg 3,600 
CP, %  19.91 
Lysine, % 1.19 
Calcium, % 0.72 
Phosphorus, % 0.60 
1 Supplied per kg of diet: vitamin A, 6,600 IU; vitamin D3, 880 IU; vitamin E, 44 IU; vitamin K 
(as menadione sodium bisulfite complex), 6.4 mg; thiamin, 4.0 mg; riboflavin, 8.8 mg; 
pyridoxine, 4.4 mg; vitamin B12, 33 µg; folic acid, 1.3 mg; niacin, 44 mg; pantothenic acid, 22 
mg; D-biotin, 0.22 mg. 
2 Supplied per kg of diet: Zn, 131 mg as ZnO; Fe, 131 mg as FeSO4·H2O; Mn 45 mg, as MnO; 
Cu, 13 mg as CuSO4·5H2O; I, 1.5 mg as CaI2O6; Co, 0.23 mg as CoCO3; Se, 0.28 mg as 
NaSeO3.  
3 Supplied 55 mg carbadox per kg of diet. 
4 Supplied 130 mg ethoxyquin per kg of basal diet. 
 
 
 103
4.2.2. Lipopolysaccharide challenge 
At 0 h (09:00), animals were weighed and given an intraperitoneal injection of 
either PBS or LPS (50 μg/kg BW). The LPS (Escherichia coli serotype 0111:B4 phenol 
extract; Sigma L-2630, Sigma-Aldrich, Inc., St. Louis, MO) was dissolved in PBS 
solution (P-4417, Sigma-Aldrich, Inc., St. Louis, MO) to make 0.4 mg/ml LPS solution. 
A volume of 5 ml was made for each pig by combining PBS with the appropriate amount 
of LPS solution. Animals were suspended by the rear legs, and the solution was injected 
into the peritoneal cavity, three nipples down from the caudal end and approximately 3 
cm lateral to the nipple of the left side of the pig. 
 
4.2.3. Data and sample collection 
Animal weight and feed intake were measured at 0, 2, 4, 6, 12, 24, 48, and 96 h. 
Wasted feed and orts were collected and weighed to measure accurate feed intake. Rectal 
temperature was measured at 0, 2, 4, 6, 8, 10, 12, 24, and 48 h. Respiratory rate was 
visually measured by counting flank movements over a period of 1 min in resting pigs at -
1, 1.3, 3.7, 6, 8.5, 12, and 23 h. At 3 h, blood samples were collected via the jugular vein 
from pigs restrained in dorsal recumbency using a V-trough. The time point of blood 
collection was decided based on previous studies (Warren et al., 1997; Webel et al., 1997; 
Sakumoto et al., 2003). The collected blood samples were kept on ice until the plasma 
was obtained by centrifugation of the blood at 800 × g and 4°C for 20 min. Plasma 
samples were stored at -20°C until the chemical assays.  
 
4.2.4. Laboratory analysis 
The frozen plasma samples were allowed to thaw at room temperature for the 
chemical analysis. The cortisol concentrations in the plasma samples were determined 
using coated tube radioimmunoassays from Diagnostic Products Corporation (Los 
Angeles, CA). Standards and plasma samples were added to antibody-coated tubes. 
Radiolabeled cortisol (125I) was added to tubes and incubated for 45 minutes at 37°C 
using a waterbath. Then, all moisture in the tube was thoroughly removed and the 
radioactivity was measured using a Packard Cobra Auto-gamma counter (Packard 
Instrument Co., Meriden, CT). Standards and samples were analyzed in triplicate and 
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duplicate, respectively. A new set of standards was prepared and analyzed for each 
separate analysis. The glucose concentration in the plasma was analyzed using a glucose 
autoanalyzer (YSI 2300 STAT PLUS, Yellow Springs Instrument Co., Yellow Springs, 
OH). Samples were analyzed in duplicate, and the calibration was automatically 
performed every 30 min. 
 
4.2.5. Statistical analysis 
The experimental data were analyzed using GLM procedures of SAS (SAS Inst. 
Inc., Cary, NC). The model included two main effects and interaction as follows: 
 
Yijk = k + bi + tj + eij   
 
In this equation, the parameters represent: 
Y = response variables (growth performance, vital signs, and blood parameters) 
k = a constant 
bi = block effect 
tj = treatment effect 
eijk = error term of the model  
 
Orthogonal polynomials were used to determine the linear and quadratic effects of the 
dietary Cr supplementation. Each pen was considered as an experimental unit for feed 
intake; individual animals served as the experimental unit for other measurements. The 
alpha level used for determination of statistical significance was 0.05. 
 
4.3. Results 
4.3.1. Growth performance 
The LPS injection clearly affected BW changes of pigs (Table 4.2). All pigs 
injected with LPS lost weight during the first 2 h post injection. During the first 12 h post 
injection, pigs challenged with LPS lost 951 g, while the PBS injected pigs gained 170 g 
(P < 0.001). This weight loss began to be recovered after 12 h, and the weight gain of the 
LPS group tended to be higher than the PBS group during 24 to 48 h (1,014 vs. 723 g; P 
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= 0.09). In a cumulative basis, the weight gain of LPS challenged pigs was still negative 
at 24 h (-746 vs. 492 g; P < 0.001), and the weight gain of the LPS group still remained 
lower than the PBS group at 96 h (1,729 vs. 2,545 g; P < 0.05). Weight gain of pigs 
challenged with LPS was linearly decreased as dietary Cr supplementation increased 
during 6 to 12 h (P < 0.05). During 48 to 96 h, pigs fed diets supplemented with Cr 
gained less weight than pigs fed no supplemental Cr in a linear trend (P = 0.06). However, 
cumulative weight gains of pigs were not affected by dietary Cr supplementation during 
any of the periods or over the entire period. 
Pigs challenged with LPS consumed less feed during the first 2 h post injection, 
during 2 to 4 h, and during 12 to 24 h (P < 0.05; Table 4.3). Feed intake of the LPS group 
was higher than the PBS group during 48 to 96 h (4,834 vs. 3,924 g; P < 0.05). On a 
cumulative basis, pigs challenged with LPS had less feed consumption during 0 to 24 h 
(874 vs. 2,179 g; P < 0.01), but cumulative feed intake was similar in pigs injected with 
LPS or PBS at 96 h post injection (7,810 vs. 7,917 g; P = 0.88). The supplementation of 
dietary Cr had no effects on feed intake of pigs challenged with LPS during any of the 
periods or over the entire experiment. 
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Table 4.2. Effects of dietary chromium (III) picolinate (CrPic) supplementation on body 
weight of lipopolysaccharide (LPS) challenged pigs1 
Injection2: PBS  LPS P-values3 
0  0 1,000 2,000
SEM 
PBS vs. LPS LPS Linear QuadraticCr, ppb:
Body weight, kg         
0 h 24.0  26.5 26.2 27.3 0.8 0.007 0.033 0.510 0.555 
24.1  26.2 25.9 26.9 0.7 0.016 0.061 0.534 0.553 2 h 
4 h 24.0  25.8 25.7 26.6 0.7 0.023 0.088 0.494 0.610 
24.0  25.7 25.6 26.4 0.7 0.029 0.106 0.509 0.651 6 h 
12 h 24.1  25.6 25.5 26.1 0.7 0.070 0.161 0.677 0.709 
24.5  25.8 25.5 26.5 0.8 0.116 0.235 0.575 0.540 24 h 
48 h 25.2  26.7 26.5 27.5 0.8 0.083 0.200 0.542 0.577 
26.5  28.4 28.8 28.8 0.7 0.017 0.073 96 h 0.723 0.739 
Body weight gain, 
g         
0 to 2 h 91 -299 -318 -371 70 <0.001 0.001 0.397 0.814 
2 to 4 h -61 -352 -220 -314 86 0.030 0.028 0.760 0.300 
4 to 6 h -11 -148 -102 -186 47 0.023 0.054 0.389 0.104 
6 to 12 h 152 -64 -125 -352 109 0.017 0.179 0.039 0.457 
12 to 24 h 322 189 8 417 146 0.494 0.528 0.292 0.123 
24 to 48 h 723 947 1019 1076 141 0.091 0.276 0.521 0.965 
48 to 96 h 1330 1667 1300 1212 157 0.727 0.138 0.056 0.572 
Cumulative body weight gain, g      
0 to 2 h 91 -299 -318 -371 70 <0.001 0.001 0.397 0.814 
0 to 4 h 30 -652 -538 -686 112 <0.001 <0.001 0.845 0.394 
0 to 6 h 19 -799 -640 -871 131 <0.001 <0.001 0.702 0.243 
0 to 12 h 170 -864 -765 -1223 207 <0.001 0.002 0.210 0.260 
0 to 24 h 492 -674 -758 -807 241 <0.001 0.003 0.733 0.960 
0 to 48 h 1216 273 261 269 275 0.008 0.026 0.993 0.979 
0 to 96 h 2545 1939 1765 1481 317 0.036 0.183 0.242 0.744 
1 Each least squares mean represents six pigs. 
2 At 0 h, phosphate buffered saline (PBS) or lipopolysaccharide (LPS) was intraperitoneally
injected. The volume of LPS solution was determined to deliver 50 μg/kg BW, and PBS was 
filled to make 5 ml. 
3 P-values are from single degree of freedom contrast. PBS vs. LPS represents the contrast 
between pigs injected with PBS and pigs injected with LPS and fed 0, 1,000, or 2,000 ppb of
supplemental Cr; LPS represents the contrast between pigs injected with PBS and pigs injected
with LPS and fed 0 ppb of supplemental Cr. Linear and quadratic effects of dietary CrPic were
tested within the LPS challenged groups. 
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Injection2: PBS  LPS 
Table 4.3. Effects of dietary chromium (III) picolinate (CrPic) supplementation on feed 
intake of lipopolysaccharide (LPS) challenged pigs1 
P-values3 
Cr, ppb: 0  0 1,000 2,000
SEM 
PBS vs. LPS LPS Linear Quadratic
Feed intake, g          
0 to 2 h 250 15 30 23 23 <0.001 <0.001 0.643 0.435 
2 to 4 h 167 38 30 30 47 0.048 0.100 0.840 0.907 
4 to 6 h 152 45 30 - 64 0.139 0.287 0.325 0.840 
6 to 12 h 523 265 106 129 156 0.096 0.288 0.483 0.584 
12 to 24 h 1,106 636 576 667 109 0.009 0.022 0.878 0.661 
24 to 48 h 1,795 1,826 1,735 2,068 271 0.805 0.940 0.592 0.589 
48 to 96 h 3,924 5,061 4,783 4,659 254 0.023 0.020 0.060 0.668 
Cumulative feed intake, g       
0 to 2 h 250 15 30 23 23 <0.001 <0.001 0.643 0.435 
0 to 4 h 417 53 61 53 39 <0.001 <0.001 1.000 0.742 
0 to 6 h 568 98 91 53 82 0.002 0.007 0.520 0.800 
0 to 12 h 1,091 364 197 182 193 0.009 0.038 0.490 0.733 
0 to 24 h 2,197 1,000 773 848 259 0.005 0.017 0.724 0.685 
0 to 48 h 3,992 2,826 2,508 2,917 480 0.066 0.136 0.915 0.628 
0 to 96 h 7,917 7,886 7,967 7,576 586 0.876 0.970 0.506 0.292 
1 Each least squares mean represents three pens of two pigs/pen. 
2 At 0 h, phosphate buffered saline (PBS) or lipopolysaccharide (LPS) was intraperitoneally
injected. The volume of LPS solution was determined to deliver 50 μg/kg BW, and PBS was 
filled to make 5 ml. 
3 P-values are from single degree of freedom contrast. PBS vs. LPS represents the contrast 
between pigs injected with PBS and pigs injected with LPS and fed 0, 1,000, or 2,000 ppb of
supplemental Cr; LPS represents the contrast between pigs injected with PBS and pigs injected
with LPS and fed 0 ppb of supplemental Cr. Linear and quadratic effects of dietary CrPic were
tested within the LPS challenged groups. 
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Effects of PBS or LPS challenge on cumulative BW gain and feed intake of pigs 
fed no supplemental Cr are demonstrated in Figure 4.1.  
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Figure 4.1. Effects of phosphate buffered saline (PBS) or lipopolysaccharide (LPS) 
challenge on cumulative BW gain (a; n = 6 pigs) and cumulative feed intake (b; n = 3 
pens) of pigs fed no supplemental Cr. At 0 h, LPS or PBS was intraperitoneally injected. 
The volume of LPS solution was determined to deliver 50 μg/kg BW, and PBS was filled 
to make 5 ml. 
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4.3.2. Vital signs 
Table 4.4 and 4.5 demonstrate rectal temperature and respiratory rate responses. 
Rectal temperature was higher in the LPS group compared with the PBS group at 2 h 
(40.2 vs. 39.5°C; P < 0.01) and 4 h (40.2 vs. 39.5°C; P < 0.05). Rectal temperature was 
not different between the LPS and the PBS group at 6 h and after. Respiratory rate was 
also higher in the LPS compared with the PBS group at 1.3 h (83.4 vs. 58.0 breath/min; P 
< 0.05) and at 8.5 h (55.1 vs. 43.0 breath/min; P < 0.05). The dietary Cr had no effects on 
body temperature or respiratory rate at any time point of the experiment.  
 
Table 4.4. Effects of dietary chromium (III) picolinate (CrPic) supplementation on rectal 
temperature of lipopolysaccharide (LPS) challenged pigs1 
Injection2: P-values3 PBS  LPS 
SEM 
Cr, ppb: 0  0 1,000 2,000 PBS vs. LPS LPS Linear Quadratic
Rectal temperature, °C          
0 h 39.8  39.8 40.1 39.9 0.13 0.313 0.920 0.666 0.163 
2 h 39.5  40.1 40.2 40.4 0.16 0.001 0.021 0.346 0.937 
4 h 39.5  39.9 39.9 40.8 0.25 0.038 0.330 0.044 0.202 
6 h 39.6  39.9 39.5 40.2 0.33 0.375 0.437 0.566 0.257 
8 h 39.7  39.7 39.3 39.8 0.24 0.667 0.916 0.682 0.152 
10 h 39.5  39.3 39.3 39.4 0.16 0.343 0.307 0.643 0.983 
12 h 39.8  39.6 39.6 39.9 0.19 0.766 0.552 0.312 0.554 
24 h 39.5  39.3 39.1 39.4 0.13 0.298 0.536 0.700 0.122 
48 h 39.5  39.4 39.1 39.6 0.16 0.383 0.584 0.498 0.107 
1 Each least squares mean represents six pigs. 
2 At 0 h, phosphate buffered saline (PBS) or lipopolysaccharide (LPS) was intraperitoneally
injected. The volume of LPS solution was determined to deliver 50 μg/kg BW, and PBS was 
filled to make 5 ml. 
3 P-values are from single degree of freedom contrast. PBS vs. LPS represents the contrast 
between pigs injected with PBS and pigs injected with LPS and fed 0, 1,000, or 2,000 ppb of
supplemental Cr; LPS represents the contrast between pigs injected with PBS and pigs injected
with LPS and fed 0 ppb of supplemental Cr. Linear and quadratic effects of dietary CrPic were 
tested within the LPS challenged groups. 
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Injection2: PBS  LPS P-values3 
Cr, ppb: 0 0 1,000 2,000
SEM 
PBS vs. LPS LPS  Linear Quadratic
Respiratory rate, breath/min         
-1.0 h 63.2  52.0 53.8 55.3 3.99 0.055 0.063 0.547 0.972 
 1.3 h 58.0  75.0 83.8 91.5 10.03 0.041 0.246 0.316 0.967 
3.7 h 65.5  81.7 80.8 81.5 11.45 0.247 0.331 0.993 0.964 
6.0 h 54.8  68.5 62.3 63.2 5.05 0.109 0.072 0.472 0.584 
8.5 h 43.0  58.5 58.0 48.7 4.50 0.032 0.026 0.127 0.413 
12.0 h 54.5  54.0 58.3 49.3 7.63 0.946 0.964 0.708 0.538 
23.0 h 42.0  40.5 39.5 45.5 2.83 0.960 0.712 0.246 0.344 
1 Each least squares mean represents six pigs. 
2 At 0 h, phosphate buffered saline (PBS) or lipopolysaccharide (LPS) was intraperitoneally 
injected. The volume of LPS solution was determined to deliver 50 μg/kg BW, and PBS was 
filled to make 5 ml. 
3 P-values are from single degree of freedom contrast. PBS vs. LPS represents the contrast between 
pigs injected with PBS and pigs injected with LPS and fed 0, 1,000, or 2,000 ppb of supplemental
Cr; LPS represents the contrast between pigs injected with PBS and pigs injected with LPS and
fed 0 ppb of supplemental Cr. Linear and quadratic effects of dietary CrPic were tested within the 
LPS challenged groups. 
 
Table 4.5. Effects of dietary chromium (III) picolinate (CrPic) supplementation on 
respiratory rate of lipopolysaccharide (LPS) challenged pigs1 
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Effects of PBS or LPS challenge on rectal temperature and respiratory rate of pigs 
fed no supplemental Cr are shown in Figure 4.2.  
 
(a)       
39.0
39.2
39.4
39.6
39.8
40.0
40.2
40.4
0 10 20 30 40 5
Hours post PBS or LPS challenge
R
ec
ta
l t
em
pe
ra
tu
re
, °
C
0
PBS LPS
 
 (b) 
30
40
50
60
70
80
90
100
-5 0 5 10 15 20 25
Hours post PBS or LPS challenge
R
es
pi
ra
to
ry
 ra
te
, b
re
at
h/
m
in
PBS LPS
 
Figure 4.2. Effects of phosphate buffered saline (PBS) or lipopolysaccharide (LPS) 
challenge on rectal temperature (a) and respiratory rate (b) of pigs fed no supplemental Cr 
(n = 6). At 0 h, LPS or PBS was intraperitoneally injected. The volume of LPS solution 
was determined to deliver 50 μg/kg BW, and PBS was filled to make 5 ml. 
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4.3.3. Blood variables 
Plasma collected at 3 h had higher cortisol (178 vs. 29 ng/ml; P < 0.001) and 
lower glucose (5.87 vs. 6.88 mmol/l; P < 0.05) concentrations in the LPS group than the 
PBS group (Table 4.6). However, plasma measurements were unaffected by dietary Cr 
supplementation. 
 
Table 4.6. Effects of dietary chromium (III) picolinate (CrPic) supplementation on 
plasma cortisol and glucose of lipopolysaccharide (LPS) challenged pigs1 
Injection2: PBS  LPS P-values3 
SEM
Cr, ppb: 0  0 1,000 2,000 PBS vs. LPS LPS Linear Quadratic 
Cortisol, ng/ml 29.1  166.9 163.3 203.5 19.8 <0.001 <0.001 0.278 0.447 
Glucose, mmol/l  6.88  6.03 5.57 6.01 0.35 0.021 0.100 0.967 0.362 
1 Each least squares mean represents six pigs. 
2 At 0 h, phosphate buffered saline (PBS) or lipopolysaccharide (LPS) was intraperitoneally
injected. The volume of LPS solution was determined to deliver 50 μg/kg BW, and PBS was 
filled to make 5 ml. 
3 P-values are from single degree of freedom contrast. PBS vs. LPS represents the contrast 
between pigs injected with PBS and pigs injected with LPS and fed 0, 1,000, or 2,000 ppb of
supplemental Cr; LPS represents the contrast between pigs injected with PBS and pigs injected
with LPS and fed 0 ppb of supplemental Cr. Linear and quadratic effects of dietary CrPic were 
tested within the LPS challenged groups. 
 
4.4. Discussion 
Effects of dietary CrPic supplementation on the immune responses in pigs have 
been inconsistent (van Heugten and Spears, 1997; Lee et al., 2000; van de Ligt et al., 
2002c). At a dose of 200 ppb Cr, supplemental CrPic resulted in no or minimal effects on 
pigs challenged with ACTH (van Heugten and Spears, 1997), whereas 400 ppb of Cr as 
CrPic modulated cortisol response in pigs challenged with LPS (Lee et al., 2000). The 
supplemental Cr levels were fed for 7 d before the initial immune challenge in the former 
study; for 21 d in the latter study. The discrepancy of dietary Cr effects on immune 
stressed pigs may be attributed to supplemental Cr levels and/or pre-feeding periods. 
Immune systems may require greater than 200 ppb of supplemental Cr due to high 
proliferation rate, as suggested by van Heugten and Spears (1997).  In addition, dietary 
supplementation of Cr as CrPic at the concentrations of 200, 400, 800, and 1,200 ppb 
linearly increased feed intake, weight gain, feed efficiency, and egg production, and 
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linearly decreased serum corticosterone concentration in heat stressed laying quail (Sahin 
et al., 2002b). In the present study, thus, Cr levels of 1,000 and 2,000 ppb and 35 d of 
pre-feeding period were employed. 
 
4.4.1. Growth performance 
Weight gain responded acutely to LPS challenge. During 0 to 2 h, all pigs 
challenged with LPS lost weight, and the weight loss continued until 12 h. The acute 
weight loss may be due to increased defecation, increased urination, and reduced feed 
intake (Johnson and von Borell, 1994; Warren et al., 1997; Sakumoto et al., 2003). On a 
cumulative basis, weight gain of the LPS group was still negative at 24 h and was not 
fully recovered at the end of the experiment (96 h). In agreement, Mao et al. (2005) 
reported growth retardation in pigs challenged with LPS during the first 7 d post injection. 
In a longer term, however, weight gain may be recovered by the elevated compensatory 
feed intake observed in the present study and other experiments depending on the LPS 
dose (Johnson and von Borell, 1994; Warren et al., 1997). 
 Although behavioral activities were not quantified in the present study, all pigs 
injected with LPS instantly showed depressed behavior and very rarely accessed the 
feeder during 0 to 6 h, whereas the PBS group was more active and often accessed the 
feeder. Similar to our observation, depressed behavior increased with a higher dose of 
LPS (intraperitoneal) and decreased time-dependently after an acute peak at between 0 
and 3 h in a previous study (Warren et al., 1997). However, Sakumoto et al. (2003) 
reported that intravenous administration of LPS actually increased the activity of Chinese 
Meishan pigs. The discrepancy among the studies may be related to the LPS injection 
methods, dose levels, pig breeds, and/or experimental conditions.     
 According to the reduction of behavioral activity by immune stress, the present 
study confirmed the feed intake reduction by immune stress during 0 to 24 h. In 
agreement, acute decrease of feed intake by LPS challenge was reported in a number of 
previous studies (Johnson and von Borell, 1994; Warren et al., 1997; Sakumoto et al., 
2003; Frank et al., 2005). In our study, relatively low feed intake in the PBS group during 
2 to 4 h was perhaps due to the stress inevitably caused in blood collection procedures 
without catheter settings. Compensatory increase in feed intake was observed in the LPS 
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group during 48 to 96 h. Similarly, Johnson and von Borell (1994) reported that pigs 
injected with a low dose (0.5 μg/kg BW) of LPS showed a compensatory elevation of 
feed intake during 4 to 8 h post challenge. Although feed intake after 8 h was not 
demonstrated herein, a compensation of feed intake may occur later with a higher dose (5 
or 50 μg/kg BW) of LPS. 
 We failed to observe ameliorating effects of dietary Cr on weight gain or feed 
intake of pigs challenged with immune stress, in agreement with other studies (van 
Heugten and Spears, 1997; Lee et al., 2000).  
 
4.4.2. Vital signs 
In the present study, the endotoxin-induced elevation of body temperature was 
consistent with previous research (Johnson and von Borell, 1994; Warren et al., 1997; 
Sakumoto et al., 2003). However, supplemental Cr did not affect body temperature of 
pigs under immune stress. Similarly, Lee et al. (2000) reported that rectal temperature 
was elevated by LPS but dietary Cr had no effects on rectal temperature in pigs under 
immune stress. 
  Respiratory rate was also higher in pigs under immune stress. Respiratory rate has 
been often assessed to measure other types of stress such as heat stress (Morrow-Tesch et 
al., 1994; Hicks et al., 1998). However, respiratory rate has been rarely measured in 
immune stressed animal models. Although respiratory rate in this study was measured 
once for each time by a single panelist, immune stress significantly affected the 
measurement at two time points, and all LPS treatment means were greater than PBS 
means through 8.5 h. Employing multiple panels system will potentially make respiratory 
rate a good criterion in immune stress research. 
 
4.4.3. Blood variables 
The administration of LPS is generally known to activate macrophages and to 
trigger the release of proinflammatory cytokines including tumor necrosis factor-α, 
interleukin-1, and interleukin-6, which activate the hypothalamus-pituitary-adrenal axis 
causing increased corticosteroid secretion from the adrenal cortex (Webel et al., 1997). In 
the present study, plasma cortisol concentration was elevated 6.1-fold by LPS challenge 
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consistent with previous studies (Warren et al., 1997; Webel et al., 1997; Sakumoto et al., 
2003). However, dietary Cr supplementation did not affect circulating cortisol 
concentration in the pigs under immune stress. van Heugten and Spears (1997) also failed 
to detect effects of Cr on serum cortisol concentrations in pigs stressed with ACTH. In 
contrast, Lee et al. (2000) reported that dietary Cr decreased plasma cortisol 
concentration at 2 h post LPS challenge on d 35 of the experiment. But, it should be 
noted that dietary Cr did not affect cortisol concentrations in the first LPS injection on d 
21, and supplemental Cr even increased plasma cortisol concentration at 4 h post 
injection on d 35.  
 In the present study, plasma glucose concentration was 15% lower in the LPS 
group than in the PBS group. Myers et al. (1997) also reported that blood glucose 
concentration was decreased at 6 to 8 h post LPS challenge. The low glucose 
concentration in the pigs challenged with LPS may be attributed to the low feed intake 
during the first few hours. If the elevated cortisol concentration continues for a longer 
term, gluconeogenesis may be enhanced and circulating glucose concentration may be 
increased (McMahon et al., 1988). With a single injection of LPS, elevated cortisol 
concentration generally lasted no more than 24 h (Webel et al., 1997). Multiple 
challenges with endotoxin may result in high glucose concentration and potentially 
glucose intolerance.  
 Taken together, an LPS challenge acutely caused growth retardation, feed intake 
reduction, body temperature elevation, respiration rate increase, plasma cortisol elevation, 
and plasma glucose reduction. However, dietary Cr had minimal effects on the pigs under 
immune stress. 
 
4.5. Implications 
The present research indicated that pigs challenged with acute immune stress 
consumed less feed, gained less weight, but had higher body temperature and respiratory 
rate compared with those challenged with saline. The immune stress by endotoxin 
challenge increased circulating cortisol concentration but decreased glucose 
concentration. However, supplemental Cr as CrPic added to the diet failed to ameliorate 
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the effects of immune stress in pigs. Further research to assess effects and mechanism of 
Cr on the pigs under other types of stress may be needed. 
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CHAPTER 5. The Effects of Dietary Chromium (III) Picolinate on Growth 
Performance, Respiratory Rate, Plasma Variables, and Carcass Traits of Pigs Fed 
High-fat Diets 
 
Abstract 
The present experiment investigated the effects of dietary chromium (Cr) as Cr 
(III) picolinate on growth, respiration, plasma variables, and carcass traits of pigs fed the 
high-fat diets (HFD). A total of 32 crossbred weanling pigs (BW of 9.56 ± 1.64 kg) were 
grouped into four blocks by initial BW, and randomly assigned to four treatment groups 
with two pigs per pen. Dietary treatments included: 1) low-fat diet (LFD) with no 
supplemental Cr, 2) HFD with no supplemental Cr, 3) HFD with 1,000 ppb supplemental 
Cr, and 4) HFD with 2,000 ppb supplemental Cr. Crude fat contents in LFD and HFD 
were less than 3.5% and more than 30.0%, respectively. During d 0 to 56, pigs fed the 
HFD gained faster (800 vs. 727 g/d; P = 0.024), consumed less feed (1,130 vs. 1,397 g/d; 
P < 0.001), and had lower feed:gain (1.41 vs. 1.92; P < 0.001). Dietary Cr 
supplementation caused an increase in feed:gain of pigs fed the HFD (1.43 vs. 1.38; P = 
0.035) in a quadratic manner (P = 0.033). Pigs fed the HFD had more frequent respiration 
than pigs fed the LFD on d 13 (64.5 vs. 57.3 breath/min; P = 0.080), d 41 (75.9 vs. 61.9 
breath/min; P < 0.001) and d 55 (43.3 vs. 35.6 breath/min; P = 0.061). However, the 
supplemental Cr had no effect on respiratory rate. Plasma cortisol concentration on d 42 
tended to be higher in the pigs fed HFD than the pigs fed LFD (47.8 vs. 34.3 ng/ml; P = 
0.081). Plasma insulin concentration on d 14 decreased with dietary Cr supplementation 
(2.84 vs. 5.71 μIU/ml; P = 0.024) in a linear manner (P = 0.050). Consumption of the 
HFD resulted in increases of slaughter weight (62.5 vs. 57.7 kg; P < 0.001), hot carcass 
weight (45.8 vs. 37.8 kg; P < 0.001), perirenal fat (496 vs. 261 g; P < 0.001), first rib fat 
(2.97 vs. 1.98 cm; P < 0.001), last rib fat (1.69 vs. 1.17 cm; P = 0.006), last lumbar fat 
(2.23 vs. 1.30 cm; P < 0.001), average backfat (2.30 vs. 1.49 cm; P< 0.001), and tenth rib 
fat (1.79 vs. 1.06 cm; P < 0.001) compared with the LFD group. Estimated carcass fat-
free lean percentages were lower in pigs fed the HFD than in the LFD group (52.8 vs. 
59.9 %; P < 0.001). The supplemental levels of Cr resulted in linear reductions of hot 
carcass weight (P = 0.083), cold carcass weight (P = 0.106), the last rib fat (P = 0.070), 
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the last lumbar fat (P = 0.004) and average backfat (P = 0.036). The effects of Cr on 
carcass fat measurements were more significant in barrows than in gilts. These results 
indicate that dietary Cr supplementation attenuates some effects of HFD, mainly on body 
fat accretion of pigs, especially in barrows. 
Key Words: High-fat diet, Chromium, Pigs 
 
5.1. Introduction 
Since chromium (Cr) was identified as an essential component in the glucose 
tolerance factor (Schwarz and Mertz, 1959), the roles of Cr have been widely studied in 
humans and animals. Generally Cr has been shown to potentiate the action of insulin 
(Mertz et al., 1974; Vincent, 2000) and accordingly to modulate carbohydrate, protein, 
and lipid metabolism (Davis and Vincent, 1997; Cefalu et al., 2002; Bernao et al., 2004).  
In animals, Cr has been recognized as an essential trace mineral (Anderson, 1987; 
Offenbacher and Pi-Sunyer, 1988) and suggested to ameliorate stress related effects 
(Chang and Mowat, 1992; Anderson, 1994; NRC, 1997). The effects of Cr have been 
investigated in various stress situations of animals including thermal stress (Sahin et al., 
2002b; Onderci et al., 2003), immune stress (van Heugten and Spears, 1997; Lee et al., 
2000), and transportation stress (Chang and Mowat, 1992; Moonsier-Shageer and Mowat, 
1993). However, studies on dietary Cr in animals under nutritional stress of high-fat diets 
(HFD) have been rare and limited only to rodent models (Striffler et al., 1998; 
Bhattacharya et al., 2006).  
The consumption of HFD has been reported to cause obesity in humans (Lissner 
and Heitmann, 1995; Shepard et al., 2001) and rodents (Masek and Fabry, 1959; 
Lemonnier et al., 1975). And animals with obesity induced by HFD have been widely 
used as experimental models in studies of human obesity (Inoue et al., 1977; Hansen et 
al., 1997; Han et al., 2000; Jones et al., 2005; Kishino et al., 2006). Furthermore, dietary 
high-fat may result in insulin resistance (Lavau et al., 1979; Rocchini et al., 1997; Jones 
et al., 2005) and cardiovascular disease (Aguila and Mandarim-de-Lacerda, 2003; Davis 
et al., 2006). Pigs, perhaps rather than rodents, would be excellent experimental animal 
models for human nutrition studies, because of the anatomical and physiological 
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similarities between swine and human digestive systems (Miller and Ullrey, 1987; 
Nafikov and Beitz, 2007).  
Supplemental Cr as Cr (III) picolinate (CrPic) has been reported to increase 
leanness and/or decrease fat deposition of pigs in some studies (Page et al., 1993; 
Lindemann et al., 1995; Mooney and Cromwell, 1995; Lien et al., 2001) but not in others 
(Evock-Clover et al., 1993; Mooney and Cromwell, 1999; Matthews et al., 2001). In a 
commercial environment, dietary CrPic has been suggested to be more effective in 
animals with high propensity for body fat deposition (Lindemann and Purser, 1997). But 
the influence of Cr on pigs fed fat-enriched diets has not been tested. Therefore, the 
objective of the present study was to determine the effect of supplemental Cr on growth, 
respiratory rate, plasma variables, and carcass traits of pigs fed HFD.   
 
5.2. Experimental procedures 
The growth trial was carried out at the University of Kentucky. The animal 
slaughter and carcass traits assessment were performed at the meat laboratory of the same 
institution. The experiments were conducted under protocols approved by the 
Institutional Animal Care and Use Committee of the University of Kentucky.  
 
5.2.1. Animals and dietary treatments 
 In a 56-d experiment, a total of 32 crossbred weanling pigs with an average initial 
BW of 9.56 ± 1.64 kg were used. Animals were grouped into four blocks by initial BW 
and randomly assigned to four treatment groups with two animals per pen, with balanced 
gender and ancestry using the Experimental Animal Allotment Program (Kim and 
Lindemann, 2007). One barrow and one gilt were housed in each plastic woven wire 
floored 1.2 m × 1.2 m pen. Each pen was equipped with a stainless steel feeder and a 
nipple waterer. Pigs had ad libitum access to feed and water.  
Dietary treatments included: 1) a low-fat diet (LFD) with no supplemental Cr, 2) a 
HFD with no supplemental Cr, 3) the HFD with 1,000 ppb supplemental Cr, and 4) the 
HFD with 2,000 ppb supplemental Cr. The experimental diets for d 0 to 14 were 
formulated to contain 3.29% crude fat, 22.17% crude protein, and 1.38% Lys for the low-
fat treatment group and 30.07% crude fat, 20.66% crude protein, and 1.38% Lys for the 
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high-fat treatment groups (Table 5.1). The experimental diets for d 14 to 56 were 
formulated to contain 3.48% crude fat, 21.79% crude protein, and 1.22% Lys for the low-
fat treatment group and 30.11% crude fat, 20.43% crude protein, and 1.25% Lys for the 
high-fat treatment groups (Table 5.2). A dried fat product (SOWEENA Dry Fat 4-80, 
Merrick Animal Nutrition, Inc., Middleton, WI) containing 80% crude fat, 4.4% crude 
protein, and less than 3.5% ash was used to achieve the high fat contents. Analysed fatty 
acid profile of treatment diets is shown in Table 5.3. Dietary Cr was supplemented as 
CrPic (CHROMAX, Prince Agri Products, Inc., Quincy, IL) at the expense of limestone, 
the carrier of CrPic in CHROMAX. The organic form of trivalent Cr, CrPic, was used 
based on previous reports suggesting that Cr is more available as an organic chelate (Page 
et al., 1993). Minerals and vitamins were added to meet or exceed NRC (1998). 
Antibacterial agents and antioxidants were also included in the diets.  
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Dietary fat: Low High 
Cr, ppb: 0 
Table 5.1. Percentage composition of experimental diets for starting pigs (d 0 to 14; as-
fed basis) 
0 1,000 2,000 
Ingredients      
Corn 58.635 28.535 28.535 28.535 
Soybean meal, 48% CP 30.00 30.00 30.00 30.00 
Whey dried 5.00 - - - 
Spray dried animal plasma 3.00 3.00 3.00 3.00 
Dried fat 4-801 - 35.00 35.00 35.00 
L-Lysine·HCl 0.10 0.09 0.09 0.09 
DL-Methionine 0.02 0.09 0.09 0.09 
L-Threonine - 0.04 0.04 0.04 
Dicalcium phosphate 1.30 1.30 1.30 1.30 
Limestone 1.10 1.10 0.85 0.60 
CHROMAX2 - - 0.25 0.50 
Iodized salt 0.40 0.40 0.40 0.40 
Vitamin premix3 0.10 0.10 0.10 0.10 
Trace mineral premix4 0.075 0.075 0.075 0.075 
Antibiotic5 0.25 0.25 0.25 0.25 
Antioxidant6 0.02 0.02 0.02 0.02 
Calculated nutrient composition    
ME, kcal/kg 3,296 4,576 4,576 4,576 
Crude fat, % 3.29 30.07 30.07 30.07 
Crude protein, % 22.17 20.66 20.66 20.66 
Lysine, % 1.38 1.38 1.38 1.38 
Calcium, % 0.84 0.89 0.89 0.89 
Phosphorus, % 0.69 0.66 0.66 0.66 
Available phosphorus, % 0.38 0.42 0.42 0.42 
1 A homogeneous, co-dried product (SOWEENA Dry Fat 4-80, Merrick Animal Nutrition, Inc., 
Middleton, WI) containing micro-encapsulated lard, tallow, and whey proteins. This product
contains 7,054 kcal/kg ME, 80% crude fat, 4.4% crude protein, 0.36% lysine, 0.17%
methionine + cystine, 0.20% threonine, 0.27% calcium, 0.26% phosphorus, and 0.25%
available phosphorus (calcium and phosphorus contents are estimated assuming that the ratios
of these contents to crude protein are the same as in dried whey). 
2 Supplied 0, 1,000, or 2,000 ppb Cr as chromium (III) picolinate (CHROMAX, Prince Agri
Products, Inc., Quincy, IL). 
3 Supplied per kg of diet: vitamin A, 6,600 IU; vitamin D3, 880 IU; vitamin E, 44 IU; vitamin K 
(as menadione sodium bisulfite complex), 6.4 mg; thiamin, 4.0 mg; riboflavin, 8.8 mg;
pyridoxine, 4.4 mg; vitamin B12, 33 µg; folic acid, 1.3 mg; niacin, 44 mg; pantothenic acid, 22
mg; D-biotin, 0.22 mg. 
4 Supplied per kg of diet: Zn, 131 mg as ZnO; Fe, 131 mg as FeSO4·H2O; Mn 45 mg, as MnO; Cu, 
13 mg as CuSO4·5H2O; I, 1.5 mg as CaI2O6; Co, 0.23 mg as CoCO3; Se, 0.28 mg as NaSeO3.  5 Mecadox-10 (Phibro Animal Health, Fairfield, NJ) supplied 55 mg carbadox per kg of diet. 
6 Santoquin (Monsanto, St. Louis, MO) supplied 130 mg ethoxyquin per kg of diet. 
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Dietary fat: Low High 
Table 5.2. Percentage composition of experimental diets for growing pigs (d 14 to 56; as-
fed basis) 
Cr, ppb: 0 0 1,000 2,000 
Ingredients      
Corn 62.255 27.255 27.255 27.255 
Soybean meal, 48% CP 35.00 35.00 35.00 35.00 
Dried fat 4-801 - 35.00 35.00 35.00 
Dicalcium phosphate 1.10 1.10 1.10 1.10 
Limestone 1.00 1.00 0.75 0.50 
CHROMAX2 - - 0.25 0.50 
Iodized salt 0.40 0.40 0.40 0.40 
Vitamin premix3 0.10 0.10 0.10 0.10 
Trace mineral premix4 0.075 0.075 0.075 0.075 
Antibiotic5 0.05 0.05 0.05 0.05 
Antioxidant6 0.02 0.02 0.02 0.02 
Calculated nutrient composition    
ME, kcal/kg 3,312 4,584 4,584 4,584 
Crude fat, % 3.48 30.11 30.11 30.11 
Crude protein, % 21.79 20.43 20.43 20.43 
Lysine, % 1.22 1.25 1.25 1.25 
Calcium, % 0.74 0.82 0.82 0.82 
Phosphorus, % 0.62 0.61 0.61 0.61 
Available phosphorus, % 0.28 0.36 0.36 0.36 
1 A homogeneous, co-dried product (SOWEENA Dry Fat 4-80, Merrick Animal Nutrition, Inc., 
Middleton, WI) containing micro-encapsulated lard, tallow, and whey proteins. This product
contains 7,054 kcal/kg ME, 80% crude fat, 4.4% crude protein, 0.36% lysine, 0.17%
methionine + cystine, 0.20% threonine, 0.27% calcium, 0.26% phosphorus, and 0.25% 
available phosphorus (calcium and phosphorus contents are estimated assuming that the ratios
of these contents to crude protein are the same as in dried whey). 
2 Supplied 0, 1,000, or 2,000 ppb Cr as chromium (III) picolinate (CHROMAX, Prince Agri 
Products, Inc., Quincy, IL). 
3 Supplied per kg of diet: vitamin A, 6,600 IU; vitamin D3, 880 IU; vitamin E, 44 IU; vitamin K 
(as menadione sodium bisulfite complex), 6.4 mg; thiamin, 4.0 mg; riboflavin, 8.8 mg;
pyridoxine, 4.4 mg; vitamin B12, 33 µg; folic acid, 1.3 mg; niacin, 44 mg; pantothenic acid, 22
mg; D-biotin, 0.22 mg. 
4 Supplied per kg of diet: Zn, 131 mg as ZnO; Fe, 131 mg as FeSO4·H2O; Mn 45 mg, as MnO; 
Cu, 13 mg as CuSO4·5H2O; I, 1.5 mg as CaI2O6; Co, 0.23 mg as CoCO3; Se, 0.28 mg as 
NaSeO3.  
5 Tylan 40 Sulfa-G (Elanco Animal Health, Indianapolis, IN) supplied 110 mg of tylosin and 110
mg of sulfamethazine per kg of diet. 
6 Santoquin (Monsanto, St. Louis, MO) supplied 130 mg ethoxyquin per kg of diet. 
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Table 5.3. Analysed fatty acid profile of the dietary treatments 
Experimental period: D 0 to 14  D 14 to 56 
Dietary fat: Low High  Low High 
Crude fat 2.58 25.98 2.17 26.45 
Fatty acid profile, % of total fat1    
C14:0 -2 2.12 - 2.14 
C16:0 12.61 22.04 12.36 21.98 
C16:1 - 2.72 - 2.74 
C17:0 - 0.92 - 0.93 
C17:1 - 0.62 - 0.64 
C18:0 2.55 13.28 2.77 13.45 
C18:1t-9 - 2.55 - 2.61 
C18:1n-9  21.99 38.67 23.58 38.98 
C18:2 57.08 12.17 55.81 11.37 
C18:3 3.93 0.93 3.15 0.77 
Saturated fatty acid 15.16 38.36 15.13 38.50 
Polyunsaturated fatty acid 61.01 13.10 58.96 12.14 
PUFA:SFA3 4.02 0.34 3.90 0.32 
1 Fatty acids lower than 0.5% are removed from the list. 
2 Not detectable.  
3 PUFA and SFA represent polyunsaturated fatty acid and saturated fatty acid, 
respectively. 
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5.2.2. Data and sample collection 
Animal weights and feed intake were measured biweekly. Blood samples were 
collected from all pigs via the jugular vein on d 14, 28, 42, and 56. Animals were fasted 
for 16 h before the blood collection on d 42 and 56. The collected blood samples were 
kept on ice for approximately 1 to 2 h, and the plasma samples were then obtained by 
centrifugation of the blood at 800 × g and 4°C for 20 min. Plasma samples were stored at 
-20°C until the chemical assays.  
Respiratory rate was visually measured on d 13, 27, 41, and 55 by counting flank 
movements over a period of 1 min in resting pigs. To facilitate the counting of respiration 
in resting pigs, respiratory rate was determined between 20:30 and 24:30. The respiratory 
rate was measured by three independent panelists, and means of three observations were 
used for analysis. 
Growth data were recorded until d 56, and the treatments diets continued to be fed 
until the animals were slaughtered on d 58 or 65 for determination of body fat measures. 
After fasting for 16 to 20 h, animals were humanely slaughtered using conventional 
methods. One pig died before slaughter, and carcass data of this pig were not collected. 
The perirenal fat (leaf fat) surrounding the kidney was removed from the carcass and 
weighed. The head was removed, and the carcass was split along the dorsal midline. The 
hot carcass was weighed, and carcass traits were measured after chilling the carcass at 
1°C for 72 h. The midline backfat was measured at the first rib, the last rib, and the last 
lumbar vertebrae. The tenth-rib fat thickness was measured at three-fourths of the 
distance across the longissimus muscle, and the longissimus muscle area (LMA) was 
determined by assessing the surface area at primal cuts of tenth rib following the methods 
described by NPPC (2000).  
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5.2.3. Carcass fat-free lean estimation and carcass data adjustment 
From the carcass data, initial fat-free lean (FFL) weight, carcass FFL weight, FFL 
gain, daily FFL gain, and the percentage FFL in carcass were estimated using the 
equations (NPPC, 2000) adapted to metric units as follows: 
 
Initial fat-free lean weight, kg = (0.418 × initial BW, kg) – 1.825 
 
Carcass fat-free lean = 3.899 + (0.465 × hot carcass weight, kg) – (3.914 × 
tenth rib fat, cm) + (0.2115 × longissimus muscle area, cm2) 
 
Fat-free lean gain, kg = carcass fat-free lean, kg – initial fat-free lean, kg 
 
Daily fat-free lean gain, kg/d = fat-free lean gain, kg ÷ days on test  
 
Percentage fat-free lean in carcass, % = carcass fat-free lean, kg ÷ hot 
carcass weight, kg 
 
Backfat depth and LMA were adjusted to 41.6 kg cold carcass weight (the mean 
weight). Adjustment equations for backfat depth and LMA are available (NPPC, 2000) 
but applicable only to the pigs of 107 to 120 kg BW. Thus, considering different 
dimensional parameters, the following adjustment equations were used:  
 
Adjusted fat depth, cm = actual fat depth, cm × (41.61/3 ÷ cold carcass 
weight1/3, kg) 
 
Adjusted longissimus muscle area, cm2 = actual longissimus muscle area, 
cm2 × (41.62/3 ÷ cold carcass weight2/3, kg). 
 
5.2.4. Laboratory analysis 
Crude fat contents of diet samples were analysed by a solvent extraction method 
(AOAC, 1995) using a Soxtec System HT (Tecator AB, Hoganas, Sweden). Fatty acid 
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profiles of treatment diets were determined (AOAC, 1995) at Experiment Station 
Chemical Laboratory (University of Missouri, Columbia). 
The frozen plasma samples were allowed to thaw at room temperature for the 
chemical analysis. The cortisol and insulin concentrations in the plasma samples were 
determined using coated tube radioimmunoassays (Diagnostic Products Corporation, Los 
Angeles, CA). The radioactivity was measured using a Packard Cobra Auto-gamma 
counter (Packard Instrument Co., Meriden, CT). Standards and samples were analyzed in 
triplicate and duplicate, respectively. A new set of standards was prepared and analyzed 
for each separate analysis. 
  
5.2.5. Statistical analysis 
The experimental unit for the growth performance responses was the pen and data 
were analyzed using GLM procedures of SAS (SAS Inst. Inc., Cary, NC). The model 
included two main effects and interaction as follows: 
 
Yij = k + bi + tj + eij   
 
In this equation, the parameters represent: 
Y = response variables 
k = a constant 
bi = block effect 
tj = treatment effect 
eij = error term of the model  
 
For other data including respiratory rate, plasma hormones, and carcass measurements, 
the individual pig was considered as the experimental unit. Respiratory rates and plasma 
hormone concentrations were analyzed using MIXED procedure of SAS for repeated 
measures (Littell et al., 1998). For the analysis of carcass measurements the model 
included block effect, treatment effect, sex effect, and treatment × sex interaction. 
Orthogonal polynomials were used to determine the effects of dietary high-fat inclusion 
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and the linear and quadratic effects of the dietary Cr supplementation in the HFD 
treatments. 
 
5.3. Results 
5.3.1. Growth performance 
The growth performance was affected by dietary fat inclusion levels but 
minimally by supplemental Cr (Table 5.4 and 5.5). During d 0 to 14, pigs fed the HFD 
gained 16% more weight (671 vs. 579 g/d; P = 0.025), had 19% lower feed:gain (1.24 vs. 
1.53; P < 0.001), consumed more energy (3.80 vs. 2.94 Mcal ME/d; P = 0.001), and had 
higher ME:gain (5.65 vs. 5.06; P = 0.023) than pigs fed the LFD. During d 14 to 56, pigs 
in the HFD groups gained 9 % more weight (843 vs. 776 g/d; P = 0.064), consumed 21% 
less feed (1,231 vs. 1,566 g/d; P < 0.001), and had 28% lower feed:gain (1.46 vs. 2.02; P 
< 0.001) with no discernible difference in energy intake or ME:gain. Over the entire 
experimental period, the HFD group gained 10% faster (800 vs. 727 g/d; P = 0.024), 
consumed 19% less feed (1,130 vs. 1,397 g/d; P < 0.001) but 12% more energy (5.18 vs. 
4.62 Mcal ME/d; P = 0.028), and showed 26% lower feed:gain (1.41 vs. 1.92; P < 0.001) 
with no detectable changes in ME:gain (P = 0.291). Dietary Cr supplementation had no 
effect on the growth performance of the pigs fed the HFD except that feed:gain was 3.3% 
increased (1.43 vs. 1.38; P = 0.035) in a quadratic manner (P = 0.033) by Cr 
supplementation for the overall period.  
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Dietary fat: Low  High P-values2 
Cr, ppb: 0  0 1,000 
Table 5.4. Effects of dietary chromium supplementation on biweekly body weight,
average daily gain (ADG, g/d), average daily feed intake (ADFI, g/d), and feed:gain of 
pigs fed the experimental diets1 
2,000 
SEM 
Fat1 Fat2 Cr Linear Quad. 
Body weight, kg            
  D 0 9.6 9.4 9.6 9.6 0.13 0.752 0.382 0.213 0.320 0.398 
  D 14 17.7 18.8 19.1 18.9 0.43 0.033 0.094 0.798 0.882 0.798 
  D 28 28.3 29.8 28.7 29.1 0.85 0.400 0.252 0.441 0.611 0.498 
  D 42 38.1 42.6 40.2 40.5 1.28 0.070 0.033 0.244 0.341 0.459 
  D 56 50.3 55.5 53.8 53.8 1.38 0.031 0.025 0.399 0.461 0.666 
D 0 to 14            
  ADG 579 672 673 668 29 0.025 0.053 0.967 0.926 0.939 
  ADFI 891 811 852 826 34 0.152 0.130 0.574 0.790 0.506 
  Feed:gain 1.53 1.21 1.26 1.24 0.05 <0.001 0.001 0.348 0.520 0.427 
D 14 to 28            
  ADG 760 785 688 728 46 0.636 0.713 0.146 0.327 0.186 
  ADFI 1299 1054 1004 1013 58 0.003 0.015 0.375 0.482 0.559 
  Feed:gain 1.71 1.34 1.46 1.39 0.03 <0.001 <0.001 0.095 0.331 0.077 
D 28 to 42            
  ADG 697 915 822 814 60 0.054 0.030 0.304 0.350 0.640 
  ADFI 1509 1304 1260 1228 80 0.027 0.104 0.571 0.536 0.955 
  Feed:gain 2.17 1.43 1.57 1.51 0.08 <0.001 <0.001 0.163 0.343 0.210 
D 42 to 56            
  ADG 870 920 968 944 44 0.183 0.450 0.512 0.702 0.510 
  ADFI 1891 1384 1438 1392 55 <0.001 <0.001 0.664 0.918 0.493 
  Feed:gain 2.18 1.51 1.50 1.47 0.06 <0.001 <0.001 0.738 0.659 0.922 
D 0 to 14            
  ADG 579 672 673 668 29 0.025 0.053 0.967 0.926 0.939 
  ADFI 891 811 852 826 34 0.152 0.130 0.574 0.790 0.506 
  Feed:gain 1.53 1.21 1.26 1.24 0.05 <0.001 0.001 0.348 0.520 0.427 
D 14 to 56            
  ADG 776 873 826 829 28 0.064 0.034 0.252 0.328 0.518 
  ADFI 1566 1247 1234 1211 55 <0.001 0.003 0.688 0.612 0.937 
  Feed:gain 2.02 1.43 1.49 1.46 0.03 <0.001 <0.001 0.088 0.295 0.081 
Overall            
  ADG 727 823 788 789 23 0.024 0.018 0.342 0.411 0.615 
  ADFI 1397 1138 1138 1115 46 <0.001 0.003 0.834 0.713 0.827 
  Feed:gain 1.92 1.38 1.44 1.41 0.02 <0.001 <0.001 0.035 0.173 0.033 
1 Each least squares mean represents four pens of two pigs/pen. 
2 P-values are from single degree of freedom contrast. Fat1 represents the comparison between low- and 
high-fat diets. Fat2 represents the comparison between low- and high-fat diets with no supplemental 
Cr. Cr represents the comparison of Cr added vs. non-added within pigs fed the high-fat diet. Linear 
and quadratic effects of dietary Cr were tested within pigs fed the high-fat diet. 
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Dietary fat: Low  High P-values2 
Cr, ppb: 0  0 1,000 2,000 
SEM 
Fat1 Fat2 
Table 5.5. Effects of dietary chromium supplementation on body weight, average daily
gain (ADG, g/d), average daily feed intake (ADFI, g/d), feed:gain, average daily ME 
intake (ADMEI, Mcal/d), and ME:gain (kcal/g gain) of pigs fed the experimental diets1 
Cr Linear Quad. 
Body weight, kg            
  D 0 9.6 9.4 9.6 9.6 0.13 0.752 0.382 0.213 0.320 0.398 
  D 14 17.7 18.8 19.1 18.9 0.43 0.033 0.094 0.798 0.882 0.798 
  D 56 50.3 55.5 53.8 53.8 1.38 0.031 0.025 0.399 0.461 0.666 
D 0 to 14            
  ADG 579 672 673 668 29 0.025 0.053 0.967 0.926 0.939 
  ADFI 891 811 852 826 34 0.152 0.130 0.574 0.790 0.506 
  Feed:gain 1.53 1.21 1.26 1.24 0.05 <0.001 0.001 0.348 0.520 0.427 
  ADMEI 2.94 3.71 3.90 3.78 0.16 0.001 0.007 0.574 0.790 0.506 
  ME:gain 5.06  5.53 5.76 5.67 0.19 0.023 0.111 0.348 0.520 0.427 
D 14 to 56           
  ADG 776 873 826 829 28 0.064 0.034 0.252 0.328 0.518 
  ADFI 1566 1247 1234 1211 55 <0.001 0.003 0.688 0.612 0.937 
  Feed:gain 2.02 1.43 1.49 1.46 0.03 <0.001 <0.001 0.088 0.295 0.081 
  ADMEI 5.19 5.72 5.66 5.55 0.22 0.105 0.120 0.688 0.612 0.937 
  ME:gain 6.69 6.55 6.85 6.69 0.11 0.946 0.368 0.088 0.295 0.081 
Overall            
  ADG 727 823 788 789 23 0.024 0.018 0.342 0.411 0.615 
  ADFI 1397 1138 1138 1115 46 <0.001 0.003 0.833 0.713 0.827 
  Feed:gain 1.92 1.38 1.44 1.41 0.02 <0.001 <0.001 0.035 0.173 0.033 
  ADMEI 4.62 5.22 5.22 5.11 0.18 0.028 0.050 0.833 0.713 0.827 
  ME:gain 6.36 6.34 6.62 6.48 0.09 0.291 0.883 0.035 0.173 0.033 
1 Each least squares mean represents four pens of two pigs/pen. 
2 P-values are from single degree of freedom contrast. Fat1 represents the comparison between low- and 
high-fat diets. Fat2 represents the comparison between low- and high-fat diets with no supplemental 
Cr. Cr represents the comparison of Cr added vs. non-added within pigs fed the high-fat diet. Linear 
and quadratic effects of dietary Cr were tested within pigs fed the high-fat diet. 
 
 
5.3.2. Respiratory rate 
Respiratory rate (Table 5.6) was numerically higher in pigs fed the HFD than pigs 
fed a LFD on d 13 (65.4 vs. 57.3 breath/min; P = 0.080; 24.6°C ambient temperature), d 
27 (50.0 vs. 44.1 breath/min; P = 0.147; 23.7°C ambient temperature), and d 55 (43.3 vs. 
35.6 breath/min; P = 0.061; 22.3°C ambient temperature). The frequency of respiration 
was markedly higher in pigs fed the HFD than in pigs fed the LFD on d 41 (75.9 vs. 61.9 
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breath/min; P < 0.001; 27.1°C ambient temperature). Dietary Cr supplementation did not 
affect respiration rate. 
 
Dietary fat: Low  High P-values2 
Cr, ppb: 0  0 1,000 2,000 
SEM
Fat1 Fat2 Cr Linear Quad.
Respiratory rate, breath/min           
D 13 57.3  65.3 63.2 65.0 3.3 0.080 0.112 0.782 0.960 0.642
D 27 44.1  51.8 45.2 53.2 3.7 0.147 0.127 0.552 0.772 0.093
D 413 61.9  73.4 74.9 79.3 3.8 <0.001 0.023 0.395 0.239 0.731
D 55 35.6  43.8 42.3 43.8 2.7 0.061 0.103 0.865 0.993 0.724
1 Each least squares mean represents eight pigs (four animals for each sex). The respiratory rate 
was measured by three independent panelists (two panelists on d 27) and means of these three
observations were used for statistical analysis. 
2 P-values are from single degree of freedom contrast. Fat1 represents the comparison between
low- and high-fat diets. Fat2 represents the comparison between low- and high-fat diets with 
no supplemental Cr. Cr represents the comparison of Cr added vs. non-added within pigs fed 
the high-fat diet. Linear and quadratic effects of dietary Cr were tested within pigs fed the 
high-fat diet. In the analysis of repeated measures, treatment effects (P = 0.003) and time
effects (P < 0.001) were significant, but no interaction between treatment and time existed (P
= 0.829).  
3 The ambient temperature on d 41 was unintentionally high (27.1°C), while the temperature was 
maintained as thermoneutral on d 13 (24.6°C), 27 (23.7°C), and 55 (22.3°C). 
 
5.3.3. Plasma cortisol and insulin 
As shown in Table 5.7, plasma cortisol concentration on d 42 tended to be higher 
in the pigs fed HFD than the pigs fed LFD (47.8 vs. 34.3 ng/ml; P = 0.081). Plasma 
insulin concentration on d 14 was decreased by dietary Cr supplementation (P = 0.024) in 
a linear manner (P = 0.050). 
 
Table 5.6. Effects of dietary chromium supplementation on respiratory rate of pigs fed 
the experimental diets1 
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5.3.4. Carcass traits 
Feeding the HFD caused increases of slaughter weight, carcass weight, and 
carcass fat measures. Carcass weights and some of the fat parameters increased by the 
HFD were reversed by dietary Cr supplementation (Table 5.8). Feeding the HFD caused 
increases of slaughter weight (62.5 vs. 57.7 kg; P < 0.001), and hot carcass weight (45.8 
vs. 37.8 kg; P < 0.001). Consumption of the HFD resulted in 90% greater perirenal fat 
(496 vs. 261 g; P < 0.001) compared with the LFD group. Pigs provided with the HFD 
had deeper first rib fat (2.97 vs. 1.98 cm; P < 0.001), last rib fat (1.69 vs. 1.17 cm; P = 
0.006), last lumbar fat (2.23 vs. 1.30 cm; P < 0.001), average backfat (2.30 vs. 1.49 cm; P 
< 0.001), and tenth rib fat (1.79 vs. 1.06 cm; P < 0.001) by 50, 44, 72, 55, and 69%, 
respectively, compared with the LFD group. The greater fat deposition by dietary fat was 
similarly observed in adjusted carcass fat traits. The tenth rib LMA was unaffected by 
Table 5.7. Effects of dietary chromium supplementation on plasma cortisol and insulin of 
pigs fed the experimental diets1 
Dietary fat: Low  High P-values2 
Cr, ppb: 0  0 1,000 2,000 
SEM
Fat1 Fat2 Cr Linear Quad.
Cortisol, ng/ml             
D 14 60.8 57.8 67.2 56.4 8.6 0.965 0.745 0.618 0.884 0.213
D 28 33.2 41.8 42.8 46.1 7.3 0.177 0.358 0.747 0.652 0.891
D 42 34.3 52.5 48.0 42.8 5.8 0.081 0.055 0.386 0.305 0.964
D 56 31.7 39.8 32.0 31.7 4.8 0.711 0.386 0.328 0.387 0.646
Insulin, μIU/ml3            
D 14 4.78 5.71 2.83 2.84 1.44 0.404 0.522 0.024 0.050 0.252
D 28 5.38 5.31 6.86 4.94 1.06 0.786 0.958 0.636 0.801 0.169
D 42 3.41 2.60 4.28 3.43 0.77 0.984 0.578 0.322 0.569 0.318
D 56 2.66 3.64 2.31 2.76 0.64 0.837 0.499 0.380 0.546 0.477
1 Each least squares mean represents eight pigs (four animals for each sex).  
2 P-values are from single degree of freedom contrast. Fat1 represents the comparison between
low- and high-fat diets. Fat2 represents the comparison between low- and high-fat diets with no 
supplemental Cr. Cr represents the comparison of Cr added vs. non-added within pigs fed the 
high-fat diet. Linear and quadratic effects of dietary Cr were tested within pigs fed the high-fat 
diet. In the analysis of repeated measures data of cortisol, time effects (P < 0.001) were
significant, but treatment effects (P = 0.524) nor interaction between treatment and time (P =
0.676) existed. For insulin, similarly, time effects (P = 0.002) were observed whereas treatment
effects (P = 0.713) and the interaction (P = 0.452) were insignificant.  
3 One IU of insulin is the biological equivalent of about 45.5 μg pure crystalline insulin (1 μIU =
45.5 pg pure crystalline insulin).  
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dietary fat inclusion (P = 0.485) whereas the tenth rib LMA adjusted to 41.6 kg cold 
carcass weight was 11% smaller (25.2 vs. 28.5 cm2; P = 0.035). Estimated carcass FFL 
percentages were lower in pigs fed the HFD than in the LFD group (52.8 vs. 59.9 %; P < 
0.001). But, carcass FFL (P = 0.504), and daily FFL gain (P = 0.442) were not influenced 
by dietary fat levels. 
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Dietary fat: Low  High P-values2 
Cr, ppb: 0  0 1,000
Table 5.8. Effects of dietary chromium supplementation on carcass traits of pigs fed the 
experimental diets1 
2,000
SEM
Fat1 Fat2 Cr Linear Quad.
Measurements3              
Initial BW, kg 9.6 9.5 9.6 9.6 0.2 0.947 0.821 0.702 0.780 0.762
BW at slaughter, kg 57.7 65.5 61.1 60.8 2.0 0.036 0.009 0.102 0.132 0.430
Hot carcass, kg 40.3 48.1 44.7 44.5 1.3 <0.001 <0.001 0.058 0.083 0.341
Cold carcass, kg 37.8 45.1 42.2 42.1 1.2 <0.001 <0.001 0.077 0.106 0.378
Perirenal fat, g 261 560 466 462 48 <0.001 <0.001 0.170 0.214 0.496
First rib fat, cm 1.98 2.94 3.08 2.89 0.18 <0.001 0.001 0.613 0.956 0.256
Last rib fat, cm 1.17 1.97 1.57 1.54 0.16 0.006 0.001 0.050 0.070 0.344
Last lumbar fat, cm 1.30 2.57 2.19 1.94 0.16 <0.001 <0.001 0.008 0.004 0.747
Average backfat, cm 1.49 2.49 2.28 2.12 0.14 <0.001 <0.001 0.064 0.036 0.938
10th rib fat, cm 1.06 1.97 1.73 1.68 0.16 <0.001 <0.001 0.263 0.280 0.674
10th rib LMA, cm2 26.8 27.2 25.0 25.2 1.3 0.485 0.829 0.244 0.323 0.485
Estimations4             
Initial FFL, kg 2.19 2.16 2.20 2.18 0.10 0.947 0.821 0.702 0.780 0.762
Carcass FFL, kg 24.1 24.3 23.2 23.3 0.7 0.504 0.839 0.272 0.362 0.490
FFL gain, kg 21.9 22.2 21.0 21.1 0.6 0.477 0.799 0.220 0.310 0.433
Daily FFL gain, kg/d 365 368 349 351 10 0.442 0.833 0.217 0.307 0.429
Carcass FFL, % 59.9 50.7 52.2 52.5 1.6 <0.001 <0.001 0.478 0.488 0.802
Adjusted carcass traits5            
First rib fat, cm 2.05 2.86 3.07 2.88 0.18 <0.001 0.003 0.332 0.739 0.156
Last rib fat, cm 1.21 1.91 1.57 1.53 0.15 0.010 0.003 0.069 0.090 0.396
Last lumbar fat, cm 1.34 2.50 2.18 1.93 0.15 <0.001 <0.001 0.011 0.005 0.882
Average backfat, cm 1.53 2.43 2.27 2.11 0.13 <0.001 <0.001 0.100 0.049 0.874
10th rib fat, cm 1.10 1.91 1.72 1.68 0.14 <0.001 <0.001 0.320 0.333 0.718
10th rib LMA, cm2 28.5 25.8 24.9 25.0 1.4 0.035 0.154 0.678 0.747 0.768
1 Each least squares mean represents eight pigs (four animals for each sex).  
2 P-values are from single degree of freedom contrast. Fat1 represents the comparison between low- and 
high-fat diets. Fat2 represents the comparison between low- and high-fat diets with no supplemental 
Cr. Cr represents the comparison of Cr added vs. non-added within pigs fed the high-fat diet. Linear 
and quadratic effects of dietary Cr were tested within pigs fed the high-fat diet. 
3 The midline fat depth was measured at the first rib, the last rib, and the last lumbar vertebrae. Average
backfat depth was calculated as a mean of three fat depth values at the first rib, the last rib, and the
last lumbar vertebrae. The off-midline fat depth and longissimus muscle area (LMA) were assessed 
at primal cuts of 10th rib. 
4 Fat-free lean (FFL) values were estimated using the equations in Pork Composition & Quality
Assessment Procedures (NPPC, 2000): Initial FFL, kg = (0.418 × initial BW, kg) – 1.825; Carcass 
FFL = 3.899 + (0.465 × hot carcass weight, kg) – (3.914 × 10th rib fat, cm) + (0.2115 × LMA, cm2); 
FFL gain, kg = carcass FFL, kg – initial FFL, kg; Daily FFL gain, kg/d = FFL gain, kg ÷ days on test
(60.5 d on average); Carcass FFL, % = carcass FFL, kg ÷ hot carcass weight, kg. 
5 Backfat depth and LMA were adjusted to 41.6 kg cold carcass weight using the equations: Adjusted
fat depth, cm = actual fat depth, cm × (41.61/3 ÷ cold carcass weight1/3, kg); Adjusted LMA, cm2 = 
actual LMA, cm2 × (41.62/3 ÷ cold carcass weight2/3, kg).  
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 The increased carcass fat measures caused by the HFD were moderated by 
feeding supplemental Cr (Table 5.8). The supplemental levels of Cr resulted in linear 
reductions of hot carcass weight (P = 0.083), cold carcass weight (P = 0.106), the last rib 
fat (P = 0.070), the last lumbar fat (P = 0.004) and average backfat (P = 0.036). Adjusted 
backfat depths were also similarly responded to supplemental Cr. The interactions (or 
trends) of dietary Cr × sex were observed in the last lumbar fat (P = 0.014; not shown) 
and average backfat (P = 0.090; not shown). In barrows, the last lumbar fat (P = 0.002) 
and average backfat (P = 0.037) were linearly reduced by increasing levels of 
supplemental Cr (Table 5.9). In gilts, however, the effects of dietary Cr on carcass fat 
measurement were not observed (P > 0.20; Table 5.10). In addition, the perirenal fat 
weight also tended to linearly decrease with supplemental Cr in barrows (675, 521, and 
423 g; P = 0.147; Table 5.9), but not in gilts (449, 412, and 501 g; P = 0.394; Table 5.10).  
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Table 5.9. Effects of dietary chromium supplementation on carcass traits of barrows fed 
the experimental diets1 
Dietary fat: Low High P-values2 
Cr, ppb: 0 0 1,000 2,000
SEM
Fat1 Fat2 Cr Linear Quad.
Measurements3             
Initial BW, kg 9.2 9.2 9.2 9.7 0.3 0.563 0.939 0.486 0.300 0.651
BW at slaughter, kg 57.6 67.6 61.7 59.3 4.2 0.238 0.105 0.328 0.302 0.803
Hot carcass, kg 39.7 49.8 44.6 43.2 2.7 0.050 0.021 0.210 0.207 0.642
Cold carcass, kg 37.3 46.5 42.2 40.9 2.4 0.038 0.019 0.230 0.220 0.688
Perirenal fat, g 295 675 521 423 96 0.031 0.016 0.194 0.147 0.899
First rib fat, cm 2.19 3.14 3.30 2.86 0.25 0.006 0.020 1.000 0.582 0.324
Last rib fat, cm 1.46 2.30 1.65 1.56 0.28 0.211 0.051 0.123 0.134 0.466
Last lumbar fat, cm 1.27 3.14 2.19 1.84 0.21 <0.001<0.001 0.003 0.002 0.187
Average backfat, cm 1.64 2.86 2.38 2.08 0.21 0.005 0.002 0.056 0.037 0.802
10th rib fat, cm 1.14 2.25 1.87 1.59 0.28 0.024 0.016 0.241 0.181 0.956
10th rib LMA, cm2 25.2 26.0 23.4 26.3 1.7 0.966 0.703 0.389 0.780 0.046
Estimations4             
Initial FFL, kg 2.01 2.03 2.03 2.21 0.13 0.563 0.939 0.486 0.300 0.651
Carcass FFL, kg 23.2 23.7 22.2 23.3 1.1 0.901 0.729 0.539 0.827 0.348
FFL gain, kg 21.2 21.7 20.2 21.1 1.0 0.834 0.719 0.446 0.699 0.332
Daily FFL gain, kg/d 353 360 337 351 16 0.831 0.733 0.466 0.720 0.345
Carcass FFL, % 58.5 47.6 50.5 54.1 2.5 0.014 0.011 0.213 0.126 0.819
Adjusted carcass traits5            
First rib fat, cm 2.27 3.02 3.29 2.88 0.21 0.006 0.028 0.712 0.785 0.220
Last rib fat, cm 1.51 2.22 1.65 1.56 0.27 0.279 0.073 0.152 0.164 0.506
Last lumbar fat, cm 1.31 3.03 2.18 1.85 0.19 <0.001<0.001 0.003 0.003 0.225
Average backfat, cm 1.70 2.76 2.37 2.10 0.18 0.004 0.002 0.064 0.040 0.911
10th rib fat, cm 1.19 2.17 1.86 1.60 0.25 0.022 0.016 0.257 0.189 0.991
10th rib LMA, cm2 27.1 24.1 23.5 26.7 1.7 0.195 0.212 
 
0.418 0.072 0.073
1 Each least squares mean represents four barrows.  
2 P-values are from single degree of freedom contrast. Fat1 represents the comparison between low- and 
high-fat diets. Fat2 represents the comparison between low- and high-fat diets with no supplemental Cr. 
Cr represents the comparison of Cr added vs. non-added within pigs fed the high-fat diets. Linear and 
quadratic effects of dietary Cr were tested within pigs fed the high-fat diets. 
3 The midline fat depth was measured at the first rib, the last rib, and the last lumbar vertebrae. Average
backfat depth was calculated as a mean of three fat depth values at the first rib, the last rib, and the last
lumbar vertebrae. The off-midline fat depth and longissimus muscle area (LMA) were assessed at primal
cuts of 10th rib. 
4 Fat-free lean (FFL) values were estimated using the equations in Pork Composition & Quality Assessment
Procedures (NPPC, 2000): Initial FFL, kg = (0.418 × initial BW, kg) – 1.825; Carcass FFL = 3.899 + 
(0.465 × hot carcass weight, kg) – (3.914 × 10th rib fat, cm) + (0.2115 × LMA, cm2); FFL gain, kg = 
carcass FFL, kg – initial FFL, kg; Daily FFL gain, kg/d = FFL gain, kg ÷ days on test (60.5 d on
average); Carcass FFL, % = carcass FFL, kg ÷ hot carcass weight, kg. 
5 Backfat depth and LMA were adjusted to 41.6 kg cold carcass weight using the equations: Adjusted fat 
depth, cm = actual fat depth, cm × (41.61/3 ÷ cold carcass weight1/3, kg); Adjusted LMA, cm2 = actual 
LMA, cm2 × (41.62/3 ÷ cold carcass weight2/3, kg).
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Table 5.10. Effects of dietary chromium supplementation on carcass traits of gilts fed the 
experimental diets1 
Dietary fat: Low High P-values2 
Cr, ppb: 0 0 1,000
SEM
2,000 Fat1 Fat2 Cr Linear Quad.
Measurements3             
Initial BW, kg 10.0 10.1 10.0 9.5 0.2 0.583 0.813 0.334 0.146 0.458
BW at slaughter, kg 57.8 64.1 60.6 62.3 1.5 0.027 0.014 0.217 0.447 0.225
Hot carcass, kg 40.8 46.9 44.8 45.8 1.2 0.004 0.005 0.324 0.545 0.341
Cold carcass, kg 38.3 44.2 42.3 43.3 1.1 0.004 0.005 0.358 0.594 0.349
Perirenal fat, g 227 449 412 501 39 <0.001 0.003 0.884 0.394 0.247
First rib fat, cm 1.78 2.73 2.86 2.92 0.28 0.010 0.041 0.299 0.282 0.828
Last rib fat, cm 0.89 1.65 1.49 1.52 0.19 0.015 0.021 0.550 0.643 0.688
Last lumbar fat, cm 1.33 2.06 2.19 2.03 0.25 0.028 0.071 0.861 0.919 0.603
Average backfat, cm 1.33 2.15 2.18 2.16 0.21 0.008 0.023 0.911 0.962 0.889
10th rib fat, cm 0.98 1.65 1.59 1.78 0.17 0.007 0.021 0.899 0.662 0.614
10th rib LMA, cm2 28.4 28.2 26.6 24.0 1.8 0.349 0.952 0.153 0.087 0.795
Estimations4             
Initial FFL, kg 2.36 2.39 2.37 2.16 0.08 0.583 0.813 0.334 0.146 0.458
Carcass FFL, kg 25.0 25.2 24.2 23.3 0.8 0.426 0.861 0.127 0.095 0.908
FFL gain, kg 22.6 22.8 21.8 21.2 0.8 0.439 0.876 0.136 0.115 0.809
Daily FFL gain, kg/d 376 378 361 351 13 0.404 0.919 0.137 0.120 0.778
Carcass FFL, % 61.3 53.8 53.9 51.0 1.8 0.003 0.017 0.605 0.374 0.589
Adjusted carcass traits5            
First rib fat, cm 1.82 2.68 2.84 2.88 0.28 0.014 0.059 0.192 0.210 0.632
Last rib fat, cm 0.91 1.62 1.48 1.50 0.19 0.018 0.025 0.576 0.650 0.734
Last lumbar fat, cm 1.37 2.02 2.18 2.00 0.24 0.034 0.089 0.785 0.951 0.520
Average backfat, cm 1.37 2.10 2.17 2.13 0.20 0.009 0.030 0.804 0.908 0.768
10th rib fat, cm 1.01 1.62 1.58 1.75 0.16 0.008 0.027 0.832 0.615 0.652
10th rib LMA, cm2 29.9 27.1 26.3 23.4 1.8 0.067 0.297 0.285 0.149 0.621
1 Each least squares mean represents four gilts.  
2 P-values are from single degree of freedom contrast. Fat1 represents the comparison between low- and 
high-fat diets. Fat2 represents the comparison between low- and high-fat diets with no supplemental Cr. 
Cr represents the comparison of Cr added vs. non-added within pigs fed the high-fat diet. Linear and 
quadratic effects of dietary Cr were tested within pigs fed the high-fat diet. 
3 The midline fat depth was measured at the first rib, the last rib, and the last lumbar vertebrae. Average
backfat depth was calculated as a mean of three fat depth values at the first rib, the last rib, and the last
lumbar vertebrae. The off-midline fat depth and longissimus muscle area (LMA) were assessed at primal 
cuts of 10th rib. 
4 Fat-free lean (FFL) values were estimated using the equations in Pork Composition & Quality Assessment
Procedures (NPPC, 2000): Initial FFL, kg = (0.418 × initial BW, kg) – 1.825; Carcass FFL = 3.899 + 
(0.465 × hot carcass weight, kg) – (3.914 × 10th rib fat, cm) + (0.2115 × LMA, cm2); FFL gain, kg = 
carcass FFL, kg – initial FFL, kg; Daily FFL gain, kg/d = FFL gain, kg ÷ days on test (60.5 d on average);
Carcass FFL, % = carcass FFL, kg ÷ hot carcass weight, kg. 
5 Backfat depth and LMA were adjusted to 41.6 kg cold carcass weight using the equations: Adjusted fat
depth, cm = actual fat depth, cm × (41.61/3 ÷ cold carcass weight1/3, kg); Adjusted LMA, cm2 = actual 
LMA, cm2 × (41.62/3 ÷ cold carcass weight2/3, kg). 
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5.4. Discussion 
Several methods of dietary fat inclusion are available: 1) high-fat/high-energy due 
to high energy density of fat, 2) high-fat/isoenergetic diet by lowering energy density 
with the inclusion of low- or non-energy ingredients, and 3) high-fat/isoenergetic intake 
by reducing feed allowance. We used the first method to maximize the nutritional stress, 
although it may be unclear if the effects are caused by high-fat and/or high-energy in the 
diet. Thus HFD had high energy as well as high fat concentrations compared to the LFD. 
In the present experiment, as expected, the HFD resulted in dramatic changes in growth 
performance, respiration, and body fat deposition. To the best of our knowledge, this is 
the first study to investigate the effects of CrPic in the pigs fed over 30% of fat in the diet. 
In most pig trials supplemental Cr treatments were lower than 1,000 ppb and the 
effects of Cr have been inconclusive. The excretion of Cr may increase in stress 
situations (Anderson, 1994) and dietary supplementation of Cr as CrPic at concentrations 
of 200, 400, 800, and 1,200 ppb has resulted in linear beneficial effects in heat stressed 
poultry (Sahin et al., 2002b). In human studies, moreover, 1,000 μg/d of Cr 
(approximately 2,000 ppb Cr assuming 500 g daily intake) from CrPic had improved 
positive effects in diabetic subjects (Anderson et al., 1997; Martin et al., 2006) compared 
to lower levels. Thus, we used 1,000 and 2,000 ppb of supplemental Cr concentration 
with this nutritional stress.  
  
5.4.1. Growth performance 
In the present study, the high inclusion level of dietary fat clearly resulted in 
greater weight gain, and reduced feed intake and feed:gain. In agreement, pigs near 
market weight fed 10% poultry fat in the diet for 28 d gained 4% faster, consumed 11% 
less feed and had 14% lower feed:gain (Azain et al., 1991). Although the studies using 
over 30% of fat in swine diets have been sparse, in a meta-analysis of swine studies, 
including over 3% supplemental fat caused increased weight gain and feed efficiency, 
and decreased feed intake (Azain, 2001).  
Energy intake was higher in the pigs fed HFD than in the pigs fed LFD because 
reduced feed intake was compensated by high energy concentration in HFD. During 
overall period, ADFI was 19% lower but energy concentration was at least 38% higher in 
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HFD group compared to LFD group. Similarly, ME:gain was unaffected by dietary fat 
concentration whereas feed:gain was 27% lower in HFD group than in LFD group. 
The effects of Cr on growth performance of pigs have been variable. Some 
researchers have reported that supplemental CrPic to the swine diet may improve weight 
gain (Mooney and Cromwell, 1995) and feed efficiency (Lindemann et al., 1995). Others 
have reported that dietary CrPic effects on growth performance were absent or may be 
even negative (Boleman et al., 1995; Mooney and Cromwell, 1999; Matthews et al., 
2001). In a review of supplemental CrPic in pig trials, an interaction between 
supplemental Cr and dietary protein level was suggested (Lindemann, 1999), in that 
supplemental Cr improves feed efficiency in the pigs fed protein marginal to the 
requirement whereas not in the pigs fed excess protein. In the present study, supplemental 
Cr increased feed:gain in pigs fed HFD throughout the 8-week feeding trial. The 
increased feed:gain due to supplemental Cr was associated with the numerical decrease in 
weight gain, and it may be related to the decreased fat deposition in the pigs fed 
supplemental Cr (Table 5.8). In a recent study of mice fed HFD, similarly, supplemental 
Cr decreased BW gain and body fat mass (Bhattacharya et al., 2006). 
 
5.4.2. Respiratory rate 
The present study demonstrates apparent elevation of respiratory frequency in the 
pigs fed the HFD. In contrast, respiratory rate was unaffected by 13% of dietary fat in 
lactating sows (Schoenherr et al., 1989). In our study, however, the HFD included over 
30% fat. An accentuated respiratory rate was observed on d 41 perhaps due to the 
hyperthermal environment. The increased respiratory rate of pigs in high ambient 
temperature has been reported in multiple studies (Schoenherr et al., 1989; Quiniou and 
Noblet, 1999; Renaudeau et al., 2001). In the present study, the elevated respiration 
frequency by HFD was not moderated by dietary Cr supplementation.  
 
5.4.3. Plasma cortisol and insulin 
High-fat feeding has been suggested to influence the hypothalamic-pituitary-
adrenal axis, elevating blood corticosteroid concentration (Brindley et al., 1981; Pascoe et 
al., 1991; Tannenbaum et al., 1997). In the present study, circulating cortisol 
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concentration tended to be elevated in the pigs fed HFD compared with the pigs fed LFD 
on d 42. The increased cortisol concentration due to the dietary fat was reversed only 
numerically (P = 0.386) by supplemental Cr, although the d 42 and d 56 responses raise 
interesting questions about longer periods of supplementation.  
Dietary fat has been reported to elevate blood insulin and glucose (Reaven et al., 
1967; Muurling et al., 2002). Supplemental Cr lowered circulating insulin concentration 
in rats fed HFD (Striffer et al., 1998) and in swine (Lien et al., 2001). In the present study, 
plasma insulin concentration of pigs fed HFD linearly decreased by Cr supplementation 
on d 14. 
 
5.4.4. Carcass traits 
Diets enriched with fat have been known to induce obesity in humans (Lissner 
and Heitmann, 1995; Shepard et al., 2001) and experimental animals (Masek and Fabry, 
1959; Lemonnier et al., 1975). In the present study, as anticipated, the consumption of 
HFD resulted in marked increases of carcass weights, perirenal fat weight, and back fat 
depths compared with the LFD group.  
The BW was only numerically decreased (P = 0.461, linear) by supplemental Cr 
in the pigs fed HFD (Table 5.4). However, supplemental Cr decreased slaughter BW (P = 
0.132) and hot carcass weight (P = 0.083) of the pigs fed HFD in a linear trend (Table 
5.8). The improved significance may be attributed both to the increased degree of 
freedom by considering each individual animal as an experimental unit and to the 
extended feeding period to the slaughter date.  
The effects of supplemental Cr on the carcass characteristics of pigs have been 
inconsistent. Since Page et al. (1993) reported that the supplemental Cr increased LMA 
and percentage of muscling but decreased the tenth rib back fat, similar effects of 
supplemental Cr have been demonstrated in multiple studies (Lindemann et al., 1995; 
Lien et al., 2001). In other studies, contrastingly, supplemental Cr was ineffective in 
modulating carcass leanness or fatness of pigs (Evock-Clover et al., 1993; Mooney and 
Cromwell, 1999; Matthews et al., 2001). Mooney and Cromwell (1995) observed 
increased muscle percentage and decreased fat percentage of dissected carcass by 
supplemental Cr, but found no changes in backfat thickness or LMA. More recently, 
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effects of CrPic on the pigs under nutritional stress of deficient dietary energy (van de 
Ligt et al., 2002a) or dietary amino acids (van de Ligt et al., 2002b) were assessed. In 
these experiments, supplemental Cr had no or only minor effects on carcass traits.    
In the present study, the supplemental Cr from CrPic moderated the increased 
carcass fat measures due to the HFD. The effects of Cr on body composition of the 
animals fed HFD have been rarely studied, but our findings are strongly supported by a 
study employing obese mice induced by HFD (Bhattacharya et al., 2006). They observed 
reductions of body weight gain (3.04 vs. 7.29 g), body fat mass gain (0.95 vs. 3.13 g), 
and visceral fat mass gain (0.26 vs. 1.09 g) by dietary Cr as Cr carnosinate 
(Carnochrome) in mice fed experimental diets for 14 weeks (P < 0.05). In a recent study 
of patients with non-insulin-dependent (Type 2) diabetes mellitus taking an antidiabetic 
drug (sulfonylurea), dietary CrPic intake for 24 weeks decreased weight gain (0.9 vs. 2.2 
kg; P < 0.05), the changes of body fat percentage (0.12 vs. 1.17 %), subcutaneous fat (P < 
0.05), visceral fat (P < 0.05), and total abdominal fat (P < 0.01) compared with placebo 
group (Martin et al., 2006). Our findings agree with these data in that CrPic moderated 
increased body weight gain and body fat percentage.   
Although many studies including the present study have reported that Cr may 
decrease body fat storage, the mechanism has not been fully elucidated. Trivalent Cr has 
been shown to potentiate the action of insulin (Mertz et al., 1974; Vincent, 2000) and 
theoretically should increase glucose uptake in adipocytes and muscle cells. Indeed, the 
lipogenic rate in the porcine adipose was accelerated by supplemental Cr with no changes 
of lipolysis in contradiction to decreased whole body fat deposition (Lien et al., 2001). 
They hypothesized that Cr stimulates protein synthesis and only a little remaining energy 
can be used for fat storage. In a genomic study of subcutaneous adipose tissue, niacin-
bound Cr supplementation upregulated genes related to glycolysis, muscle contraction, 
muscle metabolism, and muscle development (Rink et al., 2006). They suggested that 
supplemental niacin-bound Cr may trigger myogenesis in the fat tissue. 
 Taken together, a HFD decreased feed intake, and increased weight gain and feed 
efficiency. The respiratory rate and carcass fat retention were elevated by HFD 
consumption. The increased body weight and fat retention were moderated by 
supplemental Cr as CrPic. 
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5.5. Implications 
The present research indicated that the high-fat diet fed to pigs induced obesity in 
spite of less feed consumed and higher feed efficiency compared with those fed the low-
fat diet. Pigs fed the high-fat diet had more frequent respiration and showed increases in 
carcass weights, perirenal fat weight, and back fat depths compared with the low-fat diet 
group. The supplemental Cr as CrPic attenuated the increased carcass weight and carcass 
fat measures due to the fat-enriched diet in pigs especially barrows which are normally 
fatter than gilts. Further research to elucidate effects and mechanism of chromium on the 
pigs fed the high-fat diet seems warranted.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Beob Gyun Kim 2007 
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CHAPTER 6. Chromium (III) Picolinate Affects Cortisol and DHEAs Secretion in 
H295R Human Adrenocortical Cells 
 
Abstract 
Dietary chromium (III) picolinate (CrPic) effects on circulating steroid hormones 
have been reported in various experimental animal models. However, direct effects of 
CrPic on adrenocortical steroidogenesis are uncertain. The H295R cell line, derived from 
human adrenocortical carcinoma cells, serves as a model system for adrenal steroid 
metabolism studies. Therefore, the objective of our study was to determine the effects of 
CrPic on cortisol and dehydroepiandrosterone sulfate (DHEAs) secretion from H295R 
cells. In experiment 1, 24 h of exposure to CrPic (0, 0.1, 1, 10, 100, and 200 μM) dose-
dependently increased cortisol secretion (P < 0.05). When forskolin (10 μM) was 
included in the incubation media, CrPic had both a linear (P < 0.001) and quadratic (P < 
0.001) effect on cortisol secretion with the highest cortisol secretion at 0.1 μM of CrPic 
and the lowest at 200 μM of CrPic. In experiment 2, 48 h exposure to CrPic (200 μM) 
decreased cortisol (P < 0.07) release from forskolin-stimulated cells during a 24 h 
collection period. Additionally, 1 μM of CrPic increased DHEAs (P < 0.05) secretion 
from these cells. In experiment 3, 48 h exposure to CrPic (100 μM) decreased cortisol (P 
< 0.05) and DHEAs (P < 0.01) from forskolin-stimulated cells during a 24 h collection 
period. In experiment 4, a 24 h exposure to forskolin followed by 24 h exposure to both 
forskolin and CrPic (100 and 200 μM) also decreased both cortisol (P < 0.001) and 
DHEAs (P < 0.01) secretion. This study suggests that at high concentrations, CrPic 
inhibits aspects of steroidogenesis in agonist-stimulated adrenocortical cells. 
Key words: chromium, cortisol, DHEAs, steroid, H295R, adrenocorticoid 
 
6.1. Introduction  
Trivalent chromium (Cr) is an essential micro nutrient for humans and animals 
(Anderson, 1987; Offenbacher and Pi-Sunyer, 1988). Since the first report on the 
essentiality of Cr in rats (Schwarz and Mertz, 1959), the roles of Cr have been widely 
studied in humans, animals, and in vitro models. A well-known function of Cr is to 
potentiate the action of insulin (Mertz et al., 1974; Vincent, 2000). Chromium (III) 
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picolinate (CrPic) is a biologically active form of Cr for insulin internalization in muscle 
cells (Evans and Bowman, 1992).    
The effects of a variety of dietary Cr sources on adrenal steroid hormones have 
been investigated, but results are inconclusive. Dietary Cr decreased circulating adrenal 
steroids in young stressed calves (Moonsie-Shageer and Mowat, 1993; Mowat et al., 
1993), in epinephrine challenged lambs (Gentry et al., 1999), in stressed dairy cows 
(Pechova et al., 2002), and in postmenopausal women (Roussel et al., 2002). In other 
studies, however, dietary Cr had no effects on adrenal steroids (van Heugten and Spears, 
1997; Baldi et al., 1999; Pollard et al., 2002).  
A human adrenocortical carcinoma cell, NCI-H295, maintains hormonal and 
enzymatic characteristics similar to those of normal human adrenocortical cells (Gazdar 
et al., 1990; Rainey et al., 1993; Staels et al., 1993). The H295R, a cell line used in the 
current study, is a subpopulation of H295 that forms a monolayer in culture (Rainey et al., 
1994), and has been extensively used as a model system in adrenal steroid metabolism 
investigations (Rainey et al., 2004; Vakharia and Hinson, 2005; Oskarsson et al., 2006; 
Mikhaylova et al., 2007).  
The effects of Cr on insulin secretion from islets of Langerhans (Ghafghazi et al., 
1980) and on catecholamine secretion from bovine medullary cells were reported (Liu 
and Lin, 1997). To the best of our knowledge, however, direct effects of Cr on 
adrenocortical steroidogenesis have not been reported. Therefore, our objective was to 
investigate the effect of CrPic on cortisol and dehydroepiandrosterone sulfate (DHEAs) 
secretion from H295R adrenocortical cells. 
     
6.2. Materials and methods 
6.2.1. Materials 
Human NCI-H295R adrenocortical cell line derived from human adrenocortical 
cells was obtained from the American Type Culture Collection (ATCC, Manassas, VA). 
The sources for the other materials are given below. 
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6.2.2. Cell culture 
Cells were cultured in an equal mixture (vol/vol) of Dulbecco’s Modified Eagle’s 
Medium and Ham’s F-12 medium (DMEM/F-12, Invitrogen, Chicago, IL) containing 
HEPES (15 mM), sodium pyruvate (0.5 mM), and sodium bicarbonate (1.2 g/L) 
supplemented with 1% ITS Plus (insulin, 6.25 μg/mL; transferrin, 6.25 μg/mL; selenium, 
6.25 ng/mL; bovine serum albumin, 1.25 mg/mL; linoleic acid, 5.35 μg/mL, BD 
Bioscience, Bedford, MA), and Nu-Serum (2.5%, BD Bioscience). Cells were grown in 
75 cm2 flasks under a humidified atmosphere of 95% air/5% carbon dioxide at 37°C. The 
medium was changed every 3 d and cells were detached weekly using a solution of 
0.25% trypsin-EDTA for subcultures at a ratio of 1:4. For experiments, cells were 
subcultured from 70% confluent cultures into 24 well culture plates (Exp. 1) or 12 well 
culture plates (Exp. 2-4). 
 
6.2.3. Treatment structure 
The treatment structure for each experiment is demonstrated in Table 6.1. In 
experiment 1, treatments included six levels of CrPic (0, 0.1, 1, 10, 100, and 200 μM) 
with or without forskolin (10 μM) in the media for 24 h of incubation. In experiment 2, 
three levels of CrPic (0, 1, and 200 μM) were used for 48 h of incubation with or without 
forskolin in the media for the last 24 h. In experiment 3, treatments included negative 
control (media), and four levels of CrPic (0, 100, 200, and 400 μM) for 48 h of 
incubation with forskolin during the last 24 h. In experiment 4, treatments included 
negative control (media), and 24 h exposure to forskolin followed by 24 h exposure to 
both forskolin and four levels of CrPic (0, 100, 200, and 400 μM). In experiment 2, 3, 
and 4, media samples for steroid assay were collected from the last 24 h of incubation 
and kept frozen at -20°C until steroid analysis.  
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  ├─── Media sampling period1  ───┤ 
 −24 h 0 h +24 h
Exp 1  ├────── Forskolin −/+ ──────┤ 
  ├─ CrPic 0, 0.1, 1, 10, 100, and 200 μM ┤ 
   
Exp 2  ├────── Forskolin −/+ ──────┤ 
 ├────────────── CrPic 0, 1, and 200 μM ──────────────┤ 
   
Exp 3  ├──────   Forskolin −2/+  ─────┤ 
 ├────────────  CrPic 0, 100, 200, and 400 μM  ───────────┤ 
   
Exp 4 ├───────────────── Forskolin −2/+ ────────────────┤ 
  ├─   CrPic 0, 100, 200, and 400 μM  ─┤ 
1 Media samples were collected after the last 24 h in all the experiments. 
2 Forskolin-free medium without CrPic treatment was used as a negative control group. 
In experiment 3 and 4, therefore, five treatment groups included a negative control and 
four CrPic levels with forskolin (10 μM) stimulation. 
 
 
6.2.4. Analysis of cortisol and DHEAs 
The cortisol and DHEAs concentrations in the sample media collected from each 
well were determined using coated tube radioimmunoassays from Diagnostic Products 
Corporation (Los Angeles, CA). Briefly, steroid standard solution was made by 
dissolving cortisol and DHEAs (Steraloids, Newport, RI) to DMEM/F-12. Media samples 
or standards were added to antibody-coated tubes. Radiolabeled cortisol (125I) was added 
to tubes and incubated for 45 (cortisol assay) or 30 (DHEAs assay) minutes at 37°C using 
a waterbath. Then, all moisture in the tube was thoroughly removed and the radioactivity 
was measured using a Packard Cobra Auto-gamma counter (Packard Instrument Co., 
Meriden, CT). Calibrators and samples were analysed in triplicate and duplicate, 
respectively.  
 
Table 6.1. Treatment structure for experiment 1 to 4 
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6.2.5. Protein determination 
After removing media, the cells in each well were solubilized in sodium dodecyl 
sulfate (SDS, 5%) and  protein content was determined using the colorimetric detergent 
compatible (DC) protein assay kit (Bio-Rad, Hercules, CA). The DC protein assay 
technique is similar to Lowry protein analysis. Bovine serum albumin was used as a 
standard.  
 
6.2.6. Calculations and statistical analysis 
The steroid analysis results were standardized to the concentration of steroid per 
mg of protein using the protein concentration of each well. The standardized steroid 
concentration was divided by the result from the CrPic and forskolin-free media (i.e., the 
control treatment). Values were expressed as mean ± SEM. Each well was considered an 
experimental unit. Orthogonal polynomial contrasts were conducted to test linear and 
quadratic effects of CrPic on cortisol secretion using SAS (1988). Appropriate 
coefficients for unequally spaced log concentration of CrPic were obtained using the 
interactive matrix language procedure (Proc IML) of SAS (1988). Because the logarithm 
of zero is undefined, 0.01 μM, one log units lower than the lowest concentration (0.1 μM) 
in experiment 1, was used for zero concentration of CrPic in Proc IML. The unpaired 
Student’s t-test was applied to compare the means of the different CrPic treatments. P-
values less than 0.05 were considered as statistically significant.  
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6.3. Results 
In experiment 1, 24 h of exposure to CrPic (0, 0.1, 1, 10, 100, and 200 μM) 
affected cortisol production in a dose dependent manner (Figure 6.1). In the absence of 
forskolin, a linear increase of cortisol was observed (P < 0.05). When forskolin (10 μM) 
was included in the incubation media, CrPic had both a linear (P < 0.001) and quadratic 
(P < 0.001) effect on cortisol secretion. At 0.1 and 1 μM CrPic potentiated stimulatory 
effects of forskolin on cortisol release (P < 0.05), but at 200 μM CrPic diminished effects 
of forskolin (P < 0.001). 
 
 
Figure 6.1. Effects of CrPic on the cortisol secretion by agonist-stimulated or non-
stimulated H295R cells (n=8). In the absence of forskolin, the exposure to CrPic had a 
linear (P < 0.05) effect on cortisol secretion. When forskolin (10 μM) was included in the 
media, CrPic had both a linear (P < 0.001) and quadratic (P < 0.001) effect on cortisol 
secretion. Differences significant from 0 μM CrPic treatment of same forskolin inclusion 
level are indicated: *, P < 0.05; ***, P < 0.001. 
 
In experiment 2, a 48 h exposure to CrPic (0, 1, and 200 μM) had linear (P < 0.05) 
and quadratic (P < 0.05) effects on cortisol secretion from forskolin-stimulated cells 
during a 24 h collection period (Figure 6.2-a). The lowest cortisol release was at 200 μM 
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of CrPic (P < 0.07). In the absence of forskolin, however, cortisol production was 
unaffected by CrPic. The secretion of DHEAs was quadratically (P < 0.001) affected by 
CrPic in forskolin-stimulated cells with the highest DHEAs release at 1 μM of CrPic (P < 
0.05; Figure 6.2-b). In the forskolin-free media, CrPic affected DHEAs secretion linearly 
(P < 0.05) and quadratically (P < 0.07). The secretion of DHEAs was lowest at 1 μM of 
CrPic (P < 0.05).  
 
 
 
 
Figure 6.2. Effects of CrPic on the cortisol (a) and DHEAs (b) secretion by agonist-
stimulated or non-stimulated H295R cells (24 h pretreatment of CrPic; n=4). The 
exposure to CrPic had linear (P < 0.05) and quadratic (P < 0.05) effects on cortisol 
secretion from forskolin-stimulated cells. The secretion of DHEAs was quadratically (P < 
0.001) affected by CrPic in forskolin-stimulated cells. Differences significant from 0 μM 
CrPic treatment of same forskolin inclusion level are indicated: †, P < 0.07; *, P < 0.05. 
 
In experiment 3, a 48 h exposure to high concentration of CrPic (100, 200, and 
400 μM) decreased cortisol (P < 0.05) secretion from forskolin-stimulated cells during a 
24 h collection period (Figure 6.3-a). The dose-dependent effect of CrPic on cortisol 
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secretion was linear (P < 0.001). In the same experiment, DHEAs secretion in agonist-
stimulated cells was also decreased (P < 0.01) in high concentration of CrPic groups (100, 
200, and 400 μM; Figure 6.3-b). The dose-dependent effect of CrPic on DHEAs secretion 
was linear (P < 0.001) and quadratic (P < 0.01). 
 
 
Figure 6.3. Effects of CrPic on the cortisol (a) and DHEAs (b) secretion by agonist-
stimulated H295R cells (24 h pretreatment of CrPic; n=4). The exposure to CrPic had 
linear (P < 0.001) effects on cortisol secretion. The effects of CrPic on DHEAs secretion 
were linear (P < 0.001) and quadratic (P < 0.01). Differences significant from 0 μM CrPic 
with forskolin are indicated: *, P < 0.05; **, P < 0.01; ***, P < 0.001. 
 
 
(a) (b)
In experiment 4, a 24 h exposure to forskolin followed by a 24 h exposure to both 
forskolin and CrPic (100, and 200 μM) decreased both cortisol (P < 0.001) and DHEAs 
(P < 0.01) secretion (Figure 6.4-a,b). The linear effects of CrPic were observed on 
cortisol (P < 0.001) and DHEAs (P < 0.01) secretion. 
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Figure 6.4. Effects of CrPic on the cortisol (a) and DHEAs (b) secretion by agonist-
stimulated H295R cells (24 h pretreatment of forskolin; n=4). The exposure to CrPic had 
linear effects on cortisol (P < 0.001) and DHEAs (P < 0.01). Differences significant from 
0 μM CrPic with forskolin are indicated: *, P < 0.05; **, P < 0.01; ***, P < 0.001. 
 
6.4. Discussion 
In the present study, we used H295R cells as a model system and forskolin as an 
agonist (stressor) for adrenocortical steroid secretion. In stress situations, the 
hypothalamic-pituitary-adrenal axis is known to be activated. The pituitary 
adrenocorticotropic hormone (ACTH) released from the pituitary regulates glucocorticoid 
synthesis in the adrenal cortex. In the human adrenocortical cell line, H295R, however, 
ACTH effects on steroidogenesis are relatively insignificant perhaps due to the lack of 
ACTH receptors (Rainey et al., 1993; Penhoat et al., 2000) whereas forskolin bypasses 
ACTH receptors and triggers steroid synthesis (Rainey et al., 1993). Thus, forskolin was 
employed as an agonist in our study, and this agonist (10 μM) dramatically increased 
cortisol and DHEAs secretion from H295R cells (Figures 6.1 to 6.4) in agreement with 
(a) (b)
0
50
100
150
200
250
300
350
0 0 100 200 400
CrPic (μM)
D
H
EA
s 
(%
 o
f u
nt
re
at
ed
)
0
200
400
600
800
1000
1200
0 0 100 200 400
CrPic (μM)
C
or
tis
ol
 (%
 o
f u
nt
re
at
ed
)
***
*
*** 
** 
***
 151
other studies (Rainey et al., 1993; Gell et al., 1998; Ehrhart-Bornstein et al., 2003) and 
our pilot study (data not shown). Forskolin is known to activate adenylate cyclase 
(Seamon et al., 1981), followed by increased cyclic adenosine monophosphate (cAMP) in 
the cell and the activation of the protein kinase A (PKA) signal transduction pathway 
(Litvin et al., 1984; Rainey et al., 1993). The effect of forskolin is also induced through 
the PKA-independent pathway (Ding and Staudinger, 2005).  
The results of experiment 1 indicate that the low concentration of CrPic (0.1 and 1 
μM) increases the secretion of cortisol, but high concentration of CrPic (200 μM) 
dramatically inhibits the secretion of cortisol from agonist-stimulated adrenocortical cells. 
In contrast, adrenocortical cells cultured in forskolin-free media, CrPic (10 and 100 μM) 
slightly increased the cortisol secretion (Figure 6.1). Similar dual effects of Cr were 
observed in catecholamine secretion from bovine adrenal medullary cells (Liu and Lin, 
1997). High concentrations of CrCl3 (500 to 1,000 μM) significantly inhibited 
catecholamine release stimulated by 56 mM of K+ from adrenal medullary cells. 
Similarly, when 10 μM of 1,1-dimethyl-4-phenylpiperazinium (DMPP) was used as an 
agonist, CrCl3 (5 to 1,000 μM) significantly inhibited catecholamine release. In the 
adrenal medullay cells cultured without agonist, a slight increase of catecholamine 
secretion by CrCl3 was reported. Insulin release from isolated rat islet of Langerhans was 
also inhibited by high concentration of CrCl3 (250 to 1,500 μM) in a dose dependent 
manner (Ghafghzi et al., 1980).  
The decreased cortisol release from agonist-stimulated adrenocortical cells by 
high concentration of CrPic was confirmed in the following experiments (Figure 6.2 to 
6.4). In experiment 2, 3, and 4, cells were pretreated with CrPic or forskolin to mimic 
either a situation of CrPic administration followed by stress or a situation of stress 
occurrence followed by CrPic administration, respectively. In experiment 2, cells were 
pretreated with CrPic for 24 h, and the CrPic treatment concentrations continued during 
the following sampling period. The doses of CrPic (0, 1, 200 μM) were based on the 
results in experiment 1. As anticipated, CrPic affected cortisol release from agonist-
stimulated cells in a linear and quadratic manner consistent with experiment 1. However, 
further enhancement of CrPic effects by pretreatment relative to cotreatment was not 
observed. In experiment 3, a 48 h treatment of CrPic at 100, 200, or 400 μM inhibited 
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cortisol secretion from forskolin-stimulated cells. In contrast, in experiment 1, a 24 h 
treatment of CrPic at 100 μM had no effects on cortisol release from agonist-stimulated 
cells. These observations are consistent with the concept of an effect being related to both 
dose and time. Although periods longer than 48 h of CrPic treatments were not tested in 
the present study, the current results suggest that longer treatment of CrPic may be more 
effective in regulating forskolin effects. 
The inhibitory effect of CrPic on cortisol secretion observed in the current study 
may partially explain decreased blood cortisol concentration in stressed calves (Chang 
and Mowat, 1992; Moonsie-Shageer and Mowat, 1993; Mowat et al., 1993) and dairy 
cows (Pechova et al., 2002) by dietary supplementation of Cr-yeast or chelated Cr. In 
other studies, however, supplemental dietary Cr had no effect on circulating cortisol 
concentration in immune stressed pigs (van Heugten and Spears, 1997) fed 0.2 mg/kg Cr 
from CrCl3, CrPic or Cr-nicotinate, weaning stressed piglets (Baldi et al., 1999) fed 0.3 
mg/kg Cr from Cr yeast, and steers (Pollard et al., 2002) fed 0.2 or 0.4 mg/kg Cr from Cr 
yeast. The discrepancy of cortisol responses by dietary Cr in animal studies may be 
attributed to the dosage and source of Cr, duration of dietary Cr treatment, source and 
intensity of stress, animal species, and environmental variation. It may be that the most 
important factors on the effects of dietary Cr are the animal species and the dosage of Cr 
as most of stressed ruminants had lower circulating cortisol concentration with high dose 
(> 0.4 mg/kg) supplementation of dietary Cr.  
The increase of cortisol secretion from the cells pretreated with forskolin is 
notable (Figure 6.4-a). Forskolin stimulation during the 24 h of media collection period 
increased cortisol secretion by three to five-fold (Figure 6.1, 6.2-a, and 6.3-a). 
Pretreatment of forskolin for 24 h before the media collection period induced ten-fold 
increase in cortisol secretion (Figure 6.4-a). The higher fold change of cortisol secretion 
by pretreatment of forskolin implies that the second 24 h of cortisol secretion is higher 
than the first 24 h of that in the cortical cells cultured for 48 h with forskolin. In 
agreement, compared with 24 h of incubation with 10 μM forskolin, approximately three 
times higher cortisol concentration was reported in 48 h incubation with forskolin 
(Rainey et al., 1993; Asif, 2004). This result may be attributed to intracellular cAMP 
accumulated during the pretreatment period. 
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The release of DHEAs was also inhibited by high concentration of cortisol in 
agonist-stimulated adrenocortical cells (Figure 6.3-b and 6.4-b). In postmenopausal 
women, dietary Cr tended to decrease serum DHEAs and cortisol (Roussel et al., 2002).  
 The present study indicates that CrPic can appreciably regulate steroid secretion 
from agonist-stimulated cells, but minimally from non-stimulated cell. Thus the action 
sites of CrPic may be closely related to the sites affected by forskolin. H295R cells 
stimulated with forskolin have been reported to induce increases in cAMP, steroidogenic 
acute regulatory protein (StAR), several enzymes involved in the adrenal steroidogenic 
pathway, and organic anion transporter 3 (OAT3) (Rainey et al., 1993; Bird et al.. 1998; 
Zenkert et al., 2000; Asif et al., 2006; Oskarsson et al., 2006). Because high 
concentration CrPic inhibited the secretion of both cortisol and DHEAs from agonist-
stimulated cell in our study, we postulate that CrPic affects the factors related to cortisol 
and DHEAs synthesis in common. These factors include cAMP, StAR, cytochrome P450 
enzyme (CYP)11A1, and CYP17A1. Cholesterol transport is triggered by StAR, which is 
the rate limiting step in the steroid synthesis. Desmolase, also called CYP11A1, converts 
cholesterol to pregnenolone, a common precursor of adrenal steroidogenic pathway. This 
precursor can be converted to 17α-hydroxy pregnenolone by CYP17A1, which can be 
transformed to either cortisol or DHEAs by further steps. Oskarsson et al. (2006) reported 
that the mRNA of CYP17A1 was increased 5-fold by 24 h of forskolin exposure to 
H295R cells, and CYP17A1 expression was the highest compared to the other enzymes. 
These steroidogenesis regulating factors are affected by cAMP through PKA pathway. 
Asif et al. (2006) observed that OAT3 expression, involved in cortisol and DHEAs 
transport, was markedly potentiated by forskolin exposure but the enzymes of 
steroidogeneis were increased to a lesser extend. Further studies to elucidate detailed 
mechanism of CrPic on steroidogenesis in the adrenal cortex seem warranted. 
This study suggests that at high concentrations, CrPic inhibits aspects of 
steroidogenesis in agonist-stimulated adrenocortical cells.  
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CHAPTER 7. General Discussion 
 
Trivalent chromium has been shown to potentiate the action of insulin (Mertz et 
al., 1974; Vincent, 2000) and accordingly to modulate carbohydrate, protein, and lipid 
metabolism (Davis and Vincent, 1997; Cefalu et al., 2002; Bernao et al., 2004). In 
addition, Cr has been suggested to alleviate stress associated effects in animals and 
humans (Chang and Mowat, 1992; Anderson, 1994; NRC, 1997). The objective of the 
present research was to study the effects of dietary Cr on pigs exposed to a variety of 
stressors. These stressors included heat or cold stress, immune stress, and stress of high-
fat feed. The doses of supplemental Cr in the present animal studies were 0, 1,000, and 
2,000 ppb while the Food and Drug Administration (FDA) in the United States allows 
200 ppb Cr in the swine diet when it is supplemented as Cr picolinate (CrPic). The high 
concentration of supplemental Cr in this research was based on poultry studies that 
showed linear effects of supplemental Cr of 200 to 1,200 ppb in thermal stress situations 
(Sahin et al., 2001; Onderci et al., 2003). The cell culture study (Chapter 6) preceding the 
animal studies also suggests that at high concentration, CrPic inhibits cortisol secretion 
from agonist-stimulated adrenocortical cells.  As a source of supplemental Cr, the organic 
form of trivalent Cr, CrPic, was used based on previous reports suggesting that Cr is 
more available as an organic chelate (Page et al., 1993). 
In a number of animal and human studies, the effects of dietary Cr on adrenal 
steroid hormones have been assessed, but the results are inconsistent (Moonsie-Shageer 
and Mowat, 1993; Gentry et al., 1999; Roussel et al., 2002; Baldi et al., 1999; Pollard et 
al., 2002). Thus, in addition to the animal studies effects of Cr on adrenocortical steroid 
secretion from adrenocortical cells were studied employing a human adrenocortical cell 
line, NCI-H295R. 
In the thermal stress study (Chapter 3), heat stress clearly caused feed intake 
reduction and weight gain retardation as anticipated. Similar responses by high ambient 
temperature have been reported in a number of studies (Stahly and Cromwell, 1979; 
Stahly et al., 1979; Schenck et al., 1992ab; Kerr et al., 2003). However, dietary Cr 
supplementation did not affect the growth performance of pigs either in high ambient 
temperature or in thermoneutral environment. In many poultry trials, dietary 
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supplementation of Cr ameliorated the negative effects of heat stress on growth and egg 
production performance (Sahin et al., 2002ab; Onderci et al., 2005; Sahin et al., 2005).  
In the present study, cold stress resulted in increased feed intake and feed:gain in 
agreement with previous reports (Stahly and Cromwell, 1979; Stahly et al., 1979; Frank 
et al., 2003). However, dietary Cr supplementation had no beneficial effects on 
performance of pigs in a low ambient temperature. In poultry studies, dietary 
supplementation of Cr increased weight gain, egg production, and feed efficiency of birds 
in a cold stress (Sahin et al., 2001; Sahin et al., 2002c). 
The discrepancy between the present studies and poultry studies may be attributed 
to the physiological differences between these species and/or the degree of thermal stress. 
Although the ambient temperatures of thermal stress treatments were over or below the 
thermoneutral zone, and the feed intake was affected by the thermal stress, it may be that 
the degree of thermal stress was not unduly stressful to the pigs and which they were able 
to manage by altering feed intake.  
In the immune stress study (Chapter 4), the endotoxin challenge acutely resulted 
in growth retardation, feed intake reduction, body temperature elevation, hyperpnea, 
plasma cortisol elevation, and plasma glucose reduction, which are consistent with 
literature. However, supplemental Cr failed to alleviate the effects of this type of immune 
stress in pigs. 
The acute weight loss by LPS challenge may be attributed to increased defecation, 
increased urination, and reduced feed intake (Johnson and von Borell, 1994; Warren et al., 
1997; Sakumoto et al., 2003). Supplemental Cr of 0, 1,000 or 2,000 ppb had no effects on 
weight gain or feed intake of pigs challenged with immune stress in agreement with other 
reports with lower doses of Cr (van Heugten and Spears, 1997; Lee et al., 2000). 
In the present study, the endotoxin-induced elevation of body temperature and 
plasma cortisol concentration was observed as shown in other studies (Warren et al., 
1997; Sakumoto et al., 2003). However, supplemental Cr did not affect body temperature 
or circulating cortisol concentration of pigs under immune stress. Similarly, Lee et al. 
(2000) reported that rectal temperature was elevated by LPS but dietary Cr had no effects 
on rectal temperature in pigs under immune stress. While van Heugten and Spears (1997) 
also failed to detect effects of Cr on serum cortisol concentrations in pigs injected with 
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ACTH, Lee et al. (2000) did report that dietary Cr decreased plasma cortisol 
concentration at 2 h post secondary LPS challenge. Multiple injections of endotoxin may 
result in high glucose concentration for an extended period and potentially cause glucose 
intolerance. In addition, extended immune stress may lead to urinary excretion of Cr and 
thus Cr deficiency. Therfore, the possibility that supplemental Cr alleviates longer term 
immune stress cannot be ruled out. 
In the dietary stress study (Chapter 5), the high inclusion level (30% crude fat in 
calculated composition) of dietary fat caused 10% faster weight gain, and 19% reduced 
feed intake and 27% lower feed:gain compared to the control (3% crude fat). The HFD 
treatment resulted in clear hyperpnea and an increase of plasma cortisol concentration in 
the pigs. As expected, the consumption of HFD resulted in marked increases of carcass 
weights, perirenal fat weight, and back fat depths compared with the LFD group. 
Supplemental Cr increased feed:gain in pigs fed HFD. The increased feed:gain 
due to supplemental Cr was associated with the numerical decrease in weight gain, and it 
may be attributed to the decreased fat deposition in the pigs fed supplemental Cr. 
Circulating cortisol concentration was elevated in the pigs fed HFD compared with the 
pigs fed LFD on d 42. The increased cortisol concentration due to the dietary fat was 
reversed only numerically by supplemental Cr. In the present study, plasma insulin 
concentration of pigs fed HFD tended to decrease by Cr supplementation on d 14. In 
other studies, supplemental Cr lowered circulating insulin concentration in rats fed HFD 
(Striffer et al., 1998) and in swine (Lien et al., 2001).  
The supplemental Cr as the CrPic form moderated the increased carcass fat 
measures including visceral fat and backfat thickness due to the HFD in the present study. 
Although the effects of Cr on body composition of the animals fed HFD have been 
scarcely studied, our findings are strongly supported by a study employing obese mice 
induced by HFD (Bhattacharya et al., 2006). They observed reductions of body weight 
gain, body fat mass gain, and visceral fat mass gain by dietary Cr from Cr carnosinate 
(Carnochrome) in mice fed experimental diets for 14 weeks. In a recent study of patients 
with non-insulin-dependent (Type 2) diabetes mellitus taking an antidiabetic drug (Martin 
et al., 2006), dietary CrPic intake for 24 weeks decreased BW gain, the changes of body 
fat percentage, subcutaneous fat, visceral fat, and total abdominal fat compared with the 
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placebo group. Our findings agree with these data in that CrPic moderated increased body 
weight gain and body fat percentage.  
In the adrenocortical cell study (Chapter 6), the low concentration of CrPic (0.1 
and 1 μM) increased the secretion of cortisol, but high concentration of CrPic (200 μM) 
dramatically inhibited the secretion of cortisol from forskolin-stimulated adrenocortical 
cells (experiment 1). Further experiments confirmed the inhibitory effect of high 
concentration CrPic (100 to 400 μM) on cortisol release from agonist-stimulated 
adrenocortical cells. Similarly, Liu and Lin (1997) reported that high concentrations of 
CrCl3 (500 to 1,000 μM) significantly inhibited catecholamine release from adrenal 
medullary cells stimulated by K+ or 1,1-dimethyl-4-phenylpiperazinium. Insulin release 
from isolated rat islet of Langerhans was also inhibited by high concentration of CrCl3 
(250 to 1,500 μM) dose-dependently (Ghafghzi et al., 1980).  
In experiment 2, 3, and 4, cells were pretreated with CrPic or forskolin to mimic 
either a situation of CrPic administration followed by stress or a situation of stress 
occurrence followed by CrPic administration, respectively. In experiment 2, cells were 
pretreated with CrPic for 24 h, and the CrPic treatment concentrations (0, 1, 200 μM) 
continued during the following sampling period. As anticipated, CrPic affected cortisol 
release from agonist-stimulated cells linearly and quadratically in agreement with 
experiment 1. However, further enhancement of CrPic effects by pretreatment relative to 
cotreatment (experiment 1) was not observed. In experiment 3, a 48 h treatment of CrPic 
(100, 200, or 400 μM) inhibited cortisol release from agonist-stimulated cells. 
Interestingly, in experiment 1, a 24 h treatment of CrPic at 100 μM had no effects on 
cortisol release from agonist-stimulated cells. These observations are consistent with the 
concept of an effect being related to both dose and time. Although periods longer than 48 
h of CrPic treatments were not tested in the present study, the current results suggest that 
longer treatment of CrPic may be more effective in regulating forskolin effects in 
adrenocortical cells. 
The inhibitory effect of CrPic on cortisol secretion observed in the current study 
may partially explain decreased blood cortisol concentration in stressed calves (Chang 
and Mowat, 1992; Moonsie-Shageer and Mowat, 1993; Mowat et al., 1993) and dairy 
cows (Pechova et al., 2002) by dietary supplementation of Cr-yeast or chelated Cr.  
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The present study indicates that CrPic can appreciably regulate steroid secretion 
from agonist-stimulated cells, but minimally from non-stimulated cell. Thus the action 
sites of CrPic may be closely related to the sites affected by forskolin. H295R cells 
stimulated with forskolin have been reported to induce increases in cAMP, steroidogenic 
acute regulatory protein (StAR), several enzymes involved in the adrenal steroidogenic 
pathway, and organic anion transporter 3 (OAT3) (Rainey et al., 1993; Bird et al.. 1998; 
Zenkert et al., 2000; Asif et al., 2006; Oskarsson et al., 2006). Because high 
concentrations of CrPic inhibited the secretion of both cortisol and DHEAs from agonist-
stimulated cell in the present study, it may be that CrPic affects the factors related to 
cortisol and DHEAs synthesis in common. These factors include cAMP, StAR, 
cytochrome P450 enzyme (CYP)11A1, and CYP17A1.  
Taken together, thermal stress, immune stress, and dietary stress induced clear 
changes in growth performance and some physiological parameters consistent with 
previous studies. Thus the stress models employed in the present study were valid for 
testing stress alleviating effects of dietary Cr. Stress moderating effects of dietary Cr 
supplementation were not observed in thermal or immune stressed animals, although we 
are unable to rule out the possibility of dietary Cr effects in more severely stressed 
animals. However, the increased body weight and fat retention by high-fat diet 
consumption were moderated by supplemental Cr indicating potential values of dietary 
Cr in obese human.  
In agonist-stimulated adrenocortical cells, high concentrations of CrPic inhibited 
aspects of steroidogenesis. Although Cr concentration in the mammalian blood even with 
supplemental Cr of 2,000 ppb would be much lower than the 200 μM concentration that 
dramatically inhibited cortisol secretion in vitro, long term treatment with lower 
concentration potentially have similar effects to short term treatment with high 
concentration as  shown in our in vitro study. In addition, dietary Cr is accumulated in the 
adrenal gland of pigs in a linear manner with supplemtal Cr concentration (Lindemann et 
al., 2004). Therefore, the inhibitory effects of high concentration Cr on cortisol secretion 
in vitro at least partially explain decreased circulating cortisol concentration by dietary Cr 
in stressed animals. In the present animal studies, however, plasma cortisol 
concentrations were largely unaffected by supplemental Cr. 
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Further studies to assess the effects of Cr on pigs in severely hot or cold 
environment or under chronic immune stress and to elucidate the mechanism of Cr 
effects on the pigs fed the high-fat diet seem warranted. Further research to elucidate 
detailed mechanism of CrPic on steroidogenesis in the adrenal cortex in vitro and in vivo 
may also be needed. 
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APPENDICES 
 
Appendix 1. Cold stress study (Exp. 2 and 3) in Chapter 3 
In Exp. 2, the cold stress affected growth performance, but dietary Cr treatment 
had no effect on the growth of pigs (Table A.1). Pigs in low ambient temperature (LT) 
had higher feed:gain (1.59 vs. 1.45; P < 0.001) than pigs in NT during d 14 to 21. Pigs in 
LT had higher ADG (712 vs. 542 g/d; P < 0.001) and ADFI (1,064 vs. 842 g/d; P = 
0.002) than pigs in NT during d 21 to 26. During d 14 to 26, pigs in LT tended to have 
higher ADFI (975 vs. 885 g/d; P = 0.079) and feed:gain (1.54 vs. 1.49; P = 0.070) than 
pigs in NT. However, dietary treatments of Cr had no effects on ADG, ADFI, or 
feed:gain. 
There was an interaction tendency between ambient temperature and 
supplemental Cr for plasma cortisol on d 18 (P = 0.074; Table A.2). Plasma glucose 
concentration tended to be lower in the pigs in LT (6.84 vs. 7.20 mmol/L; P = 0.059) than 
the pigs in NT on d 15. But other blood measure measurements were unaffected by the 
neither ambient temperature nor dietary Cr treatments.  
In Exp. 3, similar effects of thermal treatments were observed as in Exp. 2 (Table 
A.3). During D 14 to 28, LT resulted in increased ADFI (1,077 vs. 1,000 g/d; P = 0.044) 
with increased feed:gain (1.61 vs. 1.53; P = 0.011) compared with NT. Supplemental Cr 
had no effects on the growth performance. Ambient temperature × supplemental Cr 
interaction was significant for ADFI (P = 0.044). 
 Plasma cortisol and glucose were unaffected by the temperature or dietary Cr 
treatments (Table A.4).  
 161
 
Temp2: Neutral (26.5°C) Cold (16.0°C) Temp effect CrPic effect  Interaction 
Cr, ppb: 0 1,000 2,000 0 1,000 2,000 Pr SEM Pr SEM  Pr SEM 
Body weight, kg      
Table A.1. Effects of low ambient temperature (Temp) and dietary chromium (III)
picolinate (CrPic) supplementation on body weight, feed intake and feed:gain of pigs
(Exp. 2)1 
                
D 0 5.97 5.97 5.98 5.98 5.98 5.96 0.939 0.02 0.959 0.02  0.844 0.03 
D 7 7.09 7.12 6.98 7.32 7.07 7.36 0.073 0.07 0.638 0.08  0.202 0.11 
D 14 10.13 10.46 10.03 10.27 10.13 11.02 0.248 0.15 0.470 0.19  0.081 0.26 
D 21 14.49 15.15 14.27 14.26 13.84 15.35 0.712 0.29 0.683 0.35  0.106 0.50 
D 26 17.13 18.03 16.88 17.80 17.51 18.83 0.216 0.37 0.821 0.46  0.209 0.65 
D 0 to 7              
ADG, g 161 165 144 190 156 201 0.085 9.6 0.669 11.7  0.187 16.6 
ADFI, g 196 188 184 211 192 203 0.281 7.7 0.597 9.5  0.850 13.4 
Feed:gain 1.22 1.17 1.29 1.12 1.22 1.04 0.167 0.05 0.931 0.06  0.214 0.08 
D 7 to 14              
ADG, g 434 477 435 421 437 523 0.621 15.6 0.216 19.2  0.091 27.1 
ADFI, g 506 523 510 483 480 560 0.861 20.4 0.488 25.0  0.414 35.3 
Feed:gain 1.16 1.09 1.18 1.14 1.10 1.07 0.140 0.02 0.258 0.02  0.221 0.03 
D 14 to 21              
ADG, g 623 670 606 570 531 618 0.122 25.0 0.934 30.6  0.262 43.3 
ADFI, g 903 992 852 922 845 966 0.917 32.1 0.986 39.3  0.107 55.6 
Feed:gain 1.45 1.48 1.41 1.62 1.59 1.56 <0.001 0.02 0.206 0.02  0.563 0.03 
D 21 to 26              
ADG, g 527 577 522 708 732 696 <0.001 23.6 0.517 28.9  0.949 40.9 
ADFI, g 825 882 818 1076 1060 1056 0.002 36.1 0.865 44.2  0.827 62.6 
Feed:gain 1.57 1.54 1.58 1.51 1.45 1.51 0.123 0.03 0.528 0.04  0.935 0.05 
D 0 to 14              
ADG, g 297 321 290 306 296 362 0.239 10.5 0.431 12.8  0.064 18.2 
ADFI, g 351 356 347 347 336 382 0.847 13.0 0.686 15.9  0.490 22.5 
Feed:gain 1.18 1.11 1.20 1.14 1.13 1.06 0.034 0.16 0.398 0.02  0.032 0.03 
D 14 to 26              
ADG, g 583 631 571 628 615 651 0.292 23.0 0.905 28.1  0.499 39.8 
ADFI, g 870 946 838 986 934 1003 0.079 32.4 0.942 39.7  0.309 56.2 
Feed:gain 1.49 1.50 1.47 1.57 1.52 1.54 0.070 0.02 0.690 0.02  0.590 0.03 
1 Each mean represents three pens of three pigs/pen. 
2 Ambient temperature during d 14 to 26. The ambient temperature before d 14 was maintained in
the thermoneutral zone. On d 14 the ambient temperature was changed to induce thermal
stress, and the low temperature was maintained until the end of the experiment. 
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Temp2: Neutral (26.5°C) Cold (16.0°C) Temp effect CrPic effect  Interaction
Cr, ppb: 0 1,000 2,000 0 1,000 2,000 Pr SEM Pr SEM  Pr SEM
Cortisol, ng/mL             
D 15 (1)3 68.6 76.9 62.9 50.0 46.8 64.4 0.122 7.0 0.937 8.6  0.430 12.1
D 18 (4) 46.8 67.4 38.6 67.8 52.2 78.7 0.123 6.8 0.978 8.3  0.074 11.8
D 25 (11) 54.3 69.9 80.9 75.1 44.0 63.2 0.462 7.2 0.489 8.8  0.154 12.5
Glucose, mmol/L            
D 15 (1) 7.20 7.49 6.90 6.69 6.83 6.99 0.059 0.13 0.541 0.16  0.216 0.22
D 18 (4) 6.87 6.74 6.73 6.85 6.47 7.78 0.417 0.22 0.240 0.27  0.190 0.38
D 25 (11) 6.62 7.00 6.81 7.31 6.85 6.86 0.522 0.22 0.940 0.26  0.506 0.37
1 Each mean represents six pigs. 
2 Ambient temperature during d 14 to 26. The ambient temperature before d 14 was maintained in 
the thermoneutral zone. On d 14 the ambient temperature was changed to induce thermal
stress, and the low temperature was maintained until the end of the experiment. 
3 The numbers in the parenthesis represent the days after the thermal stress. 
 
 
 
 
 
 
 
 
Table A.2. Effects of low ambient temperature (Temp) and dietary chromium (III)
picolinate (CrPic) supplementation on plasma cortisol and glucose concentration of pigs
(Exp. 2)1 
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Temp2: Neutral (25.9°C) Cold (13.8°C) Temp effect CrPic effect  Interaction 
Cr, ppb: 0 1,000 2,000 0 1,000 2,000 Pr SEM Pr SEM  Pr SEM 
Body weight, kg      
Table A.3. Effects of low ambient temperature (Temp) and dietary chromium (III)
picolinate (CrPic) supplementation on body weight, feed intake and feed:gain of pigs
(Exp. 3)1 
                   
D 0 6.40 6.42 6.40 6.38 6.39 6.40 0.786 0.04 0.982 0.04  0.951 0.06 
D 7 8.08 8.05 8.12 7.87 8.10 8.04 0.351 0.06 0.489 0.07  0.458 0.10 
D 14 11.29 10.80 11.12 10.28 10.97 10.76 0.212 0.21 0.915 0.26  0.322 0.37 
D 21 16.09 14.44 15.28 14.37 15.59 15.25 0.659 0.31 0.885 0.38  0.064 0.53 
D 28 21.08 19.33 20.25 19.25 20.53 20.35 0.752 0.38 0.856 0.47  0.117 0.66 
D 0 to 7              
ADG, g 240 233 246 212 245 234 0.368 7.0 0.446 8.6  0.304 12.2 
ADFI, g 272 268 318 251 343 301 0.534 13.7 0.130 16.7  0.120 23.7 
Feed:gain 1.15 1.15 1.29 1.19 1.43 1.29 0.230 0.06 0.452 0.07  0.398 0.10 
D 7 to 14              
ADG, g 459 393 428 345 409 389 0.279 28.3 0.987 34.7  0.440 49.0 
ADFI, g 629 515 608 483 575 518 0.177 28.6 0.938 35.0  0.151 49.5 
Feed:gain 1.38 1.32 1.42 1.40 1.43 1.36 0.740 0.05 0.962 0.06  0.640 0.09 
D 14 to 21              
ADG, g 685 520 594 584 661 642 0.369 21.8 0.523 26.8  0.028 37.8 
ADFI, g 970 752 855 870 955 968 0.127 30.7 0.430 37.6  0.045 53.2 
Feed:gain 1.42 1.45 1.45 1.49 1.44 1.51 0.224 0.02 0.724 0.03  0.511 0.04 
D 21 to 28              
ADG, g 713 699 710 697 706 729 0.946 32.5 0.947 39.8  0.954 56.2 
ADFI, g 1175 1067 1179 1171 1238 1258 0.095 31.5 0.493 38.6  0.320 54.6 
Feed:gain 1.69 1.53 1.66 1.68 1.76 1.73 0.159 0.04 0.792 0.05  0.325 0.08 
D 0 to 14              
ADG, g 349 313 337 278 327 311 0.230 15.3 0.926 18.7  0.317 26.5 
ADFI, g 450 392 463 367 459 410 0.392 18.3 0.693 22.4  0.085 31.7 
Feed:gain 1.30 1.25 1.37 1.32 1.40 1.33 0.297 0.03 0.698 0.03  0.185 0.05 
D 14 to 28              
ADG, g 699 609 652 640 683 685 0.566 19.2 0.734 23.5  0.175 33.2 
ADFI, g 1072 910 1017 1021 1097 1113 0.044 23.7 0.343 29.0  0.044 41.0 
Feed:gain 1.54 1.50 1.56 1.59 1.61 1.62 0.011 0.02 0.452 0.02  0.628 0.03 
1 Each mean represents three pens of two pigs/pen. 
2 Ambient temperature during d 14 to 28. The ambient temperature before d 14 was maintained in
the thermoneutral zone. On d 14 the ambient temperature was changed to induce thermal
stress, and the low temperature was maintained until the end of the experiment. 
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Temp2: Neutral (25.9°C) Cold (13.8°C) Temp effect CrPic effect  Interaction
Cr, ppb:
Table A.4. Effects of low ambient temperature (Temp) and dietary chromium (III)
picolinate (CrPic) supplementation on plasma cortisol and glucose concentration of pigs
(Exp. 3)1 
0 1,000 2,000 0 1,000 2,000 Pr SEM Pr SEM  Pr SEM
Cortisol, ng/mL              
D 15 (1)3 57.9 72.1 56.6 51.5 61.9 50.8 0.424 6.5 0.435 8.0  0.978 11.3
D 18 (4) 57.3 57.6 54.1 66.5 68.6 51.9 0.432 5.3 0.496 6.5  0.740 9.2 
D 27 (13) 67.9 53.6 79.3 80.1 85.2 64.9 0.236 5.7 0.897 7.0  0.082 9.9 
Glucose, mmol/L            
D 15 (1) 6.95 7.13 6.75 7.22 6.59 6.92 0.842 0.13 0.474 0.16  0.163 0.22
D 18 (4) 7.47 6.67 6.56 7.04 7.12 7.17 0.287 0.14 0.212 0.17  0.078 0.24
D 27 (13) 7.35 6.83 6.74 6.79 7.13 7.08 0.918 0.17 0.863 0.21  0.248 0.30
1 Each mean represents six pigs. 
2 Ambient temperature during d 14 to 28. The ambient temperature before d 14 was maintained in
the thermoneutral zone. On d 14 the ambient temperature was changed to induce thermal 
stress, and the low temperature was maintained until the end of the experiment. 
3 The numbers in the parenthesis represent the days after the thermal stress. 
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Appendix 2. Body weight and weight gain of pigs during d 0 to 35 in the experiment 
in Chapter 4 
 
Table A.5. Body weight gain of the animals before phosphate buffered saline (PBS) or
lipopolysaccharide (LPS) challenge1 
Injection2: P-values3 PBS  LPS 
SEM 
Cr, ppb: 0  0 1,000 2,000 PBS vs. LPS LPS Linear Quadratic
BW, kg          
D 0 6.03  5.96 5.90 5.90 0.09 0.300 0.572 0.688 0.783 
D 7 8.49  8.20 8.26 8.36 0.19 0.344 0.304 0.622 0.938 
D 14 12.00  12.00 12.34 12.31 0.31 0.553 0.993 0.537 0.682 
D 21 15.81  16.67 17.02 17.05 0.48 0.061 0.219 0.634 0.821 
D 28 19.97  21.48 21.58 21.94 0.64 0.035 0.114 0.676 0.888 
D 35 23.97  26.45 26.22 27.28 0.76 0.007 0.033 0.510 0.555 
ADG, g/d           
D 0 to 14 426  431 460 458 19 0.307 0.853 0.398 0.571 
D 14 to 28 569  677 660 687 28 0.004 0.014 0.832 0.580 
D 28 to 35 572  709 663 763 33 0.002 0.008 0.188 0.048 
Overall 513  585 581 611 21 0.004 0.024 0.459 0.554 
1 Each least squares mean represents six pigs. 
2 At 0 h, phosphate buffered saline (PBS) or lipopolysaccharide (LPS) was intraperitoneally
injected. The volume of LPS solution was determined to deliver 50 μg/kg BW, and PBS was 
filled to make 5 ml. 
3 P-values are from single degree of freedom contrast. PBS vs. LPS represents the contrast 
between pigs injected with PBS and pigs injected with LPS and fed 0, 1,000, or 2,000 ppb of
supplemental Cr; LPS represents the contrast between pigs injected with PBS and pigs injected
with LPS and fed 0 ppb of supplemental Cr. Linear and quadratic effects of dietary CrPic were 
tested within the LPS challenged groups. 
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Appendix 3. Photo-micrograph of adrenocortical carcinoma cells in Chapter 6 
 
 
Figure A.1. Photo-micrograph of H295R cells at 48 h (a), 72 h (b), and 96 h (c) of 
incubation 
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Appendix 4. H295R adrenocortical cell culture procedure 
 
A.4.1. Formulus for culture medium and cryoprotectant medium 
Complete culture medium 
For 50 mL total add: 
1.25 mL (2.5%) Nu-Serum (BD Biosciences: Discovery Lab #355100) 
0.50 mL  ITS+ Premix (BD Biosciences: Discovery Lab #354352) 
0.05 mL (0.1%) Antibiotics (Sigma #A5955) 
to 
48.2 mL  DMEM/Ham’s F12 (Invitrogen #11330032) 
 
Cryoprotectant medium 
For 5 mL total add: 
4.50 mL (90.0%) Nu-Serum 
0.05 mL  ITS+ Premix 
0.25 mL (5.0%) DMSO (ATCC #4-X) 
0.20 mL  DMEM/Ham’s F12 
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A.4.2. H295R adrenocortical cell culture procedure 
Split/Subculture 
1. Warm 0.25% Trypsin-0.53 mM EDTA (ATCC 30-2101) to 37°C. 
2. Make up 100 mL complete media for H295R cells (ATCC 30-2101) to 37°C. 
3. Remove all culture medium from 75 cm2 flask. 
4. Rinse with 1.5 mL warm Trypsin-EDTA and remove it. 
5. Add 5 mL warm Trypsin-EDTA and let sit 5 to 15 minutes at 37°C (observe when they 
start lifting from bottom; do not knock flask or cells will clump). 
6. Add 8 mL warm complete culture media. 
7. Put cells in 15 mL conical tube, spin 125 × g for 10 minutes. 
8. Pour off media and resuspend in 1 mL warm complete culture media. 
9. Split cells 1:4 into 75 cm2 flasks containing 15 mL complete culture media. 
10. Incubate at 37°C with 5% CO2 and ambient air. 
11. Change media every other day. 
12. Cells split every week or so. 
 
Freeze cells in liquid nitrogen 
1. Make 10 mL of cryoprotentant medium and warm it to 37°C. 
2. Follow Split/Subculture protocol through #7 and freeze approximately 5 millon cells 
per vial. 
3. Pour off media and resuspend in 2 mL warm cryoprotectant media. 
4. Split cells 1:2 into cryoprotectant vials marked with name, date, and passage number 
(this way, when you bring them up from frozen you add one passage). 
5. Put in Styrofoam container with lid (tight fit) and place in -80°C overnight. 
6. Add to Jackson’s holders and submerge in Liquid Nitrogen the next day. 
 
Thaw cells from frozen vials in liquid nitrogen 
1. Make up 50 mL complete media for H295R cells and warm to 37°C. 
2. Thaw for 1 to 2 minutes in 37°C water bath. 
3. Spray outside of vial with ethanol. 
4. Add 9 mL of warm complete media to 15 mL conical tube. 
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5. Add thawed cells to 9 mL media in the 15 mL conical tube. 
6. Spin 125 × g for 7 minutes. 
7. Pour off media and resuspend in 1 mL warm complete culture media. 
8. Add 14 mL complete culture media to 75 cm2 flask (plain vessel with vented cap) 
9. Add cells to flask. 
10. Incubate at 37°C with 5% CO2 and ambient air. 
11. Change media every other day. 
12. Cells split every week or so. 
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 Available at: http://www.uky.edu/Ag/AnimalSciences/swine/FICS.html 
● GEPRO: Gene expression profiler for microarray data (Kim et al., 2006, FASEB 
Journal 20:Abstr. 791.7; presented as SMDP: Spreadsheet-based Microarray Data 
Platform)                                     
Available at: http://www.mc.uky.edu/cls/ko/gepro1.html 
● AA Limiting Order: A spreadsheet program for identifying the limiting amino acids 
(Cromwell and Kim, 2005, Journal of Animal Science 83 (Suppl. 1):162)  
 Available at: http://www.uky.edu/Ag/AnimalSciences/swine/AALimitingOrder.html 
 
PROFESSIONAL SERVICE        
2007 June Ad hoc Reviewer, International Journal of Dairy Science 
 
EXTENSION SERVICES            
2007 July Data administrator for National Junior Summer Spectacular (National 
Swine Registry), Louisville, KY 
2006 Aug Data administrator for Kentucky State Fair Market Hog Show, Louisville, 
KY 
2006 July Data administrator for National Junior Summer Spectacular (National 
Swine Registry), Louisville, KY 
2006 June Data administrator for Kentucky 4-H Livestock and Dairy Judging Contest, 
Lexington, KY 
2005 Nov Data administrator for Youth Market Hog Show at North American 
International Livestock Exposition, Louisville, KY 
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